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Abstract
Monitoring blood perfusion and oxygenation changes is of vital importance and for this
reason many different techniques have been developed over the decades. Photoplethys-
mography (PPG) is an optical technique that measures blood volume variations in vas-
cular tissue and it is well known for its utilisation in pulse oximetry for the estimation of
arterial blood oxygen saturation (SpO2). In pulse oximetry, mainly the pulsatile com-
ponent of the signal (AC PPG) is used while the continuous DC component is mostly
excluded. Near Infrared Spectroscopy (NIRS) is another optical technique that mea-
sures changes in the concentration of oxygenated (∆HbO2), deoxygenated (∆HHb),
and total haemoglobin (∆tHb) from the variations in light attenuations at different
wavelengths.
The main motivation of this research is to explore the capability of Photoplethysmog-
raphy in assessing tissue perfusion and oxygenation similarly as NIRS. The hypothesis
underlining this research is that the DC component of the PPG signal contains in-
formation on the overall absorbed light and this part of the PPG signal, acquired at
least two wavelengths, may be used to obtain ∆HbO2, ∆HHb, and ∆tHb as performed
in NIRS. Therefore, DC PPG attenuations may be related to haemoglobin concentra-
tions by the modified Beer-Lambert law (MBLL). In order to investigate this, novel
reflectance, custom-made PPG sensors and measurement systems, including advanced
signal processing algorithms, have been developed for the acquisition and analysis of
raw PPG signals (AC + DC) from different anatomical locations.
Three in vivo studies on healthy volunteers were carried out in order to investigate if
∆HbO2, ∆HHb, and ∆tHb estimated from PPG could indicate changes in blood per-
fusion and oxygenation. The studies consisted of vascular occlusions on the forearm,
negative bed tilting, and whole body cold exposure. Raw PPG signals were acquired
from different locations such as the forearm, fingers, and forehead, whereas simultane-
ous NIRS signals were used as a reference. The results showed that ∆HbO2, ∆HHb, and
∆tHb could be effectively estimated from PPG signals. These parameters indicated the
changes in blood volumes and/or oxygenation, whereas comparison with NIRS signals
showed good levels of correlation and trending. These promising results showed that
DC PPG signals could be used to monitor changes in blood perfusion and oxygenation,
extending the range of applications of Photoplethysmography.
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Chapter1
Introduction
Photoplethysmography (PPG) is a noninvasive optical technique that measures blood
volume changes [1]. In PPG, light is shone in tissue and the backscattered light is
measured by a photodetector. When light travels through the tissue, it is reflected,
scattered, and absorbed. In PPG, the photodetector collects the light that is absorbed
in tissue and the resulting signal represents the absorption changes due to variations
in blood volume [1]. The signal produced by the photodetector is called photoplethys-
mogram and contains information on the blood light absorption. The photoplethysmo-
gram comprises of two main components. The alternated component AC is synchronous
with the cardiac cycle and is represented by the cyclical variations in arterial blood vol-
umes [1–3]. The systole, when the arteries fill with blood, corresponds to high light
absorption, whereas during diastole, light is absorbed minimally. These alternated
variations in high and low absorption are then reflected in the signal. The second
component of the photoplethysmogram is an almost-constant DC offset. This DC com-
ponent represents the total incident light and expresses the light absorption by static
structures such as non-pulsatile arterial blood, venous blood, skin, and bones [1–3].
This DC component is represented in the photoplethysmogram as an offset on which
the AC PPG component rides on top [1].
Due to its synchronicity with the cardiac cycle, the AC PPG component has attracted
most of the interest. The component can be used to estimate heart rate, but most
importantly, it is used to calculate arterial oxygen saturation (SpO2). Since the AC
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PPG component represents arterial blood pulsations, it can be used to isolate arterial
blood from other light absorbers, and then estimate continuously SpO2 without the need
of calibrations [4, 5]. The technique is known as pulse oximetry and is performed by
shining light at two wavelengths (red and infrared) and recording the light absorption
at these two wavelengths [4]. From the spectroscopic properties of oxygenated and
deoxygenated blood, and by applying calibration curves, the SpO2 can be estimated
from the AC PPG components at two wavelengths [4–6]. Pulse oximetry has been
having a huge impact in clinical practice since it allowed to measure arterial oxygen
saturation noninvasively and continuously [3]. In this context, the AC PPG has gained
most of the attention and the DC component has not been playing any major role,
except being used for the normalization of the AC PPG in the SpO2 calculation [7, 8].
Also, the success of pulse oximetry, as an application of the AC PPG component, has
overshadowed the rest of the signal. Except this, the most significant use of the DC
PPG is the estimation of the respiration rate from the slow frequency variations of this
component [1, 9, 10].
Near Infrared Spectroscopy (NIRS) is another optical technique in which light in the
near-infrared region of the spectrum (700-1100 nm) is shone in tissues. Light in this
region of the spectrum is used in NIRS due to its high scattering and low absorption
properties, allowing a deep penetration in tissues. Light at multiple wavelengths is
shone in the tissue and the attenuation of light at this different wavelength is used to
estimate changes in the concentration of oxygenated (∆HbO2), deoxygenated (∆HHb),
and total haemoglobin (∆tHb) [11]. The modified Beer-Lambert law (MBLL) is used
in NIRS to express ∆HbO2, ∆HHb, and ∆tHb from light attenuations [11,12]. Usually,
changes in these parameters are expressed as relative changes from baseline, but abso-
lute concentrations can also be determined by Time Resolved Spectroscopy or Phase
Modulated Spectroscopy [11, 13]. If the measures of absolute concentrations are ob-
tained, the oxygenation of the tissue can be expressed as the ratio of oxygenated over
the total haemoglobin [13]. The technique provides the ability to assess changes in
tissue blood perfusion and oxygenation in vivo. This ability of the technique has at-
tracted significant interests among clinicians and researchers, and NIRS has been used
for monitoring blood perfusion and oxygenation changes in different scenarios.
As the reader could notice, PPG and NIRS share some common characteristics. Both
techniques shine light into tissue and they usually adopt similar technology for emission
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and detection of light (light emitting diodes and photodiode). PPG signals are often
used at two wavelengths for the estimation of SpO2. This requires the fast, intermittent
switching of light, as performed in NIRS for obtaining spectroscopic information on light
attenuations at different wavelengths. The main difference between the techniques is
in how the signals are processed. PPG (pulse oximetry) uses the pulsatile component
of the signals for estimation of SpO2 and uses the continuous DC for normalisation.
Contrarily, NIRS excludes any pulsatile component and uses the overall incident light
(DC) for the determination of light attenuation changes. The light attenuations are
then used to express changes in oxygenated (∆HbO2), deoxygenated (∆HHb), and
total haemoglobin (∆tHb).
1.1 Aims, objectives, and contribution of the thesis
The DC component of the PPG signal contains vital information on the overall light
absorption in tissue. Therefore, dual-wavelength DC PPGs may be used to extract
spectroscopic information on the haemoglobin content in the sampled volume. The DC
PPG is already measured in all PPG/pulse oximetry systems, and it is often acquired
at two wavelengths (red and infrared). Therefore, by taking into consideration the
different optical properties of oxygenated and deoxygenated haemoglobin, the DC PPGs
acquired at red and infrared may be used to express changes in light attenuations, and
the MBLL may be applied to extract ∆HbO2, ∆HHb, and ∆tHb.
1.1.1 Aims and objectives
The primary aim of this thesis is to investigate the feasibility of using the DC component
of the PPG signal to infer relative changes in oxygenated (∆HbO2), deoxygenated
(∆HHb), and total haemoglobin (∆tHb), and use these parameters to assess changes
in blood perfusion. In particular, it is intended to apply NIRS processing techniques
in order to extract ∆HbO2, ∆HHb, and ∆tHb from dual-wavelength PPG signals. In
order to achieve this aim, the fulfilment of the objectives listed below is required.
• Design and develop reflectance PPG sensors and couple them to a research pro-
cessing system capable of acquiring dual-wavelength and raw PPG signals (AC+DC).
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• Set up physiological measurement systems for the simultaneous acquisition of
multiple signals such as PPG and NIRS.
• Apply NIRS processing techniques such as the MBLL to extract ∆HbO2, ∆HHb,
and ∆tHb from dual-wavelength PPG signals.
• Perform in vivo studies on healthy volunteers in which changes in perfusion are
induced by different procedures (e.g. vascular occlusions, bed tilting, etc.) and
in different measurement locations (e.g. forearm, forehead, etc.).
• Apply appropriate statistical and signal processing techniques in order to evaluate
whether ∆HbO2, ∆HHb, and ∆tHb estimated from PPG were able to detect the
changes in perfusion induced and compare these changes with reference NIRS
measures (e.g. mean and standard deviation, correlation, etc.).
In addition to the primary aim, the in vivo studies mentioned above allow the investi-
gation of some secondary aims.
• Examine the simultaneous response of different noninvasive optical techniques to
vascular occlusions on the forearm. This can be performed by the acquisition of
additional physiological signals such as laser Doppler flowmetry and pulse oxime-
try, simultaneously to the PPG and NIRS measurements. Signal analysis and
statistical tests can be then used to assess the changes in several physiological
parameters during different degrees of vascular occlusions.
• Investigate whether the presence of a large vessel underneath the PPG sensor may
cause errors in the estimation of haemoglobin concentration changes by PPG.
In order to analyse this, a PPG sensor placed on top of a large vessel on the
forehead will be compared to another identical PPG sensor (reference) placed in a
vessel-free area on the forehead. Statistical comparisons between the haemoglobin
concentrations estimated from the two PPG sensors can reveal any difference in
the measurements due to the positioning of the sensor.
• Investigate any difference in perfusion between peripheral and more central lo-
cations measured by PPG and NIRS during a whole-body cold exposure study.
Such comparison can be performed by comparing the changes in PPG perfusion
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measurements between the finger and ear canal, and between NIRS perfusion
measurements at the forearm (muscle) and the head (cerebral). It is hoped that
the results may reveal whether PPG and NIRS can be used to assess blood flow
autoregulation during cold exposure.
1.1.2 Contribution of the thesis
Using the PPG/pulse oximeter signals to estimate ∆HbO2, ∆HHb, and ∆tHb could
open up to new interesting uses of the PPG. The number of parameters extracted from
the PPG signals, usually SpO2 and heart rate, can then be increased further without
the need of any additional instrumentation. Such an achievement could establish PPG
as a technique for assessing multiple parameters, such as global oxygenation through
SpO2 and regional perfusion through the measurement of ∆HbO2, ∆HHb, and ∆tHb.
At the same time, other parameters such as perfusion index and heart rate could also be
estimated from the PPG signal. This research aims to push the current limits of PPG
signal processing, which nowadays is predominately used for the measurement of SpO2.
This additional analysis of the PPG signal could offer new insights on the technique and
extend its current range of applications. Furthermore, the comparison between ∆HbO2,
∆HHb, and ∆tHb estimated by both PPG and NIRS would contribute on exploring
similarities and differences between these two techniques in different conditions and
measurement locations. Examining the effects of large vasculature on haemoglobin
concentrations by PPG (and SpO2) is complementary to the primary aim of this thesis,
as well as directly contributing to the existing body of knowledge on the placement of
PPG/pulse oximetry sensors.
The comparison of different noninvasive optical techniques during vascular occlusions
would provide a unique setting to analyse the simultaneous responses of several per-
fusion parameters measured by different modalities. Whereas some of this techniques
have been investigated alone, a similar comparison that includes NIRS, laser Doppler
flowmetry, PPG and pulse oximetry has not been previously performed and it can con-
tribute to the current knowledge on these techniques. In addition, the use of different
degrees of occlusions could provide a comparative assessment of the behaviour of these
modalities during partial vascular occlusions.
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1.2 Outline of the thesis
After introducing the aims of the thesis, this section presents the outline and contents
of the chapters in the thesis.
Chapter 2 introduces some basic principles of physiology. The composition and func-
tions of blood will be described, with a particular emphasis on haemoglobin and its
roles in the transport of oxygen. The gas exchange at the pulmonary level, between
the lungs and blood, will be explained, as well as the exchange of oxygen and carbon
dioxide at the tissue levels. The cardiovascular system will be briefly described as well.
The chapter will then conclude by describing the structure of the systemic circulation,
composed by arteries, veins, and capillaries.
Chapter 3 presents a review of techniques used to monitor blood perfusion and oxy-
genation in tissue. The chapter aims at providing an overview of the current state
of the art in techniques and technologies used in both research and clinical settings.
The principles, applications, and limitations of the different techniques will be briefly
described and discussed in this chapter.
Chapter 4 presents in more details the principles of photoplethysmography and pulse
oximetry. The description of how blood volume changes are measured in photoplethys-
mography will be described, along with the origins and composition of the signal. The
clinical applications of photoplethysmography will also be briefly introduced. The sec-
ond part of the chapter will conclude by presenting the principles and applications of
pulse oximetry.
Chapter 5 will introduce Near Infrared Spectroscopy (NIRS). The chapter will begin
by describing the physical principles used in NIRS. In particular, the modified Beer-
Lambert law will be presented as being used in NIRS to infer haemoglobin concentra-
tions changes in tissue. Different typologies of NIRS instruments such as Continuous
Wave NIRS and Spatially Resolved Spectroscopy will be briefly described. A review of
the main clinical and research applications of NIRS will be presented, and some of the
limitations will be discussed at the end of the chapter.
Chapter 6 describes the design and development of reflectance photoplethysmographic
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sensors that were used in the in vivo studies presented in this thesis. Particular atten-
tion will be given to the RPS1 sensor, which was designed to acquire PPG signals from
the forearm and forehead. The optical components selected (light emitting diodes and
photodiode) will be described, as well as the electrical and mechanical design of the
sensor. The evaluation of the sensor, along with thermal tests will also be discussed in
the chapter. The development of other versions of the reflectance PPG sensor will be
described at the end of the chapter, along with a reflectance finger PPG sensor that
was used to acquire signals from the fingers.
Chapter 7 presents the evaluation of a reflectance PPG processing system that was used
to drive the PPG sensors described in Chapter 6. This chapter reviews the functional-
ities of such PPG system, including light multiplexing (switching), current-to-voltage
conversion, and time demultiplexing. The main components of the system will be
described, along with their evaluation.
Chapter 8 describes the development of a software application to acquire physiological
signals from custom-made and commercial devices. The software application was also
developed to display in real time the acquired signals and save the measurements for
post-acquisition analysis. The second part of this chapter plays a central role in this
thesis, as it will propose the application of the modified Beer-Lambert to PPG signals
for the determination of haemoglobin concentration changes.
Chapter 9, Chapter 10, and Chapter 11 will present the in vivo studies carried out
to investigate the feasibility of using relative haemoglobin concentrations from PPG
signals to assess changes in blood perfusion and oxygenation in different physiological
settings. Chapter 9 will describe a study where changes in blood perfusion were in-
duced by different levels of vascular occlusions in the forearm. Relative haemoglobin
concentrations of oxygenated (∆HbO2), deoxygenated (∆HHb), and total haemoglobin
(∆tHb) were estimated from dual wavelength forearm PPG signals and compared with
the same parameters estimated by forearm NIRS. The settings of this study also al-
lowed investigating the simultaneous behaviour of different optical techniques during
vascular occlusions. Therefore, the second part of Chapter 9 will also present com-
parative results between different modalities such as NIRS, laser Doppler flowmetry,
photoplethysmography, and pulse oximetry during vascular occlusions.
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Chapter 10 will present the second in vivo study, consisting of a bed tilting protocol.
PPG and NIRS sensors were attached on the forehead of healthy volunteers and a bed
was tilted at -30 deg. The PPG and NIRS responses were acquired simultaneously
and the relative haemoglobin concentrations estimated by the two techniques were
compared. A second PPG sensor was placed on top of a large vein in order to analyse
the effects of large vasculature on the PPG signals.
Chapter 11 illustrates results from a whole-body cold exposure. Healthy volunteers
were exposed to a cold temperature (10 ℃) and PPG and NIRS signals were recorded
simultaneously. The relative haemoglobin concentrations from finger and ear canal
PPG were compared with forearm and forehead NIRS measurements. In addition, any
difference in perfusion between finger and ear canal was analysed by comparing the
relative haemoglobin concentrations estimated from the two PPG locations.
Finally, Chapter 12 and Chapter 13 will conclude the thesis by discussing the main
findings from the in vivo studies, the limitations, and suggestions for future work.
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Principles of Anatomy and Physiology
The human body needs oxygen to survive. Without the supply of oxygen, the cells
in our body will not be able to perform their metabolic action. The respiratory and
cardiovascular systems have the function of providing oxygen to the tissues in our body.
In this chapter, a brief overview on the anatomy and physiology relevant for this work
will be presented. In particular, the composition of blood and its main functions will
be introduced, along with the exchange and transport of oxygen and carbon dioxide
by the blood. The cardiovascular system, which composes the dense net of vessels
responsible for carrying blood in the human body, will also be described. This chapter
aims at introducing the basic principles of blood perfusion and oxygenation, but the
subjects are however vast and, for a more detailed description, the reader could refer
to anatomy and physiology textbooks such as [14–16].
2.1 Blood
Blood is a tissue in fluid form in the human body and composes around 8 % of the
total body weight [14,16]. The main function of blood is the transportation of oxygen
(O2), other nutrients, and hormones to the tissues, and the removal of waste products
(e.g. carbon dioxide, CO2) from the tissues [14–16]. The blood also plays an important
role in the maintenance of the correct levels of pH and temperature in the body and for
repairing injuries [14–16]. The work presented in this thesis focuses on measuring the
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oxygenation status of the blood in tissues, thus, a particular attention will be dedicated
to the properties and functions of the blood involved in the transport of oxygen and
CO2 in blood.
2.1.1 Blood structure and functions
Blood is a connective tissue in which living cells are dispersed in a largely water-
composed fluid called plasma [14]. Blood can be decomposed by centrifugation to
separate plasma from the living cells (or formed elements). Of the whole blood, 55 %
is composed of plasma, less than 1 % is composed of white blood cells and platelets,
and 44-45 % is composed of erythrocytes (or red blood cells) [14]. These percentages,
however, may vary depending on the gender or the health status of a subject [14]. White
blood cells mainly provide protection and immunity against infections and diseases
[14, 15], platelets prevent blood loss by repairing injuries (coagulation), and red blood
cells transport nutrients and waste products of metabolism [14,15].
Red blood cells (RBC) compose the great majority of blood cells and they are produced
in the red bone marrow [14,15]. The main function of RBCs is the transport of oxygen
to the tissues [14]. As shown in Figure 2.1, RBC have a biconcave shape (diameter of
7-8 µm), which increases the surface available for carrying oxygen molecules [14]. Also,
red blood cells can carry the CO2 produced by tissues after utilising the oxygen. Due to
the absence of a nucleus, the RBCs have a low metabolic activity [14]. One of the main
properties of the red blood cells is their colour appearance when they are bounded to O2
or CO2. Arterial blood, rich in O2, has a bright red colour, whereas venous blood, with
poor O2 content, presents a dark red colour [15]. This physical property is exploited in
several measuring techniques such as pulse oximetry and near infrared spectroscopy for
the determination of blood oxygenation. Red blood cells transport oxygen or carbon
dioxide by the haemoglobin, a protein with high gas-bounding capacity [15].
2.1.2 Haemoglobin and haemoglobin derivatives
Haemoglobin is a protein present in most vertebrates, which gives the red blood cells
the ability to transport oxygen. Each haemoglobin molecule is composed of a globin
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Figure 2.1: Red blood cell’s shape (a), haemoglobin molecule (b), and haeme (c). The red blood cell presents
a biconcave shape with a diameter of 7-8 µm. The haemoglobin molecule has two α chains and two β chains.
Each chain is bound to a single haeme. The haeme has an iron ion in the centre dedicated to binding with the
oxygen molecule. Figure reproduced from [14].
protein, which comprises of four polypeptide chains (two α chain and two β chain)
[14,17]. To each of these chains, a non-protein pigment called haeme, is bonded. Each
haeme has an iron ion at the centre, which is responsible for binding to a single oxygen
molecule [14, 15]. Then, the overall haemoglobin molecule contains four iron ions with
an overall capacity to bind four oxygen molecules to each haemoglobin molecule [14].
Figure 2.1 illustrates the structure of a haemoglobin molecule. When gas exchange
takes place in the lungs, the iron ions bind with an oxygen molecule and, after being
transported by the red blood cells, oxygen will be released in the tissue through the
systemic capillaries [14, 15]. When the oxygen is released, the haemoglobin molecule
is able to collect part of the CO2 produced by the tissue by amino-acids in the globin
part of the haemoglobin molecule, while the majority of CO2 is transported in blood
by dissolving in the plasma [14, 15]. The CO2 is then released in the lungs, where it
will be expelled by exhalation [14].
Haemoglobin is present in human blood in different forms, defined as haemoglobin
derivatives [17]. The most common haemoglobin derivatives are oxyhaemoglobin and
deoxyhaemoglobin (or oxygenated and deoxygenated haemoglobin) [17]. Oxyhaemoglobin
is a haemoglobin molecule bonded with oxygen, whereas the deoxyhaemoglobin is not
bonded to oxygen [17]. Usually, these are the only forms of haemoglobin present in
the human blood and they alternate each other in the transport of O2 and CO2 to
and from the tissues. Haemoglobin derivatives which have lost the capacity to bind
with oxygen are defined as dyshaemoglobins [17]. An example of dyshaemoglobin is
carboxyhaemoglobin, in which the iron ion has reversibly bound with carbon monox-
ide [17].
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The haemoglobin is also responsible for regulation of the blood flow. When in certain
situation nitric oxide (NO) is produced by the vessel’s endothelium, it binds with
haemoglobin. If the tissue requires more oxygen than what is supplied by the blood flow,
NO is released, causing vasodilation of the capillaries [14]. This dilation mechanism
enhances the amount of blood (oxygen) delivered to the tissue [14]. For instance, when
blood flow is restricted by vascular occlusion, capillaries vasodilate and, as soon as flow
is restored, an abnormal (hyperaemic) blood flow takes place [18].
2.1.3 The respiratory system and gas exchange
2.1.4 The respiratory system
The respiratory system is the structure in human body involved in the transport of
oxygen into the lungs and in the exchange of oxygen from the lungs into the blood.
The functions of the respiratory system can be divided in pulmonary ventilation and
respiration. Pulmonary ventilation, divided in inhalation and exhalation, is the me-
chanical process of moving air in and out of the lungs. The respiration, which is the
exchange of oxygen and carbon dioxide between lungs and blood, takes place in the
alveoli inside the lungs.
The respiratory system, divided by upper and lower respiratory system, is composed of
nasal cavity, oral cavity, pharynx, larynx, trachea, bronchi, lungs, and alveoli [14]. The
principal functions of these structures are the filtration, humidification, and direction of
air into the lungs. The lungs are organs placed in the thorax cavity and are responsible
for the gas exchange with blood. Inhalation is an active action in which the thorax
cavity expands and, by the lower pressure created in the lungs, air fills into the lungs
[14]. During exhalation, which is a passive movement created by the relaxation of the
muscles involved in the ventilation, air is expelled from the lungs [14] .
Inside the lungs, small balloon-shape structures called alveoli collect the inhaled air.
Several alveoli are grouped in a structure called alveolar sac, in which the alveolus
share the same air conduit [14]. Around each alveolar sac, there is a dense net of blood
vessels called pulmonary capillaries, where the exchange of gases between the air in
the alveolus and the blood in these capillaries takes place [14]. The regions between
12
2.1. Blood
(a) (b)
Figure 2.2: Structure of the alveoli inside the lungs and diffusion of gases between air in the alveoli and red
blood cells through the respiratory membrane. (a) Inside the lungs, alveoli are grouped in alveolar sacs. The
alveolar sacs are surrounded by a dense net of pulmonary capillaries where gas exchange between air and blood
takes place. Figure reproduced from [14] (b) The gases diffuse through the respiratory membrane, dividing the
alveolus and the capillaries. Oxygen (O2) diffuses from the alveolus into the capillaries blood, where it binds
to the red blood cells (RBCs). RBCs release carbon dioxide (CO2) inside the alveolus, where it is expelled by
exhalation. Figure reproduced from [20].
the pulmonary capillaries and the alveolus walls constitute the respiratory membrane,
across which O2 and CO2 are exchanged [14, 15]. Figure 2.2a shows the structure of
the alveoli and the pulmonary capillaries, which surround each alveolar sac.
2.1.5 Gas exchange
As mentioned earlier, the exchange of gases (i.e. O2 and CO2) between air and blood
takes place between the alveoli and the pulmonary capillaries surrounding them. This
exchange of gases is controlled by the diffusion law (or Fick’s law) [19]. This states
that the rate of diffusion of a gas through a barrier is directly proportional to the
concentration of the gas and inversely proportional to the area of the barrier [19].
Considering that the concentration, or solubility of a gas in a solution, is directly
proportional to the partial pressure of the gas (i.e. the partial pressure is defined
as the pressure at which a gas is present in a solution) [14], gases will diffuse from
solutions in which they are present in high partial pressure to solutions at lower partial
pressures [14, 15]. The large number of alveolus in the lungs (i.e. 300 million) [14]
increases the area of the alveolar barrier (respiratory membrane), increasing further
the rate of diffusion [19].
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The exchange of gases inside the lungs is called external respiration [14, 15]. The pul-
monary capillaries receive the deoxygenated blood from the venous circulation, which
collects deoxygenated blood from the tissues after these have extracted the oxygen
required for their metabolism [14,15]. Therefore, this blood has a low O2 content (pre-
viously extracted by the tissues) and a high CO2 content ( a waste product of cellular
metabolism) [14, 15]. When deoxygenated blood reaches the alveolus, the CO2, which
is in higher concentration (partial pressure) in the blood compared to the alveolus,
diffuses inside the alveolus through the respiratory membrane [14,15]. Simultaneously,
O2, which is present in higher concentration (partial pressure) in the lungs compared
to deoxygenated blood, diffuses into the blood. This exchange of O2 and CO2, between
alveolar air and the blood in the pulmonary capillaries, is represented in Figure 2.2b.
After this exchange, the blood exiting the pulmonary capillaries has a high O2 and a
lower CO2 content [14, 15] and it is directed to the left side of the heart, which will
push it towards the tissues by the arterial circulation [14].
A similar, but reversed process takes place in the systemic capillaries at the tissue level
and it is defined as internal respiration [14]. Arterial blood entering the systemic capil-
laries is rich in O2 and has a low CO2 content [14,15]. Across the systemic capillaries,
the tissues have low O2 and a high CO2 concentration because the tissues’ cells contin-
uously use O2 for their metabolism and they produce CO2 as a waste product [14,15].
When arterial blood reaches the systemic capillaries, O2 diffuses from the capillaries
into the interstitial fluid and then it reaches the cells. At the same time, CO2 diffuses
from the tissue into the capillaries’ blood [14, 15]. Once this exchange takes place,
blood with high CO2 and low O2 content enters the venous circulation when it will be
redirected to the right side of the heart, where it will be pushed towards the lungs.
Figure 2.3 shows a diagram of the internal and external respiration cycle in the body.
2.1.6 Oxyhaemoglobin dissociation curve
Haemoglobin binds with oxygen in the pulmonary capillaries and releases oxygen to
the tissue at the systemic capillaries. The haemoglobin’s ability of binding with oxygen
molecules is directly controlled by the partial pressure of oxygen in solution (PO2) [14].
In the presence of high PO2, haemoglobin is fully bonded with oxygen (i.e. fully
saturated or high saturation), whereas a low PO2 causes the haemoglobin to be only
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Figure 2.3: Cycle of internal and external respiration. After the gases exchange in the alveoli, the blood
with high oxygen (O2) partial pressure (and low carbon dioxide (CO2)) is directed to the heart. The left
side of the heart pushes the oxygenated blood through the tissues by the arterial circulation (in red). In the
systemic capillaries, the tissues extract the O2 for their metabolism and release CO2 as a waste product. The
deoxygenated blood (low O2 and high CO2) is redirected towards the heart by the venous circulation (in blue).
The right side of the heart pushes the deoxygenated blood towards the lungs, where it will be oxygenated again
and CO2 will be removed by exhalation. Figure reproduced from [14]
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Figure 2.4: Oxygen-haemoglobin dissociation curve. At high oxygen partial pressure (PO2), the haemoglobin
is highly saturated, while at low PO2, the haemoglobin is partially saturated. Arterial blood, with a high
PO2 is fully saturated (≈ 100 %), whereas deoxygenated venous blood, at lower PO2, is partially saturated
(≈ 75 %). When the tissue (muscle) is contracting, more oxygen is consumed, with a further decrease in PO2
and saturation. Figure reproduced from [14]
partially bonded with oxygen (i.e. low saturation) [14]. This relationship is described
by the oxygen-haemoglobin dissociation curve as showed in Figure 2.4.
In the pulmonary capillaries, where oxygen is present in high PO2, the haemoglobin
binds easily with oxygen and is fully (or almost entirely) saturated (≈ 100 % saturated).
In the systemic capillaries, the PO2 is lower, causing the haemoglobin to not hold the
oxygen, and easily releasing it to the tissues by diffusion [14]. In the arteries, the PO2
is high and the haemoglobin is fully saturated (≈ 100 % saturation), whereas, in the
venous circulation, after oxygen has been released to the tissue, PO2 drops to around
40 mmHg, creating a lower saturation (≈ 75 %) [14]. This means that, in normal
conditions, approximately 25 % of oxygen transported by the haemoglobin is actually
released and used by the tissue [14].
Certain factors affect the relationship between PO2 and haemoglobin saturation (or
oxygen-haemoglobin affinity). Temperature, pH (acidity), and partial pressure of CO2
(PCO2) can vary how haemoglobin binds with oxygen, shifting the oxygen-haemoglobin
curve [14]. A higher pH, lower blood PCO2, or lower temperature can shift the curve to
the left, with an increased oxygen-haemoglobin affinity. On the other side, a lower pH,
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higher PCO2, or higher temperature decrease the oxygen-haemoglobin affinity, shifting
the curve to the right [14].
2.2 The Cardiovascular System
The cardiovascular system is the dense net of vessels responsible for transporting nutri-
ents and waste products (e.g. O2 and CO2) inside the body. The right side of the heart
pushes deoxygenated blood towards the lungs for gas exchange, whereas the left side of
the heart pushes oxygenated blood towards the tissues for the extraction of nutrients
in the systemic capillaries. A complex system of tubes (blood vessels) connects the
heart, tissues, and lungs, with the aim of transporting the blood (systemic circulation).
Figure 2.5 schematically illustrates the structure of the systemic circulation, where the
arteries, veins, and the previously introduced systemic capillaries are the main com-
ponents. The following sections describe the structure and functions of arteries, veins
and systemic capillaries.
2.2.1 The arterial circulation
Arteries are responsible for transporting and distributing oxygenated blood from the
heart to the tissues [14]. Arteries branch from the left side of the heart (left ventricle)
and divide into elastic and muscular arteries. Figure 2.6 shows the major arteries of
the human body and how they branch from the heart to the tissues. Elastic arteries, as
implied by the name, are elastic vessels that, due to their thin walls composed of elastic
fibres, have the ability to stretch. Elastic arteries (also known as conducting arteries)
are the largest arteries in the human body and are also the first arteries branching from
the heart (e.g. aorta and pulmonary track) [14]. Their elastic structure allows to resist
to the high blood pressure at the heart’s exits and to propel the blood forward towards
the tissues. The initial pressure necessary to move the blood is provided by the left
ventricle’s pressure, whereas the elastic arteries, by stretching and recoiling, give the
necessary inertia for the blood to move onwards [14].
Elastic arteries branch to medium-sized, more muscular arteries also known as muscular
arteries [14]. Muscular arteries continue to branch towards the tissues (or organs)
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Figure 2.5: The systemic circulation. The newly oxygenated blood from the pulmonary capillaries reaches
the left side of the heart, where it is pushed towards the tissues. The arteries (in red colour) transport the
oxygenated blood to the systemic capillaries, where oxygen is released in the tissues. The veins (in blue colour)
transport the deoxygenated blood back to the right side of the heart, where it is pushed towards the lungs for
being oxygenated again. Figure reproduced from [14].
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and their wall can be relatively thick since it is composed of smooth muscle. This
muscular structure gives the ability to vasodilate (increase diameter) or vasoconstrict
(decrease diameter) [14]. Muscular arteries, also called distributing arteries, are present
in different sizes down to 0.5 mm, and the lack of elastic fibres prevent them to recoil
as the elastic arteries [14]. Vasodilation and vasoconstriction of muscular arteries are
controlled by stimulation of the sympathetic fibres innervating the smooth muscles of
the vessels. An increased sympathetic stimulation initiates vasoconstriction, whereas a
decreased stimulation causes vasodilation [14].
Figure 2.6: Major systemic arteries in the human body. Figure reproduced from [15].
19
2.2. The Cardiovascular System
2.2.2 The capillaries
Arteries have the main function of conducting blood from the heart to the systemic
capillaries, where the extraction of oxygen from the tissues takes place.
Arteries connect to the capillaries through small blood vessels called arterioles. By
contracting or dilating, the arterioles regulates blood flow to the capillaries (blood flow
is also controlled by pre-capillary sphincters) [14–16]. The contraction/dilation of the
arterioles directly acts on the vascular resistance and the consequent blood pressure (i.e.
increase in vascular resistance cause an increase in blood pressure, whereas a decrease
in vascular resistance make the blood pressure to drop) [14].
After passing through the arterioles, the oxygenated blood from the arteries enters the
systemic capillaries [14,15]. Capillaries are the smallest blood vessels in the body, they
have a thin wall for diffusion of substances through it, and they connect the arterial
inflow to the venous outflow (see Figure 2.5). As shown in Figure 2.7, each systemic (or
tissue) capillary bed is composed of a net of capillaries which ramifies from arterioles
to venules. This dense net of vessels increases the surface available for the diffusion of
oxygen into the tissues and it can be more extensive for tissues with a higher metabolic
demand [14,15].
Different types of capillaries are present in the human body and they vary in the
vessel’s structure and their location [14, 15]. The blood flow through the capillaries is
not only mechanically regulated by pre-capillaries sphincters and arterioles, but it is
also regulated by endothelial chemical substances (e.g. nitric oxide, NO) that control
the vasodilation or vasoconstriction of capillaries [14].The blood flow in the extensive
capillaries net is also known as microcirculation [14]. The exchange of nutrients between
blood and tissues takes place by diffusion, as explained in subsection 2.1.5. After the
exchange of nutrients and waste products between capillaries blood and tissues, the
deoxygenated blood enters the venous circulation (venules and veins) in order to be
transported back to the heart [14,15].
20
2.2. The Cardiovascular System
Figure 2.7: Schematic illustration on the succession of arteries, arterioles, capillaries, venules and veins. Figure
reproduced from [16].
2.2.3 The venous circulation
After the exchange of O2 and CO2 in the capillaries, deoxygenated blood moves towards
the venous circulation. Before entering the veins, blood from capillaries passes through
intermediate vessels known as venules [14]. As showed in Figure 2.7, venules are tiny
vessels and are also called post-capillary venules. These blood vessels are involved in
the exchange of nutrients and white cell migrations, thus playing an effective part in
the functions of the microcirculation [14].
Venules continue to enlarge until reaching the veins. Veins are large vessels transporting
the blood back to the right side of the heart. Figure 2.8 shows the major systemic veins
present in the human body. Like arteries, veins are not involved in the exchange of
nutrients between blood and tissues. Veins are composed of thinner walls compared
to arteries, they are extensible, but they cannot support high blood pressures like the
arteries (venous blood pressure is significantly lower than arterial pressure) [14]. Veins
usually accompany arteries, but often more than one vein is paired to each artery [14].
The return of blood to the heart through the veins is a passive action. Return of blood
is achieved by the heart’s action, contraction of limb muscles, and the negative pressure
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created in the thoracic cavity during ventilation [14]. Back-flow of blood towards the
capillaries is controlled by valves inside the veins, which allows the blood to move in
the heart’s direction while preventing the blood from flowing in the opposite direction
due to gravity [14,15]. The greatest amount of blood at any given time (approximately
64 %) is in the venous circulation, making this part of the circulation to act as a blood
Figure 2.8: Major systemic veins in the human body. Figure reproduced from [15].
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reservoir for the redirection of blood in situations when tissues demand higher blood
flows (e.g. exercise or haemorrhage) [14,15].
2.3 Summary
In this chapter, a brief overview of the anatomy and physiology related to this work
was presented. The structure of blood and its functions as a carrier of nutrients such
as oxygen have been described, with a particular focus to the role of red blood cells
and haemoglobin in the transport of oxygen and the removal of carbon dioxide from
tissues. Also, the process of exchange of oxygen and carbon dioxide in the lungs and
tissues (lungs-blood and blood-tissues) has been briefly introduced. The cardiovascular
system has been presented as the group of blood vessels (arteries, capillaries and veins)
responsible for transporting blood to tissues and releasing the necessary nutrients to the
tissues in the body. The concepts introduced in this chapter should form the necessary
basis of anatomy and physiology for the following chapters, where technologies and
techniques for measuring blood flow, blood volumes, and blood oxygenation will be
presented.
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Chapter3
Review on noninvasive techniques for the
in vivo monitoring of blood perfusion and
oxygenation
As described in the previous chapter, blood carries oxygen and nutrients to the tis-
sues for their functioning. Therefore, monitoring of blood perfusion and oxygenation
in tissues is of vital importance in clinical practice, and over the last decades, several
techniques have been developed for the noninvasive assessment of these parameters. In
this chapter, an overview of some techniques used for in vivo monitoring of blood per-
fusion and oxygenation will be presented. Techniques such as Laser Doppler flowmetry,
Ultrasound Doppler or traditional clinical assessments will be introduced in the follow-
ing sections of this chapter. Each of the techniques presented in this chapter occupies
extensive branches of clinical monitoring, but their fundamental principles, measured
parameters, and main applications will be briefly described in order to illustrate the
current state of the art in the noninvasive monitoring of blood perfusion and oxygena-
tion. Photoplethysmography and Near Infrared Spectroscopy will be presented in this
chapter as well, but they will be explored in more depth in Chapter 4 and Chapter 5.
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3.1 Photoplethysmography & Pulse Oximetry
Photoplethysmography (PPG) is a noninvasive optical technique used to measure blood
volume changes and forms the basis of pulse oximetry [3]. PPG exploits the light ab-
sorption properties of tissues when light is emitted in a tissue and it will be described
in details in Chapter 4. The light emitted in PPG is absorbed by structures within
the tissue and the backscattered and absorbed light is detected by a photodetector.
Moving structures within the tissue generate an intermittent absorption, while static
components will cause a relatively constant absorption. The detected light in PPG is
therefore composed of an alternated component (AC) and a constant component (DC).
The AC component represents the arterial blood, which changes volume in synchrony
with the cardiac cycle (systole and diastole) [1, 2, 9]. The DC component is result-
ing from the constant light absorption of static structures such as venous blood and
surrounding tissue [1, 3, 9].
An example of this signal is illustrated in Figure 3.1, with AC and DC PPG signals,
at both red and infrared wavelengths, acquired from the finger of a healthy volun-
teer. From this figure, the two components of the signal can be distinguished, with the
DC component being the slowly varying part of the signal (offset) and the AC PPG
overriding on top. The two components can then be separated by appropriate filter-
ing. The PPG signal has found many applications such as heart rate and respiration
estimation [1,9], but the main application of the technique remains pulse oximetry [1].
Pulse oximetry is a technique used to monitor noninvasively and continuously arterial
blood oxygen saturation (SpO2) [3, 4]. The technique exploits the optical absorption
properties of oxygenated and deoxygenated blood and the PPG signal [4]. When PPG
signals can be acquired at two wavelengths (red and infrared), the relationship be-
tween the signal amplitudes at red and infrared is directly proportional to the arterial
oxygen saturation [4]. By applying calibration curves extracted from healthy volun-
teers, the SpO2 expressed in percentage can be estimated from the red and infrared
PPG signals [3]. Since its first implementation in the 70’s, pulse oximetry has revo-
lutionised medicine by providing continuous and noninvasive measurement of arterial
saturation [1, 4]. The technique is currently used in many clinical settings and it is a
mandatory instrument during induction of anaesthesia [1, 3, 4].
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Figure 3.1: Red and infrared PPG signals acquired from the index finger of a healthy volunteer. (a) and (b)
are respectively the infrared (black trace) and red (red trace) raw PPG signals (AC+DC). A small pulsatile AC
PPG component is superimposed on a slowly varying DC PPG component. The DC component, representing the
general light absorption by the tissue, is higher in the infrared wavelength than the red (greater light absorption
by the red wavelength). (c) shows the same signals filtered and inverted. The DC component has been filtered
out and only the red and infrared AC PPGs (red and black trace respectively) are plotted against each other.
From the signals in (c), the arterial oxygen saturation (SpO2) can be estimated.
As mentioned above, photoplethysmography will be the core of the research work pre-
sented in this thesis. For this reason, a more detailed description of the technique will
be provided in the next chapter, where the principles and applications of photoplethys-
mography and pulse oximetry will be provided.
3.2 Near Infrared Spectroscopy
Near Infrared Spectroscopy (NIRS) is an optical technique used for the noninvasive
and continuous monitoring of perfusion and oxygenation in tissues. In NIRS, near
infrared light is shone into tissues and the changes in light absorption are used to infer
relative changes in oxygenated (HbO2) and deoxygenated haemoglobin (HHb). Near
infrared light (700-1000 nm) is used in NIRS due to low absorption and high scattering
properties of light in this part of the spectrum, causing the light to penetrate deep into
tissues [12,21–23].
NIRS bases its principles on the Beer-Lambert Law (BLL) and it will be further de-
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Figure 3.2: Cerebral near infrared spectroscopy measurement. Near-infrared light is emitted transcutaneously
into the brain, passing through the skull. Light undergoes absorption and scattering before being detected
by a photodetector. The detection probe collects spectral information from the superficial cerebral tissue and
transforms it into haemoglobin concentration changes and cerebral oxygen saturation. Figure reproduced from
[24].
scribed in Chapter 5. Briefly, the BLL correlates the changes in light attenuations
to the concentrations of chromophores (i.e. light absorbing structures) present in the
solution [11,12,24]. Therefore, by applying light into a solution (tissue) and observing
the changes in light attenuations, the changes in concentrations of the chromophores
present in the tissue can be determined [11]. By assuming that the only chromophores
changing concentration in tissue are HbO2 and HHb, and assuming constant scattering,
changes in HbO2 and HHb concentrations can be estimated from the light attenuations
detected by a photodetector [11, 24]. For the estimation of HbO2 and HHb, a system
of at least two equations should be solved. By applying near infrared light at least two
different wavelengths, the BLL can be solved for HbO2 and HHb [11,24]. This method,
however, only estimates relative changes in concentrations from a baseline, whereas,
for the estimation of absolute concentrations, the pathlength travelled by light or the
absorption and scattering characteristics of the tissue should be known [11,12,22–24] .
Techniques such as Time Resolved Spectroscopy or Phase Resolved Spectroscopy allow
the estimation of absolute concentrations of HbO2 and HHb and they will be described
later in Chapter 5. Once absolute concentrations of HbO2 and HHb are determined, or
by applying other computational techniques, an oxygenation index can be calculated
from the ratio HbO2 / HbO2 + HHb [11–13,24].
Due to the high penetration depth reached by NIRS in tissues and the relative trans-
parency of bones (e.g. skull) to the near infrared light, the technique has been exten-
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sively applied to monitor perfusion and oxygenation changes in the brain [12, 13]. An
example of cerebral NIRS measurement is depicted in Figure 3.2. NIRS has also been
widely used to study muscles’ metabolism during rest and during exercise [13,24]. The
technique is continuously attracting interest for its ability to monitor organs’ perfu-
sion and oxygenation and some of the technique’s applications are shock and trauma
medicine [25], surgery [22, 25], flap monitoring [26, 27], splanchnic perfusion monitor-
ing [22], as well as mapping of the brain (imaging) [24] and brain functional studies.
3.3 Laser Doppler Flowmetry
Laser Doppler Flowmetry (LDF) is an optical technique used for the noninvasive mea-
surement of blood flow in skin and organs. The technique’s name originates from the
Doppler shift, which relates the change in frequency of electromagnetic waves after
they have interacted with a moving object [28]. When light is emitted into a tissue, the
photons undergo reflection and scattering after interacting within the tissue’s struc-
ture; but when light hits a moving object such as a red blood cell, a shift in frequency
(Doppler shift) between the emitted and detected light appears [28, 29]. This shift in
frequency is directly related to the speed of the moving object [28, 29] and the general
relationship between the shift in frequency and the speed is described by Equation 3.1.
∆f = fe − fd = 2v · sinα
λ
(3.1)
Where fe is the emitted frequency, fd is the detected frequency, v is the velocity (speed)
of the moving object, α is the angle between the light beam and the normal to the
object’s direction of motion, and λ is the wavelength of the light beam. For this to
hold, the light source is considered stationary with respect to the moving object.
When light is shone into a tissue (microcirculation), the interaction between light and
moving red blood cells causes a Doppler shift in the detected light [28–30]. However, in
real situations, photons in tissues undergo more than one scattering event and multiple
shifts in frequency, with a resulting shift in frequency being the linear sum of the single
shifts [29].
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Figure 3.3: Doppler shift occurring in laser Doppler flowmetry. The transmitted light inside the tissue reflects
onto red blood cells in the blood vessels. Interaction with red blood cells causes a Doppler shift in the reflected
light. A portion of the light that does not interact with moving objects is reflected without being Doppler-shifted.
Figure reproduced from [28].
In order to be able to detect the shift in frequency between emitted and detected
light, a monochromatic and coherent light source such as a laser light beam is used
in LDF measurements. Laser light is used as it is centred to a specific wavelength λ
(monochromatic), is a coherent light beam, and it can be emitted at a specific frequency
[28]. Once the light beam enters a tissue, photons are scattered by both stationary
objects (e.g. skin, tissues, and vessels) and moving objects (blood cells) [28–30]. As
shown in Figure 3.3, reflection of light on stationary objects does not create a shift in
frequency in the reflected light, whereas light interaction with moving objects (red blood
cells) generates a frequency shift in the reflected light. When the reflected light beams,
at both shifted and non-shifted frequencies, impinge on the photodetector, they create
a beat in frequency [28–30]. Laser Doppler instruments process these beats in frequency
to have an estimation of red blood cells velocity [28]. This generated beat, however, is
the combination of the frequency shifts generated by objects moving in all directions,
making impossible to distinguish the direction of motion [30]. Different techniques may
be used to process this beat in frequency, but all of them generate a voltage signal, which
is usually transformed to a unit-less parameter known as Flux [28, 29]. As described
in (Equation 3.2), the Flux is directly proportional to the product of red blood cells’
concentration ([RBC]) and the red blood cells’ velocity (vRBC) [28–30].
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Figure 3.4: Montecarlo simulation of the spatial distribution of laser Doppler flowmetry measurements. Mea-
surement depth (0.39 mm) and volume (0.23 mm3) are marked respectively with horizontal and hemispheric
dotted lines. Fibres separation distance was set at 0.25 mm, whereas the emission wavelength was 780 nm.
Figure reproduced from [33].
Flux ≈ [RBC]× vRBC (3.2)
Laser light sources (helium-neon gas or laser diodes) are adopted along with optic fibres
to transport the light to the surface of the tissue [30,31]. Very close to the emitting fibre
(usually less than 1 mm apart), another fibre is deployed to transport the backscattered
light to a photodetector, which will convert the detected light into a voltage signal for
being processed [28,30]. This signal from the photodetector contains an alternated (AC)
and a stationary (DC) component. The AC component contains frequency information
generated from the interaction with moving objects (frequency shift), whereas the DC
component represents the light attenuation from non-moving structures [30]. Both AC
and DC are processed by the instrumentation for extracting information on RBCs’
flow and unwanted noise [30]. The wavelength of the emitted laser beam is usually
selected between the red and near-infrared part of the spectrum [28–31], in order to
increase the sensitivity of the instrument to red blood cells’ motion over other moving
objects (e.g. white blood cells) [29]. LDF measurements do not penetrate tissues
in depth and they typically interrogate a limited part of the superficial anatomical
regions, with a penetration depth between 1 and 2 mm [28, 30, 31]. This penetration
depth is dependent on the type of tissue, the specific light wavelength used and the
emitter-detector separation distance [28, 30–33]. Figure 3.4 illustrates an example of
Montecarlo simulation of the spatial distribution (penetration depth and volume) of an
LDF measurement.
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Laser Doppler flowmetry has found a multitude of applications for the noninvasive
monitoring of blood flow. The main application of LDF is the continuous monitoring
of skin blood flow changes and the assessment of the status of the microcirculation
by analysing the response to a vascular occlusion [31, 34]. Among the numerous ap-
plications, the technique has been used for diagnosis of peripheral arterial or venous
disorders [31, 34], flaps and grafts monitoring [28, 31, 35, 36], assessment of endothelial
function [34], skin diseases and tumours [28], skin ulcers and burns [28]. LDF has also
been investigated for the measure of changes in blood flow directly from organs such
as the brain [37,38] and the liver [39].
Although it has been widely used for monitoring blood flow in different settings, Laser
Doppler flowmetry suffers from some limitations. The estimated Flux is presented in
arbitrary units, it is not predictable nor reproducible [28, 29], and it has an inter- and
intra-subject variability [29]. Therefore, the users should observe the results as changes
from a baseline (trends) rather than absolute values of Flux [29, 36]. LDF does not
provide an indication of the direction of motion [30] and there is no actual knowledge of
the penetration depth [29,40]. The technique is also considerably sensitive to minimum
pressures applied on the sensor [40] or to movement artefacts [28,29,40]. Finally, laser
Doppler measurements do not have an absolute zero, because of the residual signal
(biological zero) that is measured even after complete occlusion of arterial and venous
circulation [28,29]. It was also previously reported that LDF measurements alone may
not be sufficient for distinguishing between venous and arterial occlusions [36,41].
3.4 Ultrasound Doppler Flowmetry
The Doppler effect introduced in Section 3.3 is not used with laser light only, but
it can be applied to ultrasound waves as well. Ultrasound Doppler flowmetry is a
noninvasive technique, which applies the Doppler principle to ultrasound waves for the
measurement of blood flow. Sound waves are mechanical waves that propagate trough a
medium such as air, liquid or tissue, and are usually known for constructing sounds like
voices or music [42]. Sound waves propagate through a medium in a certain frequency
and waves propagating at a frequency between 20 Hz to 20 kHz can be detectable by
the human ear [42]. Ultrasound waves used for medical application have propagating
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frequencies comprised between 2 MHz and 40 MHz [42], thus far beyond the audible
range of the human ear. Ultrasound waves are used in medical applications for their
ability to propagate through tissues noninvasively and for the capability of providing
information from their interaction with structures within the tissues.
When ultrasound waves are emitted in tissue, they undergo reflection with stationary
objects, whereas a Doppler shift in frequency is generated from the interaction with
moving structures such as blood. Reflection is created when the waves travelling in
the medium interact with a second medium with different acoustic characteristics [42].
Part of the original wave is reflected backwards, while a portion continues to diffuse
through the second medium. This principle is used in ultrasound imaging techniques,
but is rather discarded in ultrasound Doppler flowmetry, which processes the shift in
frequency for assessing blood flow [42]. Similarly to laser Doppler flowmetry, the change
in frequency in the detected sound wave is proportional to the velocity of the moving
object and their relationship is described by Equation 3.3 [42].
∆f = fd − fe = 2fev cos θ
c
(3.3)
Where ∆f is the shift in frequency, fd is the detected shifted frequency, fe is the original
emitted frequency, v is the velocity of the moving object, θ is the angle between the
sensor and the direction of motion, and c is the speed of sound in the medium [42]. The
Doppler effect of ultrasound waves for motion of blood in a vessel is also graphically
depicted in Figure 3.5a. Differently from light beams, ultrasound waves are able to
maintain their directionality. Therefore, changes in frequency detected yield the direc-
tion of motion, with a positive shift if the object is moving towards the sensor and a
negative shift in case the object is moving away [42]. Thus, the technique is able to
provide information on blood flow moving towards the sensor (forward flow) and flow
moving away from the sensor (reverse flow) [42]. In ultrasound Doppler flowmetry,
the Doppler shift is then used to infer a flow signal (spectral Doppler) which will be
proportional to the velocity and direction of blood’s motion. Figure 3.5b shows an
example of ultrasound Doppler readings (spectral Doppler) acquired from the radial
artery of a healthy subject. If the angle θ at which the sensor is held (with respect to
the direction of blood flow) is known, the blood velocity can also be estimated from
the spectral Doppler signal by solving Equation 3.3 [42].
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Figure 3.5: Doppler shift of ultrasound wave propagating in tissue and ultrasound Doppler measurement from
the radial artery of a healthy subject. (a) A sensor, inclined with an angle θ, emits ultrasound waves into a
tissue. The emitted ultrasound waves impinge on the moving blood in the vessel and, after experiencing Doppler
shift, the reflected waves return to the sensor. (b) Ultrasound Doppler measurements acquired from the radial
artery of a healthy subject. The forward flow (black trace) generates a positive Doppler shift, while a smaller
reverse flow (grey trace) is noticed from the negative Doppler shift. The sensor was held opposite to the direction
of blood movement as in (a).
Ultrasound Doppler flowmetry sensors have limited dimensions and they can be easily
held by the examiner. The sensors usually comprise of both emitting and detecting
elements. Ultrasound waves are generated and detected by plates composed of a piezo-
electric material. Piezoelectric materials produce mechanical vibrations proportional
to the intensity and frequency of the voltage at which they are supplied and, inversely,
generate a proportional voltage when mechanically strained [43]. The detecting element
transforms the reflected waves into voltages in order to be processed by the instrumen-
tation [42,43]. Emission and detection can be performed by the same piezoelectric plate
in pulsed waves ultrasound Doppler flowmetry [42].
Ultrasound Doppler is widely used for the measurement of blood flow and velocity in
arteries and veins [42], as well as for the diagnosis of vascular pathologies [42]. Hand-
held and implantable Doppler sensors are often used to monitor flaps perfusion [36,44],
whereas transcranial Doppler systems can be used to monitor cerebrovascular blood
flow [45].
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3.5 Transcutaneous PO2 and PCO2
As previously mentioned in subsection 2.1.6, the partial pressures of oxygen (PO2)
and carbon dioxide (PCO2) play an important role in the ability of haemoglobin in
transporting oxygen to tissue. Therefore, monitoring the PO2 and PCO2 can provide
an indication of the quality of oxygen delivery to tissues. The noninvasive monitoring
of PO2 and PCO2 can be performed by Clark’s electrodes. These PO2/PCO2 sensors
are based on the property of noble metals, which reduce when they enter into contact
with oxygen [43, 46]. The electrodes are composed by an anode (reference) and a
cathode, which reduce and oxidise when in contact with oxygen, generating a current
proportional to the concentration of oxygen [43, 46]. Both the anode and cathode are
placed behind a permeable membrane, which filtrates oxygen from the high-pressure
environment (skin) to the zero pressure environment (membrane) [43, 46]. The same
principle is used for measuring PCO2 as well [34]. Clark’s electrodes can be in form
of a needle or transcutaneous (surface) sensors [34, 46]. In the first configuration,
the electrode is inserted through the skin, while in the latter the sensor is placed
transcutaneously on the skin’s surface [34, 46]. When placed transcutaneously, the
sensor heats the skin to 43-45 ℃, facilitating the oxygen to diffuse through the skin
and into the sensor’s chamber, where the process of cathode-oxygen-reduction takes
place [34]. Another application of Clark’s electrode is in catheters to be placed directly
in tissues [46].
Clark’s electrodes are used in newborn infants because their thinner skin facilitates the
diffusion of oxygen through the skin [34]. The sensors can also be applied directly to
organs such as intestine and muscles [46]. Clark’s electrodes present several limitations,
which contributed to their low acceptance in clinical environments. The insertion of
needles can cause tissue damages and does not guarantee a spatially homogeneous
measurement, causing incorrect PO2/PCO2 readings [46,47], the technique has a small
penetration depth (15-20 µm) [46, 47], and it requires continuous calibration and long
times to reach equilibrium [34,43].
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3.6 Gastric Tonometry (capnography) and Sublingual Cap-
nometry
In cases of hypoperfusion or hypoxia, the tissue is deprived of the correct amount of
oxygen necessary for its metabolism. In this mismatch between oxygen delivery and
oxygen demand, CO2 accumulates and it diffuses through tissues. Gastric Tonometry
(GT) and Sublingual Capnometry are measurement techniques that estimate the partial
pressure of CO2 (PCO2) in order to detect situations of deprived oxygen delivery [47].
In gastric tonometry, a nasogastric tube is inserted into the gastric mucosa, with the
aim of monitoring PCO2 in this location as an early indicator of perfusion or metabolic
mismatches [47]. The tip of the catheter has a saline solution-filled balloon for the
determination of changes in pH. After 30 or 90 min of equilibration, the PCO2 in the
gastric mucosa is in equilibrium with the air in the balloon. By measuring the arte-
rial Bicarbonate (HCO3-) the Henderson-Hasselbalch equation can be used in order
to calculate the mucosal pH, which, in turn, is an indicator of acidosis (i.e. anaero-
bic metabolism in the case of oxygen deprivation) [46, 47]. This approach, however,
produces some flaws and a modification of the technique has been introduced, consist-
ing on the direct measure of PCO2 by a conventional air-filled capnometer [47]. This
also allows for more frequent measures of PCO2 gradients instead of the less frequent
pH [46,47].
Sublingual capnometry (SC) is a less invasive and quicker method to assess CO2 ac-
cumulation in tissues [46, 47]. SC adopts fibre optics to transport light to a sensor
placed between the tongue and the mouth mucosa [34, 48]. The sensor is composed
of a permeable membrane through which the CO2 diffuses. On the opposite side of
the membrane, a fluorescent dye solution is continuously illuminated by a fibre op-
tic [34, 48]. If the PCO2 on the other side of the membrane is high, the gas diffuses
through the membrane and an increase in CO2 causes the dye to produce fluorescence
(i.e. energy process that causes photons to be absorbed and re-emitted at a different
wavelength) [34,48]. The re-emitted light is proportional to the CO2 concentration and
is then processed to quantify the PCO2 [34, 48].
GT and SC have been demonstrated to be reliable indicators of states of deprived oxy-
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gen delivery in septic patients, anaerobic metabolism (acidosis), indicator of splanchnic
perfusion, and Multiple Organ Failure syndrome [34, 46–48]. Moreover, SC has been
demonstrated to be a more reliable indicator of hypoperfusion in septic shock patients
compared to blood lactate levels [47]. However they present different limitations such
as incorrect theoretical assumptions [46, 47], long times to perform a measurement
(GT) [46], necessity of gas calibrations and blood gas analysis [34], non-continuous
measurements [46, 48], discrepancies in the indication of regional or global oxygen de-
prived states [46,47], scattered results depending on the specific application [46–48], as
well as difficulties in the interpretation of the results [48].
3.7 White light reflectance spectrophotometry
White light reflectance spectrophotometry (WLRS) is an optical technique that exploits
the reflection and absorption properties of oxygenated and deoxygenated haemoglobin
in order to measure a haemoglobin oxygenation index (HOI) in tissues. In WLRS,
white light is applied to a tissue, but instead of acquiring only a few discrete number
of wavelengths as in pulse oximetry or NIRS, the entire spectrum range is emitted and
recorded from the tissue [49, 50]. The emitted spectrum may vary between different
instruments, but it usually ranges between 502 and 630 nm [49, 50]. The light source
is a lamp emitting white light, whereas an interference band-pass rotating filter is used
for the selection of discrete wavelengths in the 502-630 nm range, with about 2 nm
resolution (64 wavelengths) [49,50]. This process guarantees the emission of a spectrum
of wavelengths in the visible region and it is performed at high speed (100 spectra per
second). Optical fibres are usually dedicated for the emission and transportation of the
reflected light from the tissue [49,50].
The detected reflected spectra provides information on the wavelength-dependent re-
flection (absorption) of blood in the tissue. From this, concentrations of oxygenated
(HbO2) and deoxygenated haemoglobin (HHb) can be extracted. For the calculation
of HbO2 and HHb concentration, a mathematical process, relating light absorption
and scattering to concentration is used [50]. The acquired absorption at several wave-
lengths (e.g. 64 wavelengths) are correlated to the concentrations of HbO2 and HHb
in tissue [49, 50]. An example of the detected spectra by WLRS is depicted in Fig-
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ure 3.6a. The concentrations estimated by this method are, however, relative to the
basic amount of scattering, which is unknown. Nevertheless, this is not taken into
account for the calculation of oxygenation as the common scattering factor is ruled out
as in Equation 3.4.
HOI = HbO2
HbO2 +HHb
(3.4)
This process consents the determination of haemoglobin oxygenation from the mixed
spectra, but correction procedures are required to correct the collected spectra from
noise [49]. Before each measurement a black and a white reference spectra need to be
acquired for the correction of the mixed spectra acquired [49,50].
The short separation distance between fibres and the limited penetration depth of white
light cause the technique to not be able to penetrate deep into tissues, thus providing
the assessment of only superficial structures (1 mm or less in depth) [51,52]. Due to the
flexibility of transmitting and detecting light by optic fibres, WLRS has been mainly
applied to measure oxygenation and perfusion in the gastrointestinal tract [49, 51, 53].
Reflectance sensors have also been used and showed good results for transcutaneous
measurements such as flaps perfusion monitoring [52, 54]. For instance, Figure 3.6b
shows the application of a WLRS sensor on a breast flap.
3.8 NADH fluorescence and Palladium-Porphyrin phos-
phorescence
NADH (Nicotinamide Adenine Dinucleotide) is a molecule involved in the cellular
metabolism of the mitochondria. In this process, NADH is oxidised to NAD+ as
result of the reaction with oxygen for the production of ATP [46]. In situations of
hypoxia, less oxygen is delivered to the mitochondria, failing the oxidisation of NADH
into NAD+, and consequent accumulation of the reduced NADH in tissues [46, 55].
Therefore, monitoring of NADH accumulation can give an indication of a decrease in
oxygen transport to a tissue [46]. Like haemoglobin, NADH presents two main absorp-
tion peaks at 250 nm and between 320-380 nm, while NAD+ does not absorb light in the
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(a) (b)
Figure 3.6: White light reflectance spectra acquired from the skin of the back of the hand (a) and a white light
reflectance spectrophotometry sensor applied on the surface of a breast flap (b). In (a), (1) is the reflectance
spectrum from the white standard, (3) and (4) are respectively the intracapillary spectrum of haemoglobin and
the spectrum of deoxygenated haemoglobin during arterial occlusion, (2) is the reflectance spectrum from the
skin during vascular occlusion on the forearm, and (5) is the spectrum of the black standard. The figure was
reproduced from [50]. In (b) a white reflectance spectrophotometry sensor is applied transcutaneously on the
surface of a breast flap for postoperative monitoring of flaps oxygenation (figure reproduced from [54]).
range 320-380 nm [46,55]. Therefore, by monitoring light absorption in the 320-280 nm
range, only NADH absorption can be monitored, neglecting NAD+ [55]. Also, NADH
absorption in the 320-380 nm range causes fluorescence in the 420-480 nm range [46,55].
Thus, by applying light at 360 nm and detecting changes in fluorescence intensity (e.g.
photomultiplier tubes, fluorometer, or video cameras), accumulation of NADH in tis-
sues can be monitored [46, 55]. The technique can be added to microscopy and it can
be incorporated in catheters for in vivo measurements. Figure 3.7a shows images from
a NADH fluorescence video acquisition from myocardial tissue during clamping of the
left coronary artery. In addition to image/video acquisition, the technique can also
be applied to acquire trend signals of NADH fluorescence (Figure 3.7b) [55]. In vitro
and in vivo studies showed the ability of the technique to detect changes in NADH
accumulation due to hypoxia (i.e. reduce oxygen content) or ischaemia (i.e. blood
flow) [55]. Although the technique can provide trend images and signals on NADH
accumulation [55], the quantification of NADH still remains an open challenge [46,55].
Phosphorescence is a similar process to fluorescence. In phosphorescence, light is ab-
sorbed and released by a substance after the application of a pulse of light. Palladium-
Porphyrin (PP) is a water-soluble compound, which can be injected intravenously. PP
presents a quenching property when it is illuminated by light. This quenching effect is
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(a)
(b)
Figure 3.7: NADH video fluorimetry of a pig’s heart during clamping of the left coronary artery (a) and NADH
fluorimetry signals from a dog’s heart during hypoxia and ischaemia (b). In (a), baseline image (A) shows normal
blood flow. After 30 seconds (B), fluorescence increases until reaching maximum fluorescence after 3 minutes of
occlusion (C). When blood flow is restored (D), fluorescence returns to baseline. Figure reproduced from [46].
In (b), changes in fluorescence during hypoxaemia are represented in A and B. When a hypoxic mixture (N2) is
administered, fluorescence (NADH concentration) increases. When a normoxic air mixture is administered (Air),
fluorescence returns to baseline. Similar behaviour can be observed during induced ischaemia (C). Fluorescence
increases after occlusion (Occ.) and when blood flow is restored (Open), fluorescence returns to baseline. Figure
reproduced from [55].
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dependent on the oxygen presence in the solution and the decay time is proportional
to the concentration of oxygen present [46]. Thus, by injecting PP intravenously and
applying a pulse of light, the measurement of the quenching decay time by a Photomul-
tiplier Tube is possible, and the oxygen tension (or partial pressure) can be calculated
by computing this decay time [46]. Both NADH fluorescence and PP phosphorescence
are non-invasive methods that are able to provide information on oxygenation of mi-
crovascular compartments. They do not need to be in contact with the tissue, thus can
be applied to moving organs and incorporated in microscopes [46].
3.9 Imaging of the microcirculation
Imaging of the microcirculation offers the possibility to visually check the perfusion
of capillaries. Orthogonal Polarization Spectra, Sidestream Dark Field, Laser Doppler
Imaging and Laser Speckle imaging offer this possibility.
Orthogonal Polarization Spectra (OPS) is a microcirculation monitoring technique in
which filtered and polarised light is applied to the tissue [47, 56, 57]. The light beam
is then focused by a lens in order to be applied to a tissue area of around 1 mm
in diameter [56]. Polarised light is preserved in reflection and scattering, but after
more than ten scattering events, it becomes depolarised [56]. If the light emerging
from the tissue is detected by a charge-coupled device camera after passing through
a depolarization analyser, the detection of reflected light originating from only deep
structures is guaranteed [47,57]. By filtrating wavelengths in the interested absorption
range of haemoglobin (e.g. at 548 nm) only structures absorbing in that range can be
visualised (i.e. blood vessels) [56, 57]. However, this wavelength has to be carefully
selected to balance the absorption and scattering properties of tissues’ structures [56].
Sidestream Dark Field (SDF) is another imaging technique, which utilises the scattering
properties of tissues. A ring-shaped light source, with LEDs mounted on the external
ring, emits green light into the tissue (i.e. the haemoglobin’s isobestic point at 530 nm
is usually used as emission wavelength). At the centre of the sensor ring, a lens is
used for the collection of the backscattered light. Only the light reaching the deep
structures of the tissue and scattering within the tissue (i.e. changing direction) is
reflected to the lens (and the detecting system), while light reflection at the surface is
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Figure 3.8: OPS and SDF images of the same sublingual microcirculation. The images acquired by SDF
appeared to have a higher contrast and sharpness for both capillaric and venular details. Figure reproduced
from [58].
neglected [58]. The backscattered light is then acquired by a CCD video camera with
acquisition rate synchronous to the pulse light emission [57, 58]. Images acquired by
both SDF and OPS can be analysed by image or video processing techniques in order
to estimate several parameters for the assessment of the microcirculation status (e.g.
vessel density, dimensions, blood flow, etc.) [47,56–58]. Both OPS and SDF comprise of
a sensor that can be handheld by the examiner and they have been used for imaging the
circulation in several tissues such as sublingual tissue, skin, brain, liver, and lungs [57].
An example of OPS and SDF images of the sublingual microcirculation can be seen in
Figure 3.8. The techniques also have some limitations such as patient or examiner’s
movement artefacts and the lack of standards for image analysis [47,57].
Laser Doppler flowmetry was previously described in Section 3.3. A relatively re-
cent development in laser Doppler measurements is laser Doppler Imaging (LDI or
LDPI) [28, 47, 57]. LDI extends the principle of the single point, time changing laser
Doppler flowmetry to a laser Doppler perfusion image of a region of interest [57]. This
non-contact imaging technique depends on the acquisition of multiple laser Doppler
measurements from an area, for the creation of a perfusion image in which regions with
different blood flows are classified into a colour-coded image [28,29,59,60]. An example
of LDI images acquired from a skin graft can be seen in Figure 3.9. The advantage
of the technique is its ability to provide an instantaneous look at the perfusion in an
area without any contact with the tissue [28,47,57]. LDI has been mainly employed to
acquire images of blood perfusion from the skin [28,47,57], but the technique was also
investigated in organs such as bowel, colon and brain [47,57]
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Figure 3.9: Laser Doppler Imaging acquisition of a skin graft on the nose. Black areas indicate a poor perfusion,
while red and white areas indicate a high blood flow in those regions (increased blood flow around the skin graft).
Figure reproduced from [28].
3.10 Clinical assessments and temperature gradients
Tissues exhibiting a poor perfusion tend to assume a pale colour and a visual assessment
of the skin colour may give a preliminary indication of the perfusion status [34,61,62].
A simple measurement that clinicians use, as an adjunct for visual assessments, is the
Capillary Refill Time (CRT) [34]. Application of pressure on the surface of a tissue
causes the emptying of capillaries and the change into a pale colour. The CRT is
the measurement of the time that the tissue employs to return to its original colour
after the pressure is released (i.e. capillaries refilling with blood) [34,63]. A CRT < 2 s
usually indicates adequacy of perfusion, while a CRT > 4.5 s may indicate a poor blood
perfusion [34,61]. Although being quick, relatively simple to use, and not requiring any
particular instrumentation, the method is qualitative rather than quantitative, it has
an intra- and inter-observer variability, it depends on the subject’s age, and it can vary
with gender [34, 64]. Also, the method relies on the ambient light conditions and the
applied pressure, and it can be affected by administration of vasoactive drugs [61,63,64].
In order to overcome some of these limitations, automated methods such as digitally
videography and photoplethysmography were recently investigated for the accurate
measure of CRT [63,65].
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One of the main roles of the microcirculation is maintaining a correct body temper-
ature (thermoregulation) [61]. When perfusion is reduced, skin temperature drops,
most commonly at the extremities. Assessing the skin temperature is one of the quick-
est methods for the identification of hypoperfusion status and it can be qualitatively
performed by touching the patient’s skin or by measuring the skin temperature by
means of a sensor [34, 61]. Instead of measuring the temperature from a single loca-
tion, a more efficient method is the measurement of temperature gradients between
two locations, as these may better indicate the onset of temperature variations [61].
The changes in the differences in temperature between two locations (e.g. central-to-
toe or forearm-to-fingertip) or between ambient and peripheries can reliably indicate
changes in temperature (perfusion) that are independent of fluctuations in ambient
room temperature [34, 61]. Temperature gradients have been investigated in circula-
tory shock or hypovolaemic patients, post-surgery or post-resuscitation patients, and
for flaps perfusion monitoring . The results, however, vary and there is no consensus on
the relationship between temperature gradients and global haemodynamic variables or
patient’s outcomes [34,36,44,61]. Also, the application of the technique in critically ill
or surgical patients poses a contradicting limitation, due to the administration of anaes-
thetic drugs, which often suppress the thermoregulatory activity in these patients [34].
3.11 Summary
This chapter presented a brief overview of some techniques adopted for in vivo mea-
surements of blood perfusion and oxygenation. Several parameters measured by the
techniques presented in this chapter directly or indirectly relate to blood flow, blood
volumes, blood oxygenation or metabolism. Among the techniques presented in this
chapter, Photoplethysmography and Near Infrared Spectroscopy have been briefly de-
scribed. These two techniques play a central role in the research work presented in this
thesis, and separate chapters describing these techniques in more detail are deemed
necessary. Therefore, the next chapter will focus on describing the principles and ap-
plications of photoplethysmography and pulse oximetry.
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Chapter4
Photoplethysmography & Pulse Oximetry
In the last chapter, photoplethysmography and pulse oximetry have been briefly in-
troduced. This chapter describes in more details the principles and main applications
of photoplethysmography and pulse oximetry. The two techniques are strongly linked
and, sometimes, even confused and mixed. Pulse oximetry is an application of pho-
toplethysmography, and, due to its enormous success, it has overshadowed the latter.
In some cases, the greater popularity of pulse oximetry has even led to mention pho-
toplethysmography in the literature as the pulse oximeter waveform. However, in this
chapter, the two techniques will be described and defined separately. The first part
of the chapter will introduce the principles and applications of photoplethysmography,
while the second part will be dedicated to pulse oximetry. Some of the limitations are
mentioned throughout the chapter, while other major limitations and open challenges
are discussed at the end of this chapter.
4.1 Principles of Photoplethysmography
Photoplethysmography (PPG) is an optical technique that exploits the optical absorp-
tion of tissues to express variations in blood volume. The action of pumping blood
by the heart can be divided into two periods known as systole and diastole. Systole
is the period when blood has just been ejected by the heart’s left ventricle. During
systole, the arteries extend due to the high pressure exerted by the arterial blood.
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This pressure increases until reaching a maximum and decreases before the next pulse.
When the pressure starts to decrease, the diastolic phase begins. In diastole, the pres-
sure decreases until reaching a minimum, corresponding to the minimal distension of
arteries.
Photoplethysmography exploits the changes in light absorption during the cardiac cycle
between systole and diastole. The first major developments of the technique have been
attributed to Hertzman, who observed that the light passing through biological tissue
underwent cyclic changes in intensities [66]. A similar and more pragmatic example of
this phenomenon can be observed by placing one finger over a strong cold white source.
The light intensity passing through the finger can be seen oscillating due to the changes
in arterial blood (i.e. systole-diastole).
In photoplethysmography, a light beam is emitted by means of laser diodes or light
emitting diodes (LED). When light interacts with tissue, complex mechanisms like
reflection, scattering, and absorption take place. The latter has the strongest impact
on PPG measurements, while reflection and scattering are mostly neglected. When
a sensitive photodetector like a photodiode or phototransistor is used to detect the
light exciting the tissue, a physiological signal can be measured. This signal is known
as photoplethysmogram and its main feature is the alternating intensity, reflecting
the cardiac cycle. During systole, the increase in arterial blood is measured in the
photoplethysmogram as a decrease in light intensity due to greater absorption (i.e.
increased quantity of blood underneath the sensor). During diastole, the blood in the
arteries reach its minimal presence and this corresponds to a decreased absorption
measured by the photodetector. A raw photoplethysmogram acquired from a finger is
depicted in Figure 4.1, along with the main characteristics of the signal. The figure
also shows the flipped version of the signal, which is performed in order to resemble
the photoplethysmogram to the arterial blood pressure (ABP) waveform. The reversed
signal is often displayed in pulse oximeters along with the arterial oxygen saturation
and heart rate. This flipping process is important to mention, but the flipped signal
is almost always used when referring to the photoplethysmogram. The flipped version
of the signal has gained recognition because an increase in the signal corresponds to
an increase in blood volume and vice versa. The photoplethysmogram can be roughly
divided into two stages. The initial stage is the upslope coinciding with the systole phase
of the cardiac cycle. In this stage, the signal increases until reaching a maximum. The
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Figure 4.1: Original (a) and flipped (b) photoplethysmogram and features of the photoplethysmogram. In
(a), the original photoplethysmogram represents the absorption cycles measured directly by the photodetector.
The minima correspond to maximal absorption (systole), while the maxima are the minimal absorption points
(diastole). In (b), the original photoplethysmogram is conventionally flipped. The upslopes and downslopes
correspond respectively to systolic and diastolic stages respectively. The dicrotic notch is present in healthy
volunteers during the diastolic stage. The pulse amplitude can be considered as the difference between the
maximum and the minimum within one cardiac cycle.
second stage corresponds to the diastolic phase and appears as a decrease of the signal
(downslope). In the diastolic phase, an inflexion, known as the dicrotic notch, can be
observed [1].
From a more physical point of view, the generation of the photoplethysmogram can
be attributed to the Beer-Lambert law, which states that the intensity of the detected
light I is proportional to the concentration of the substance c and the distance travelled
by the light beam d.
I = I0 expεcd (4.1)
Where I0 is the emitted light intensity and ε is the specific extinction coefficient (or mo-
lar absorptivity) of the substance, expressing the absorption properties of the substance.
During the cardiac cycle, the amount (concentration) of blood in the measurement area
changes over time and the distance travelled by light varies due to the distension of
the arteries. The continuous cycle of systole and diastole, causing both variations in
blood volume and arteries diameters, generates the change in the detected light inten-
sity expressed by the photoplethysmogram. Furthermore, the different direction of red
blood cells during systole and diastole could cause changes in the light reflection, thus
contributing to the overall signal [1, 6, 67].
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Figure 4.2: Distribution of light absorption and attenuation in photoplethysmography. Part of the emitted
light I0 is absorbed by the tissue (IA), whereas the transmitted light IT is measured by the photodetector.
IT undergoes cycles of maximal (IHA) and low absorption (ILA) due to the pulsation of arterial blood. This
alternation of absorption constitutes the alternated AC component of the photoplethysmogram. Other tissue’s
structures constantly absorb light, the most significant being non-pulsatile arterial blood, venous blood, skin,
and bones. The figure was re-drawn from [8].
4.2 Components of the photoplethysmogram
Although the photoplethysmogram is widely known for the measurement of arterial
blood volume changes, the signal is not solely composed by the contribution of arterial
blood. Light interacts with several tissue structures and these interactions are then
represented in the photoplethysmogram. A schematic representation of the contribution
of different tissue structures is shown in Figure 4.2. From that figure, the signal can be
divided into two components: alternated (AC) and continuous (DC).
4.2.1 Alternated PPG component
The alternated AC component (from this point, AC PPG) represents the changes in
blood volume due to the pulsation of arteries and resembles the shape of the arterial
blood pressure waveform [68]. An example of AC PPG is illustrated in Figure 4.1. The
component is characterised by the continuous oscillations representing the systolic and
diastolic phases, thus synchronous with the cardiac cycle. The AC PPG component
varies from subject to subject, having distinct features for each subject [69] and when
it is measured from different locations (e.g. finger, forehead, ear) [1, 69].
The AC PPG is often mistaken as the only component of the PPG signal and can
be used for different applications. The primary utilisation of the AC PPG is the
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Figure 4.3: Raw PPG (AC + DC) signals acquired from the finger of a healthy subject. The small pulsatile
AC component (in grey) overrides on a slow-varying continuous DC component (black line).
estimation of arterial oxygen saturation by pulse oximetry, which will be described
in Section 4.5. By representing the arterial pulsations during the cardiac cycle, the
component is also widely used for the estimation of the heart rate or it can be used to
assess arrhythmias [1,9]. The amplitude of the component varies on the vascular status
of the arteries; for instance, diminishing during vasoconstriction or increasing during
vasodilation [9].
4.2.2 Continuous PPG component
The AC PPG component constitutes only 1-2 % of the total light detected [67]. As can
be seen from Figure 4.2, the greater proportion of light absorption originates from the
light interaction with other tissue structures other than the pulsating arterial blood.
Relatively static structures such as non-pulsatile arterial blood, venous blood, skin, and
bones dominate absorption, thus creating an offset of the photoplethysmogram, known
as DC component [1, 2, 67, 68]. Figure 4.3 shows an example of raw PPG (AC + DC)
acquired from the finger of a healthy subject. The pulsating AC component overrides
over a slowly varying DC component, which reflects the (relatively constant) absorption
of structures other than the pulsating arterial blood.
Although the DC PPG component is usually filtered out or used for normalisation in
conventional PPG processing systems (i.e. pulse oximeters display only the pulsatile
AC PPG component), it contains valuable physiological information. The DC PPG
component represents the amount of blood volume under the sensor, thus can provide
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information on blood pooling (or flowing) under the sensor [1,2]. The DC PPG oscillates
at low frequencies, synchronously with respiration [1, 2, 67, 68]. This effect is created
by variations in the resistance of venous blood flow, caused by the changes in the
intrathoracic pressure during ventilation [2, 67]. The respiratory-induced variations
represent venous blood motion and, by applying similar methods used in pulse oximetry,
they have been proposed for the estimation of venous oxygen saturation from PPG
signals (see subsection 4.5.4). Other spontaneous oscillations at lower frequencies than
the respiration can also be extracted from the DC PPG component. These very low-
frequency oscillations occur in the range 0.01-0.5 Hz and they have been related to
regulation mechanisms mediated by a sympathetic nervous system such as Mayer waves
[2], blood pressure regulation [2], or thermoregulation [1, 2].
4.3 Photoplethysmography measurement modalities
As mentioned earlier, photoplethysmography requires a light emitter and a photode-
tector. Often, light emitting diodes (LEDs) and photodiodes are used for this purpose.
Compared to other light sources, LEDs have the advantage of being smaller, produce
less noise, can be switched ON/OFF at faster rates, they are inexpensive, produce less
heat and have a long operating life [1, 2, 6]. LEDs and photodiodes can be of small
size and they can be easily incorporated directly into PPG probes [1]. Optic fibres can
also be employed in PPG measurements to transport the light to and from the tissue.
However, this solution is more fragile, but allows using the technique in the presence
of Magnetic Resonance Imagers (MRI) [6]. Depending on the configuration of light
emitters and photodetectors, there are two modalities by which PPG measurements
can be performed, known as transmission and reflectance mode [1].
4.3.1 Transmission Photoplethysmography
In transmission mode, the light emitter and photodetector are placed parallel to each
other on each side of the tissue [1, 2, 67, 68, 70]. An example of the transmission mode
is depicted in Figure 4.4, in which light is transmitted through the tissue, from one
side to the other. This configuration, however, can only be applied to small extremities
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Figure 4.4: Configuration of transmission photoplethysmography. The light emitters (diodes) and the pho-
todetector are placed opposite to each other across the tissue (finger). An enclosure protects from ambient light
interference, while a cable connects the optical components to the processing unit. In this figure, two light
emitters, red and infrared, are used for pulse oximetry. Figure reproduced from [6].
such as fingers or earlobe and requires a small pressure to hold the sensor in place
[1, 2, 6, 70]. Measurements across thicker tissues may suffer from greater absorption,
with the shortcoming of producing smaller and noisier signals.
4.3.2 Reflectance Photoplethysmography
For other measurement locations, the reflectance mode is more suitable [2]. In re-
flectance mode, the light emitter and photodetector are positioned on the same surface
of the tissue [1, 2, 67, 68, 70]. Due to light scattering in tissue, the emitted light is
back-reflected in a banana-shaped path to the same planar surface as the light emitter,
where the photodetector receives the reflected light from the tissue [68,70].
An example of reflectance mode is depicted in Figure 4.5, showing the position of the
light emitters and the photodetector. This measuring mode has been used for PPG
measurements from several locations such as fingers, forehead, or forearm [2,6,70], but
it requires a good contact between the sensor and the skin, in order to avoid movement
artefacts and ambient light interference [1]. Reflectance sensors are usually attached
to the skin by means of double-sided adhesives, and PPG measurements acquired in
reflectance mode contain a more significant contribution of venous blood due to the
absence of pressure (i.e. transmission mode exert some pressure on the tissue, thus
collapsing the venous blood) [68]. Also, PPG measurements acquired in reflectance
mode usually provide a lower signal when compared to the transmission mode [71].
The reflectance PPG measurement mode has been primarily used in the research carried
out in this thesis. This modality has been selected since it can be used to acquire signals
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Figure 4.5: Configuration of reflectance photoplethysmography. The light emitter (light emitting diode) and
the photodetector are positioned on the same plane, side by side. The backscattered light returns to the
photodetector after travelling across the different structures of the tissue and interacting with the blood vessels.
The enclosure protects from ambient light interference and allows the attachment of the sensor on the skin.
Figure reproduced from [71].
from almost any location in the body, whereas the transmission mode is limited to the
fingers and earlobes. Later in this thesis, the design and development of reflectance
PPG sensors used for this research will be described in Chapter 6.
4.4 Clinical and Research applications of PPG
The previous sections introduced the principles of photoplethysmography. This section
aims at reviewing briefly the main applications of photoplethysmography. Pulse oxime-
try will not be introduced at this point since a separate section will be dedicated to
describing pulse oximetry.
4.4.1 Heart rate
The pulsatile component of the photoplethysmogram is synchronous with the cardiac
cycle, thus information on the heart rate frequency can be estimated from the AC
PPG [1]. Two methods can be used to extract the heart rate from PPG, one being
in the time domain and the second in the frequency domain. In the time domain, the
period between two successive beats yields the beat-to-beat heart rate, whereas in the
frequency domain the cardiac frequency (usually around 1 Hz) is extracted from the
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Figure 4.6: Time domain (a) and frequency domain (b) heart rate estimation from PPG. (a) In the time
domain, the beat-to-beat period T is calculated from the time locations of the PPG signal. (b) In the frequency
domain, the peak of the cardiac frequency is extracted from the power spectra of the signal. The spectrum
refers to 10 seconds of the same signal presented in (a). The period T in (a) is 0.79 s, while the peak of the
cardiac frequency is at 1.25 Hz (the smaller peaks at higher frequencies are harmonics). The time and frequency
domain result respectively in a heart rate of 75.9 beats/min and 75 beats/min.
power spectra of the signal. Figure 4.6 illustrates how both methods estimate the heart
rate.
The heart rate estimated from PPG signals is obviously a fundamental haemodynamic
parameter and it is usually showed along with the arterial oxygen saturation in pulse
oximeters [1]. The heart rate can be estimated from PPG acquired from different lo-
cations, but the finger, forehead, and wrist have been reported as more reliable than
other locations (i.e. finger, forehead, and wrist showed less respiratory-induced varia-
tions in the PPG signals) [72]. The PPG signals can be used along with ECG to find
possible arrhythmias [9], while the beat-to-beat variability of PPG signals can be used
to obtain information on heart rate variability [70]. Recently, Grubb et al. investigated
the neonate’s forehead as a location of heart rate estimation and showed good agree-
ment with ECG measurements. The authors proposed the forehead PPG since it offers
several advantages over other conventional methods (e.g. ECG or stethoscope) [73].
Although the heart rate can be extracted from PPG measurements, the main challenge
remains the validity of PPG-derived heart rate in the presence of movements [1].
4.4.2 Respiration rate
As mentioned in the previous sections, the photoplethysmogram contains spontaneous,
respiratory-induced fluctuations. These fluctuations appear in the DC component of
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Figure 4.7: Effect of respiration on PPG signals. Measurements acquired from a spontaneously breathing
subject. Positive airway pressure (PaW) was used as an aid in ventilation. Central venous pressure (CVP)
was measured by a jugular catheter and the arterial blood pressure (Radial BP) was measured from a radial
catheter. The PPG (fourth from the top) was acquired from a finger PPG sensor. PPG Amplitude (fifth from
the top, in green) is the interpolation of the PPG peaks, while the RIIV (bottom) was obtained by low pass
filtering the PPG signal. Figure reproduced from [10].
the signal and their origins are still under debate [1, 2, 9, 10, 72]. The changes in ve-
nous flow resistance due to intrathoracic pressure variations, with the corresponding
changes in stroke volume and cardiac output, are considered the first cause of these
modulations, but respiration-synchronised mediation of the sympathetic nervous sys-
tem has been advocated as an additional source [10]. These low-frequency oscillations
are easily visible during positive pressure ventilation and can increase in amplitude after
blood withdrawal or haemorrhage [9]. Due to the synchrony with the respiration, these
fluctuations have been defined as respiratory-induced intensity variations (RIIV) and
they can be used to derive respiratory rates from the photoplethysmogram [1, 9, 10].
Depending on the specific filtering, the respiration-induced fluctuations can be fully
separated from the pulsatile component, thus appearing only in the DC component of
the PPG signals [10]. The forehead, ear, and forearm have been indicated as best loca-
tions to measure RIIV, due to a greater presence of venous blood in these locations and
the method of attachment (i.e. transmission sensors can compress the venous blood
underneath the sensor) [72,74].
The use of the PPG signal for estimation of respiration rates can offer several advantages
over traditional methods for monitoring respiration, avoiding the use of additional, and
sometimes bulkier, sensors [10]. Respiration is an important physiological parameter
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and monitoring this with a PPG/pulse oximetry sensor can have several applications
such as anaesthesia and sleep/neonatal apnoea [1].
4.4.3 Photoplethysmography as indicator of perfusion
As mentioned earlier the AC component of the photoplethysmogram is synchronous
with the cardiac cycle, thus representing the pumping action of the heart. This arterial
component can be therefore used for the assessment of the blood supply to the tissue.
Changes in the AC PPG directly reflect variations in the blood volume supplied to the
region. During cuff-induced occlusions, the AC PPG decreases or, during full arterial
occlusion, completely disappear. Different studies have been performed on this aspect
and showed how the PPG can be used in situations of compromised perfusion [75–77].
However, the use of AC PPG alone for assessing perfusion should be cautious. Firstly,
the AC PPG represent volume changes of pulsatile blood and it does not assess the
oxygen delivery to the tissue (i.e. oxygen delivery = blood flow × oxygen content)
[75]. Secondly, this component only represents the pulsatile arterial blood volume
in the measured area, whereas the venous component is neglected during filtering of
the signal. Thirdly, the presence of arterial pulsations does not preclude adequacy of
perfusion, which can be compromised by venous occlusion as well [75]. Even if decreased
during occlusion of the venous outflow, the pulsatile component is still present or it
significantly drops after a long period of time. In this regard, previous studies showed
that the AC PPG started to decrease drastically only at occlusion pressures close to
100 mmHg, much after occlusion of the venous circulation [75–77]. Furthermore, the AC
PPG amplitude physiologically varies due to sympathetic activity or small temperature
changes in normal conditions, thus significant variations may be identified only after
some time before the complication occurred.
The DC component of the photoplethysmogram seems to be more reliable for indication
of perfusion changes and it can provide important information when the AC component
may not be sufficient like in venous congestion. In 1940, Hertzman and Dillon were
the first to report changes in the DC PPG component for blood volumes variations
due to venous congestion, with an unaffected pulsatile component [78]. Almond et al.
compared the DC PPG recordings from the finger with laser Doppler flowmetry and
strain-gage plethysmography during vascular occlusions at different arm positions. The
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DC PPG significantly changed during the occlusions, indicating the changes in blood
flow perfusion [79]. Later on, Galla et al. studied the response of the DC PPG in
animal flaps in order to investigate the feasibility of distinguishing between venous and
arterial occlusion. The DC PPG showed different responses during the two occlusions,
with the signal increasing during arterial occlusion, whereas decreasing during venous
occlusion [41].
A more recent advancement in PPG processing is the calculation of the perfusion index
(PI). The index is calculated from infrared PPGs as the percentage ratio of the ampli-
tude of the pulsatile AC component and the DC level (PI = AC/DC × 100 %). The
index is nowadays displayed in modern pulse oximeters along with the photoplethys-
mogram and it is believed to reflect changes in perfusion [70,80].
Lima et al. investigated the relationship between PI and clinical measures of perfusion
such as capillary refill time and central-to-toe temperature gradients in healthy volun-
teers and critically ill patients. A positive relationship was found between changes in
peripheral PI and changes in central-to-toe temperature in critically ill patients. From
the study population, a cut-off value of 1.4 for PI measurements was considered as an
indicator of abnormal perfusion [80]. The perfusion index measured at the neonates’
foot was also correlated with blood flow and oxygen delivery derived from NIRS mea-
sured at the calf [81]. Van Genderen et al. demonstrated that changes in the perfusion
index were able to indicate the onset mild hypovolaemia during low body negative
pressure [82]. The perfusion index can be used to differentiate between high and low
severity illness in neonates (cut-off PI = 1.24) [83], as well as to detect changes in
perfusion after harvesting of the radial artery for coronary artery bypass [84].
4.4.4 Continuous arterial blood pressure
Photoplethysmography can be used for the measurement of beat-to-beat arterial blood
pressure (ABP) [85]. The method is based on the unloading of the finger arterial
walls, combining both optical (photoplethysmography) and mechanical principles (oc-
clusion). In these instruments, the optical components measuring infrared PPGs are
enclosed in a finger cuff. At the beginning of the measurement, this cuff inflates in
steps, correlating the inflation pressure to AC and DC PPG signals acquired from the
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Figure 4.8: Example of arterial blood pressure measurement from a healthy subject. The maximum point of
the curve represents the maximal pressure reached during systole, while the minimum pressure point corresponds
the diastolic pressure.
optical sensor. This step-wise calibration allows identifying the pressure at which the
finger cuffs will measure the ABP at the finger and small adjustments are performed
at regular intervals during the measurement [85]. In some instruments, this initial cal-
ibration is also performed with the aid of a cuff placed on the forearm [86]. To deter-
mine its accuracy, the method was compared against reference invasive (radial artery
catheters) and noninvasive measures (auscultation) of blood pressure, showing good
levels of agreement [85–87]. However, the main advantage of the method is the ability
to track beat-to-beat arterial blood pressure changes in a noninvasive and continuous
manner. Figure 4.8 shows an example of continuous beat-to-beat ABP measurements
on a healthy volunteer.
4.4.5 PPG for cardiovascular assessment
Vascular compliance is the ability of a vessel to adapt to variations in pressure by chang-
ing its volume. In mathematical form, the compliance C can be defined as the ratio
between changes in volume and pressure (C = ∆V/∆P). Compliance was previously
assessed by strain-gage plethysmography (∆V) and invasive intra-arterial pressure mea-
surements [88]. Shelley et al. introduced the concept of using the AC PPG amplitude
variations to measure volume changes ∆V per changes in pressure ∆P, thus assessing
alterations in vascular compliance or vascular tone. By plotting ∆V traces (PPG)
against ∆P, a loop is created, which slope is proportional to vascular tone/compliance.
As showed in Figure 4.9a, the method could be used to track changes in compliance
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(a) (b)
Figure 4.9: Changes in compliance measured by PPG (a) and Pulse Transit Time as a function of age for
different locations (b). In (a), changes in amplitude of the AC PPG component (POW) are plotted against
changes of blood pressure (BP). Compliance is represented by the slope of the loops. In this example, baseline
measurements (A) change at 60 s (B) and 120 s (C) after injection of phenylephrine. Figure reproduced from [88].
In (b), PTT measured at different locations (finger, toe, and earlobe) are plotted against age. PTT values are
proportional to the distance from the heart and decrease in PTT with age indicates the increased arterial
stiffness. Figure reproduced from [89].
after the administration of a vasoconstrictor [88].
The photoplethysmogram can also be used to assess arterial stiffness [1]. With increas-
ing age, the morphology of the pulsatile AC component change and they can be used
to assess stiffness of the arterial vessels [89]. Also, with increased stiffness, the velocity
of blood in the arteries increases. By measuring the time it takes for the pulse wave
to travel from the heart to the PPG measurement location (e.g. finger or toes), the
arterial stiffening can be assessed. This parameter is known as Pulse Transit Time
(PTT) and is measured from the time difference between simultaneous ECG (ventric-
ular ejection) and PPG measurements (arterial pulse) [89]. If the distance from the
heart and the PPG measurement location is known, the velocity of arterial blood, Pulse
Wave Velocity (PWV) can also be obtained . Figure 4.9b shows PTT measurements
from fingers, toes, and earlobe as function of age. As can be seen from the figure,
the PTT is proportional to the distance travelled and decreases with increasing age
(arterial stiffness).
PPG has attracted some interests for the assessment of fluid responsiveness. Fluid Re-
sponsiveness (FR) is the ability of the cardiovascular system to adapt to intravascular
volume administration and assessing FR can help guiding fluid resuscitation in critical
patients [69]. The main parameter involved during volume administration is the stroke
volume (SV). The photoplethysmogram gives an indication of periodic changes in SV
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due to the increase in intrathoracic pressure in respiration, reflected in the DC com-
ponent of the PPG, as well as in amplitude changes of the pulsatile component [69].
Therefore, the PPG could provide a noninvasive tool to guide fluid resuscitation. During
mechanical ventilation, the oscillations in the PPG signal are more visible and change
accordingly during intravascular volume changes such as bleeding (hypovolaemia) [90]
or volume administration [91].
4.4.6 PPG from alternative measurement locations
With the technological advancements in the last decades, optical components have
smaller sizes, allowing the miniaturisation of PPG sensors. For this, various measure-
ment locations have been investigated other than the more conventional positions such
as fingers, earlobe or forehead.
The oesophagus was investigated as a location for PPG measurements by Kyriacou.
The rationale behind is that PPG measurements from this location will be less affected
by vasoconstriction than extremities, with the ability to estimate the arterial oxygen
saturation more effectively from vulnerable patients. By means of a tiny reflectance
PPG sensor, good quality PPGs were acquired from the lumen of the oesophagus in
cardiothoracic surgery patients, burned patients, and neonates [3, 92]. To overcome
the limitations of PPG measurements under poor perfusion due to vasoconstriction,
the ear canal was also investigated as a new location for PPG measurements. The
ear canal, being supplied by branches of the carotid artery, demonstrated to provide
more stable PPG signals than fingers during hand immersion in ice and whole body
hypothermia [93,94].
In order to monitor perfusion of splanchnic organs, PPG signals were also acquired
from the small and large bowel [95, 96] or the surface of the colon [97]. A very inter-
esting application is the measurement of PPG from the spinal cord tissue or from the
cerebral cortex. Through a cranial bolt used in for intracranial pressure monitoring,
the PPG signal can be measured from the cerebral cortex by means of optic fibres [98].
This approach could provide the ability to monitor intracranial blood volume changes
and estimate cerebral arterial oxygen saturation from subjects with head injuries or
neurosurgery patients [98]. Figure 4.10 shows the insertion of the fibre optics into the
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(a) (b)
Figure 4.10: Insertion of optical fibres in the skull (a) and PPG recordings from the brain (b). (a) The cranial
bolt is inserted in the brain through a hole in the skull with the optical fibres running in the middle. (b) Top
trace: infrared PPG; bottom trace: red wavelength PPG. Figure reproduced from [98].
brain bolt and PPG recordings acquired from the brain.
Photoplethysmography has been investigated for the intra- and post-operative mon-
itoring of surgical flaps [99–102]. Being noninvasive, harmless, and inexpensive, the
technique could be a suitable method to monitor postoperative complications in these
tissues. However, extensive clinical studies are still needed to determine the ability of
photoplethysmography to detect reliably vascular complications in flaps.
4.4.7 Non-contact PPG, imaging, and smartphones applications
One of the most attractive new implementation of the PPG technique is the possibility
to acquire non-contact PPG measurements. This can be achieved by acquiring video
sequences (frame) of the backscattered light from the tissue by means of a camera
positioned at a distance greater than 1 m [103, 104]. Light sources of the wavelength
of interest can be used to illuminate the tissue under examination [104] or ambient
white light can be used as well [103]. The acquired images can either be used from the
entire area, to obtain a map of the signal intensity or can be used to extract the PPG
signal from a specific region of interest. Briefly, the processing of these time-frames
involves selecting a spot measurement area and performing a spatial averaging of the
pixels of interest. From the time variations in the intensity of these pixels, the PPG
signal can then be obtained [103]. From non-contact PPG measurements, heart rate
and/or respiration can be obtained without contact with the subject and this offers the
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Figure 4.11: Non-contact PPG measurements from a subject. In (a), the PPG signals are extracted from four
region of interest I-IV showed in (b). The power spectra of the signals extracted from the four regions are shown
in (c). The measurements have been acquired with white ambient light. The signals in (a) represent the green
channel (RGB) of the video frames. Figure reproduced from [103].
potential for monitoring these parameters from vulnerable patients [103].
PPG has also attracted the interests of smartphone manufacturers. Some new smart-
phones are equipped with built-in technology that allows measuring the user’s heart
rate based on PPG measurements. Also, several applications have been developed for
the same purpose. The light source can be a dedicated LED or the camera’s flashlight
and the PPG signal is recorded from the smartphone’s camera. The principle of non-
contact PPG has also been implemented for smartphone or tablet applications such as
Vital Signs Camera by Philips N.V., in which the PPG signal can be acquired from the
front camera of the smartphone for estimation of heart rate and respiration without any
contact with the subject. The introduction of PPG technology in smartphones could
pave the way to a future in which each person would have a photoplethysmograph in
their pockets.
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4.5 Pulse oximetry
The determination of oxygen content in blood is of vital importance in clinical settings.
Usually, this is achieved by withdrawing blood samples and analysing them in vitro in
the laboratory. One of the major parameters of interests in oxygen blood analysis is
the arterial oxygen saturation (SaO2) or functional saturation (FaO2). The calculation
of this parameter is showed in Equation 4.2 and expresses the content of oxygenated
haemoglobin HbO2 over the full amount of haemoglobin (expresses as the sum of oxy-
genated and deoxygenated haemoglobin HHb). As explained in Chapter 2, haemoglobin
plays an important role in the oxygen metabolism of tissue by transporting oxygen to
the tissues (oxygenated haemoglobin) and collecting waste products of the metabolism
(deoxygenated haemoglobin). Therefore, SaO2 is a fundamental parameter since it
represents the quantity (in percentage) of oxygen being delivered to the tissue.
SaO2 = FaO2 =
[HbO2]
[HbO2] + [HHb]
× 100% (4.2)
However, blood samples analysis have some limitations such as intermittent blood sam-
ples withdrawal, invasiveness, and it requires some minutes for the analysis. This
method, which is the gold standard for blood oxygenation measurements, is still used
in clinical practice and it was the only method available before in vivo and continuous
oxygenation measurements became available.
Before the arrival of pulse oximetry, the device for in vivo determination of arterial
saturation was an ear oximeter firstly developed by Wood and Geraci in 1949 and later
modified by Hewlett-Packard in the early 1970s [4]. The device is depicted in Figure 4.12
and consisted of an earpiece sensor emitting light at eight wavelengths. By measuring
the light attenuations at different wavelengths and comparing them with reference light
beams, the instrument was applying a spectroscopic method for the determination of
HbO2 and HHb, and therefore SaO2 [4,6]. Although being efficient, the instrument had
some limitations such as instrumentation and sensor bulkiness, it was limited to and
required heating of the ear, slight changes in position during the measurement could
cause inaccuracies, as well as intermittent calibrations [4–6, 105]. It was later that
Dr Aoyagi, while he was working on cardiac output measurements, noticed a pulsatile
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Figure 4.12: Schematics of the HP Packard ear oximeter. Figure reproduced from [6].
component in the signal measured by the Wood’s ear oximeter. This signal was initially
considered as an interference, but later Aoyagi realised that this pulsatile component
did not have any effect in the calculation of SaO2, but instead it could be effectively used
to isolate the arterial blood for oxygen saturation measurements [5]. After presenting
his first results at a conference in 1974, he was relocated without being able to continue
his work. A decade later, the first pulse oximeters incorporating Aoyagi’s principles
were commercially available [5].
4.5.1 Principles of pulse oximetry
The function of pulse oximetry is based on the absorption properties of blood at two
wavelengths, more specifically red and infrared. Figure 4.13 shows the absorption
spectra of oxygenated and deoxygenated haemoglobin. As it can be seen from the
graph, oxygenated haemoglobin absorbs less light in the red region (600-700 nm), while
it absorbs more light in the infrared region (800-1000 nm) of the spectrum. This
inversion of absorption takes place after the isobestic point (800-810 nm), where the two
haemoglobin species absorb light equally [6,8]. The figure also indicates the absorption
of oxygenated and deoxygenated haemoglobin at the two wavelengths mostly used in
pulse oximetry, 660 nm for red and 940 nm for infrared. The red wavelength is mostly
used at 660 nm, while a source between 810 to 1000 nm can be used for infrared light,
with the main criterion that oxygenated and deoxygenated haemoglobin at the two
wavelengths have different or, even better, inverted absorption (see Figure 4.13) [7].
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Figure 4.13: Absorption spectra of oxygenated (HbO2) and deoxygenated (Hb) haemoglobin in the red and
infrared regions. The two wavelengths commonly used in pulse oximetry (660 nm and 940 nm) are depicted as
well. In the red region, HbO2 has a lower absorption than Hb. In the infrared region, after the isobestic point,
the absorption of the two haemoglobin species is inverted. Figure reproduced from [6].
If light at two wavelengths is emitted in the tissue, these different absorption proper-
ties of blood can be exploited to obtain information on the quantity of oxygenated and
deoxygenated haemoglobin. This principle was used in the Wood’s ear oximeter and
consisted in the application of the Beer-Lambert law to obtain the concentrations of
oxygenated and deoxygenated haemoglobin in blood (the Beer-Lambert law is used in
Near Infrared Spectroscopy and it is extensively explained in Chapter 5). This method,
however, did not discriminate between arterial and venous blood, and it required fre-
quent calibrations and a reference light intensity. The intuition of Aoyagi to use the
pulsatile component of the signal allowed to isolate the arterial blood and to use a
method that did not require frequent calibrations or a reference [5, 7].
Figure 4.14 shows the light absorbance at red (600 nm) and infrared light (940) for a
blood sample with varying oxygen saturation. At high saturations (> 80 %), red light
is absorbed more than infrared light, while at low saturations (< 80 %) the absorption
is inverted. This relationship between oxygen saturation and absorption at red and
infrared light is the fundamental principle used in pulse oximetry. In particular, this
absorption at red and infrared is expressed as a ratio and related empirically to the
oxygen saturation [4, 7, 8].
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Figure 4.14: Absorbance of infrared (left side) and red (right side) light with varying oxygen saturation (SaO2).
On the left side plot, infrared light (940 nm) has a greater absorption at high saturations than low saturation.
On the right side plot, red light (660 nm) has a lower absorption at high saturation than at low saturation.
Measurements obtained by varying the ratio of oxygenated/deoxygenated haemoglobin in a blood sample and
keeping total haemoglobin constant. Figure reproduced from [7].
The pulsatile component of the PPG signal at red and infrared is used to express the
absorption ratio. This ratio R is known as Ratio of Ratios and expresses the relationship
between red absorption α(λR) and infrared absorption α(λIR) [7,8]. By using this ratio,
information on the incident light is no longer required as in the Wood’s ear oximeter,
but only relative changes in absorption between red and infrared are used [4, 7].
R = α(λR)
α(λIR)
(4.3)
The ratio R can be calculated from red and infrared PPG signals in different methods.
Here, the derivative method will be illustrated, while the other methods are described
in details in [8]. The ratio or ratios R in the derivative method can be expressed as:
R = ACR/DCR
ACIR/DCIR
. (4.4)
Where ACR and ACIR are the amplitude of the pulsatile component of the signals
at red and infrared respectively, and DCR and DCIR are respectively the mean light
absorptions at red and infrared. These parameters are illustrated in Figure 4.15, where
AC is considered the difference between the maximum and minimum of the pulsatile
component during the cardiac cycle, while the DC is the average absorption [4, 7, 8].
The ACs and DCs are directly dependent on the incident light intensity, thus dividing
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Figure 4.15: PPG parameters used for the calculation of the ratio of ratios. The AC amplitude at a generic
wavelength λ is obtained from the difference between lower (circle) and maximum absorption (square) during
the cardiac cycle. The DC is the average light intensity. These two parameters are extracted from red and
infrared wavelength for the calculation of the ratio of ratios R in Equation 4.4.
the ACs to the DCs provides a corrected pulsatile component AC that is not dependent
on the incident light [4, 7].
The ratio of ratios R is related to arterial oxygen saturation by empirical curves ob-
tained from healthy volunteers. These calibrations are performed by varying the in-
spired fraction of oxygen in order to change the SaO2. The SaO2 is measured by
standard devices such as Co-oximetry (gold standard) and the measured ratio R is
then related to SaO2 measurements [4, 7, 8]. Figure 4.16 shows the empirical calibra-
tion curve of pulse oximeters, relating SaO2 to the ratio R. Due to the impossibility to
desaturate the subjects < 80 %, the calibration is performed for a SaO2 range between
80 % and 100 % and the curve is then extrapolated for a full range 0-100 % [106]. Due
to the fact that the calibration curves are extrapolated for low saturation values, the
accuracy of pulse oximeters cannot be guaranteed for saturations < 70-80 % [106].
Once the calibration curve has been obtained, the ratio of ratios R can be used to
calculate the arterial oxygen saturation SpO2 by using the equation of the calibration
curve. The typical linear equation for the calibration curve in Figure 4.16 is depicted
in Equation 4.5. For fully oxygenated blood (SpO2 = 100 %) the ratio or ratios R is
about 0.4, while for a ratio R = 1, corresponding to the same relative absorption of red
and infrared light, the SpO2 is equal to 85 %. These principles of pulse oximetry allow
the noninvasive and continuous estimation of arterial oxygen saturation from red and
infrared PPG signals. Pulse oximetry had a significant impact on clinical monitoring
and it is now widely used in the hospitals around the world. The next section will
briefly describe some of the main applications of pulse oximetry.
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Figure 4.16: Pulse oximeter calibration curve. The ratio-of-ratios R is on the x-axes, while the arterial
saturation SpO2 is on the y-axes. Figure reproduced from [6].
SpO2 = 110− 25 ·R (4.5)
4.5.2 Clinical applications of pulse oximetry
Pulse oximetry has revolutionized clinical care by providing continuous and noninvasive
measurements of arterial oxygen saturation (SpO2). Pulse oximeters are commonly
used in anaesthesia and are mandatory during induction of anaesthesia [3, 4, 6]. Pulse
oximetry can be used for the detection of oxygen-deprived status such as hypoxaemia
[106–108]. The technique is used also in emergency medicine or intensive care [3,
6, 106] and in the identification of respiratory complications/diseases (e.g. obstructive
pulmonary disease, asthma, etc.) [4,6,108]. Pulse oximetry can be used in neonatal care
to monitor foetus oxygenation during labour [3, 4] or to detect apnoea in neonates [4].
Pulse oximetry probes are usually applied at extremities such as fingers or toes (in
particular in neonates). However, these locations may suffer from vasoconstriction,
degrading the quality of the PPG signal. More central locations such as the forehead
and the earlobe appear to be less susceptible to vasoconstriction and may indicate SpO2
desaturations earlier than extremities [109–111]. Other locations such as oesophagus
and ear canal have also been investigated and demonstrated that the SpO2 from these
locations is less affected by vasoconstriction compared to extremities [3, 93].
66
4.5. Pulse oximetry
Very recently, Verkruysse et al. and Shao et al. reported some results on the calibration
of non-contact pulse oximetry [112, 113]. These are based on the principles of non-
contact PPG measurements and the results may lead to an interesting future, where
SpO2 will be measured without the necessity of attaching a single sensor to the patients.
4.5.3 Pulse Co-oximetry
One of the assumptions of pulse oximetry is that the only haemoglobin species in
blood are oxygenated and deoxygenated haemoglobin. If other dyshaemoglobins such
as carboxyhaemoglobin (HbCO) or methaemoglobin (MetHb) are present in the blood,
pulse oximetry may not be able to distinguish them, giving inaccurate SpO2 measure-
ments [6]. Carboxyhaemoglobin is a haemoglobin molecule that has bound reversibly
with carbon monoxide [17]. In the red region of the spectrum, HbCO has very similar
absorption to HbO2, making it impossible to distinguish between the two and causing
false SpO2 readings, in which HbCO has been mistaken by HbO2 [4,6]. In healthy sub-
jects, HbCO does not constitute a major concern, but higher concentrations of HbCO
can be present in smokers or in carbon monoxide poisoning [6]. Co-oximeters are able
to overcome this limitation by using at least four wavelengths for the determination of
HbO2, HHb, HbCO, and MetHb [4,6]. Then, the oxygen saturation known as fractional
saturation can be expressed as the percentage ratio of HbO2 over the full haemoglobin
content [4].
FrO2 =
HbO2
HbO2 +HHb+HbCO +MetHb
(4.6)
Pulse oximeter manufacturers have recently proposed the solution of this limitation of
pulse oximetry, by providing an instrument, known as Pulse CO-oximeter, capable of
measuring the content of HbCO and MetHb in blood. The Pulse Co-oximeter uses eight
wavelengths instead of the conventional two and some studies demonstrated that it can
be used as a screening test for detection of abnormal levels of HbCO and MetHb [114].
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4.5.4 Venous saturation
As mentioned earlier, the DC component of the PPG signal contains respiratory-
induced, low-frequency oscillations. These are believed to represent blood volume
changes due to respiration. It has been proposed that these oscillations could be used
to estimate venous oxygen saturation, similarly to AC pulsations for arterial oxygen
saturation. If these low-frequency DC oscillations are isolated, a ratio Rv could be
calculated as done with the ratio R. From Rv, the venous oxygen saturation SvO2
can then be estimated. Studies evaluating this method demonstrated that SvO2 was
significantly lower than arterial SpO2, thus possibly providing venous saturation mea-
sures [115, 116]. However, challenges still remain such as validation against standard
measures of venous saturation and irregular breathing.
4.6 Limitations of PPG and Pulse Oximetry
Although photoplethysmography and pulse oximetry have found many applications in
clinical monitoring, they have some limitations that are worth mentioning.
• Movement artefacts and sensor positioning. Photoplethysmography suffers from
movement artefacts and these should be avoided during the measurement. Re-
flectance PPG sensors need to be attached properly on the skin and any detach-
ment could cause ambient light interference. Pulse oximetry measurements can
be affected by movement artefacts, but if the sensor returns in place, SpO2 mea-
sures are restored. If the movements are periodic, these can cause the generation
of pulsation of extra-arterial tissues with relative erroneous SpO2 readings. Ad-
vancements in signal processing in modern pulse oximetry allow for movement
artefact correction [108,117]. If the pulse oximeter sensor is not properly applied
to the tissue, mismatches in the red and infrared absorptions (penumbra effect)
could cause SpO2 false readings [6, 117].
• Compromised peripheral perfusion. Pulse oximetry measurements acquired from
peripheral locations such as the fingers may be affected by vasoconstriction caused
by compromised perfusion [4,108,114]. During such perfusion states, the quality
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of the PPG signal degrades and SpO2 measurements may not be accurate [108,
114,117].
• Pulse oximeters calibration. Pulse oximetry does not measure directly arterial
oxygen saturation, but it relates the measured ratio R to empirical calibrations.
These calibrations, however, are performed on healthy adult subjects [106, 114]
and may not be valid for a diverse population such as critically ill patients or
neonates [114].
• Dyshaemoglobins. As mentioned earlier, dyshaemoglobin such as carboxyhaemoglobin
and methaemoglobin can cause inaccurate SpO2 readings [6, 106, 117]. Conven-
tional pulse oximetry could not overcome this limitation, while pulse co-oximetry
appears to be able to isolate the contribution of dyshaemoglobin [114].
• Venous pulsations. Pulse oximetry relies on the pulsatile nature of arterial blood,
assuming that venous blood does not pulsate. In certain circumstances such as
changes in positions, the venous blood may pulsate. In these situations, pulse
oximeters are unable to distinguish between venous and arterial blood, giving
lower SpO2 values [4, 6, 117].
• Skin pigmentation, intravenous dyes and finger nail polish. Due to changes in
the relative absorptions at red and infrared wavelengths, skin pigmentation, in-
travenous dyes and fingernail polish can cause errors in SpO2 readings [108,117]
• Venous congestion. As mentioned earlier, the AC PPG alone may not be adequate
for the identification of venous congestions. In this regard, pulse oximetry suffers
from the same (related) limitation. SpO2 readings during venous occlusion may
still take some time before they indicate the onset of venous congestion or they
may still remain in the normoxic range [75–77,118].
4.7 Summary
In summary, this chapter described the principles of photoplethysmography and pulse
oximetry. The main clinical and research applications of the two techniques have also
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been reviewed, along with some of the limitations and open challenges. The next chap-
ter will present an overview of the principles and applications of another noninvasive
optical technique, Near Infrared Spectroscopy.
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Principles and applications of Near
Infrared Spectroscopy
Near Infrared Spectroscopy (NIRS) is a noninvasive optical technique that measures
haemoglobin concentrations and oxygenation changes in tissues. The technique ex-
ploits the transparency of tissues to the near-infrared region of the light spectrum
(700-1000 nm) in order to penetrate deep into tissues. Near Infrared Spectroscopy was
introduced among other techniques in Chapter 3, whereas the current chapter presents
a more detailed overview. The principles of the technique will be described, along with
the different typologies of Near Infrared Spectroscopy instruments and their applica-
tion. The modified Beer-Lambert law, used in Near Infrared Spectroscopy to infer
haemoglobin concentration changes, will be introduced and discussed in this chap-
ter. Finally, the limitations and the open challenges of the technique will also be
reported. This chapter is presenting the potentials that the technique offers by moni-
toring haemoglobin concentrations and oxygenation changes. In this regard, the work
in this thesis explores the feasibility of using photoplethysmography for monitoring
haemoglobin concentration changes as performed in NIRS. Therefore, after presenting
the principles of photoplethysmography in the previous chapter, this chapter aims at
presenting the principles and the advantages of in vivo Near Infrared Spectroscopy
monitoring.
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5.1 Principles of Near Infrared Spectroscopy
Near Infrared Spectroscopy (NIRS) is an opto-technique, which relies on the applica-
tion of the Beer-Lambert Law to measure haemoglobin concentrations and oxygenation
in tissue [11]. The first in vivo NIRS study has been related to Jobsis, who observed
that it was possible to monitor changes in haemoglobin oxygenation and Cytochrome
(Cyt aa3) reduction by applying light in the spectral range of 700-1300 nm (i.e. near-
infrared) through the cats’ cranium, humans’ cranium, and dogs’ myocardium. Jobsis
successfully demonstrated that the technique was able to monitor changes from nor-
moxia to anoxia states from these organs. With that study, Jobsis showed the possibility
of monitoring continuously and non-invasively the oxygenation states of haemoglobin,
Cyt aa3, and blood volume, founding the basis for in-vivo NIRS [21].
Light interaction in tissue is composed of light absorption by chromophores and by ab-
sorption and light scattering. Visible light, between 450-700 nm, is strongly attenuated
due to high absorption, being unable to penetrate more than 1 cm into tissues [12].
The near-infrared region of the light spectrum is between 700 and 1100 nm and light
absorption in this range is relatively low, creating a zone of relative transparency in
tissues [12, 21]. In this part of the spectrum, there are three major chromophores:
oxygenated haemoglobin (HbO2), deoxygenated haemoglobin (HHb), and reduced or
oxidised forms of Cytochrome Oxidase (CtOx) [11,12,119]. As introduced in Chapter 2,
haemoglobin is responsible for the transport of oxygen in blood and for the release of
oxygen into tissues, whereas CtOx is an enzyme involved in the electron chain of oxygen
metabolism in cells [11]. These chromophores have the peculiarity of changing their
light absorption properties depending on their oxygenation state [11, 12, 119]. Each
chromophore has an absorption spectrum, in which the absorption of light is expressed
as a function of wavelength. The absorption spectra of HbO2, HHb, and CtOx in
the near-infrared region are presented in Figure 5.1, where their different wavelength-
dependent absorption characteristics in the near-infrared region are described by the
curves. The isobestic point (between 800-810 nm) is the only point in the spectrum
where deoxygenated haemoglobin and oxygenated haemoglobin have the same absorp-
tion characteristics (i.e. extinction coefficient). NIRS uses the different absorption
properties of these chromophores to quantify their concentrations in tissues. The prin-
ciple used is based on the application of the Beer-Lambert law. Although some NIRS
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Figure 5.1: Absorption spectrum of oxygenated haemoglobin (HbO2), deoxygenated haemoglobin (Hb) and
Cytochrome Oxidase (CtOx) in the near-infrared range. The absorption is expressed as specific extinction
coefficient. Figure reproduced from [119].
instruments allow the additional estimation of CtOx, this chapter will mainly focus on
the determination of oxygenated and deoxygenated haemoglobin only.
The Beer-Lambert law relates the absorption of light passing through a solution to the
concentration of the chromophores present in the solution and the pathlength travelled
by light [11,24]. Initially, Lambert described the decrease in light intensity as dependent
on the distance travelled by the light beam as in Equation 5.1.
I = I0 exp−µl (5.1)
Where I0 is the intensity of the light applied to the substance, I is the measured trans-
mitted and light intensity, µ is the absorption coefficient, expressing the substance’s
light absorption (in cm−1), and l is the distance travelled by the light beam. Later
on, Beer contributed to the concept by stating that decrease of light intensity is also
due to the concentration of light absorbers in the substance. Therefore, the absorption
coefficient µ can be expressed as µ = ε × c and Equation 5.1 becomes:
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I = I0 exp−εcl . (5.2)
Where I0 is the intensity of the light applied to the substance, I is the measured
transmitted light intensity, ε is the specific extinction coefficient (or molar absorptivity)
of the substance, c is the chromophore concentration and l is the distance travelled by
the light in the substance [11, 12, 17, 24]. The specific extinction coefficient ε describes
the relationship between absorption properties of a substance (or chromophore) and
the light wavelength (see Figure 5.1). As shown later, the extinction coefficient plays
a determinant role in distinguishing two substances from each other (e.g. oxygenated
and deoxygenated haemoglobin) [11,17].
By reordering Equation 5.2 and applying the logarithm, the equation can be expressed
as:
A = ln
(
I0
I
)
= ε · c · l. (5.3)
The left side of the equation represents the light attenuation A (in natural logarithm),
also known as optical densities (OD), and directly relates to the concentration of the
light absorbers [11]. Equation 5.3 has been reported in both natural and base 10
logarithms, but in this work the natural logarithm convention will be used.
If the substance is composed of the mixture of multiple chromophores, the addictive
property of the extinction coefficients allows expressing the total light attenuation A
as the linear sum of the contribution of each chromophore’s concentration as showed
in Equation 5.4.
A = (ε1 · c1 + ε2 · c2 + ...εn · cn) · l. (5.4)
This generalised equation can be also described in terms of the light wavelength λ.
Aλ = (ε1λ · c1 + ε2λ · c2 + ...εnλ · cn) · l. (5.5)
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Where Aλ is the light attenuation at the wavelength λ, εnλ is the extinction coefficient
of substance n at wavelength λ, and cn is the concentration of substance n. Equation 5.5
is an equation with n unknowns (i.e. chromophores concentrations). In order to solve
this, at least n equations are required. By applying light at different wavelengths (λ1,
λ2, ..., λn), at which the chromophore’s extinction coefficients differ, Equation 5.5 will
become an exactly determined system [17].
Aλ1 = (ε1λ1 · c1 + ε2λ1 · c2 + ...εnλ1 · cn) · l
Aλ2 = (ε1λ2 · c1 + ε2λ2 · c2 + ...εnλ2 · cn) · l
...
Aλn = (ε1λn · c1 + ε2λn · c2 + ...εnλn · cn) · l
(5.6)
By using multi-component analysis, the system of equations in Equation 5.6 can be
solved in order to estimate the concentrations of the chromophores. This principle
is used in NIRS for the estimation of the concentration of oxygenated HbO2 and de-
oxygenated haemoglobin HHb. For the calculation of these two chromophores, Equa-
tion 5.5 is applied at least at two wavelengths in the near-infrared region. These two
wavelengths are usually selected on opposite sides with respect to the isobestic point of
the haemoglobin absorption spectra (i.e. 800-810 nm). Wavelengths are often selected
at both sides of the isobestic point of the spectra because HbO2 and HHb have opposite
absorption properties and, therefore, considerably different extinction coefficients ε (see
Figure 5.1). A minimum of two wavelengths is required for the estimation of HbO2 and
HHb, but additional wavelengths can be used, particularly if other chromophores’ con-
centrations such as CtOx should be derived [11]. For the specific purpose of calculating
the concentrations of HbO2 and HHb by NIRS, the system in Equation 5.6 transforms
to:
Aλ1 = (εHbO2λ1 · [HbO2] + εHHbλ1 · [HHb]) · l
Aλ2 = (εHbO2λ2 · [HbO2] + εHHbλ2 · [HHb]) · l.
(5.7)
Where Aλ1 and Aλ2 are the light attenuations at wavelengths λ1 and λ2 respectively,
εHbO2λ1 and εHHbλ1 are respectively the extinction coefficients of HbO2 and HHb at
wavelength λ1, εHbO2λ2 and εHHbλ2 are respectively the extinction coefficients of HbO2
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Figure 5.2: Effects of scattering on light propagation through a medium. In the non-scattering medium the
emitted light beam with intensity I0 does not undergo scattering and the detected beam I is only attenuated due
to absorption. The light path length travelled by light corresponds to the thickness of the sample. A different
behaviour can be noticed in the scattering medium. The light undergoes scattering in the sample, causing a
prolonged light path length as well as the dispersion of some of the emitted light (i.e. P2), which does not reach
the detector. Figure reproduced from [12].
and HHb at wavelength λ2, [HbO2] and [HHb] are the concentrations of oxygenated
and deoxygenated haemoglobin, and l is the pathlength travelled by light. Equation 5.7
assumes that HbO2 and HHb are the only chromophores present in the solution, which
does not hold for tissues, where other absorbers such as lipids, melanin, and myoglobin
could contribute to the overall light absorption. Later in the chapter, the approach
used in NIRS to deal with this assumption will be described.
5.1.1 The Modified Beer-Lambert law
The Beer-Lambert law described so far is based on the assumption that light only
undergoes absorption. However, this assumption is not valid in tissues, where near-
infrared light attenuation due to scattering dominates compared to absorption (roughly
80 % scattering vs. 20 % absorption) [12, 23]. The first implication on the use of
the Beer-Lambert law in presence of scattering is the impossibility of quantitatively
determining the actual light attenuation, since some part of the scattered light will
not reach the detector. [12]. Secondly, multiple scattering in tissue causes an increase
of the pathlength travelled by light [11, 12]. Figure 5.2 visually represents both these
scattering effects.
The modified Beer-Lambert law (MBLL) takes into account of the effects of scattering
in tissues, by transforming Equation 5.5 in:
Aλ = (ε1λ · c1 + ε2λ · c2 + ...εnλ · cn) · d ·DPF +G. (5.8)
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Where DPF is the Differential Pathlength Factor, expressing the increase of the light
path length due to scattering and relating the emitter-detector separation distance d to
the effective pathlength travelled by light (l = d×DPF ) [11,12,23]. The factor G is a
scattering factor, which expresses both the nature and the geometry of the tissue [11].
The DPF is a unit-less, wavelength-dependent coefficient [119] and it can be measured
by Time Resolved Spectroscopy (time of flight) or Phase Modulated Spectroscopy (both
described later in this chapter) [120, 121]. The DPF is dependent on the type of tis-
sue [120,121] and gender [120,121], but a constant range was found for emitter-detector
distances d > 2.5 cm [120]. The mean DPF values measured by Time Resolved Spec-
troscopy for the adult forearm (DPF = 3.59), neonate head (DPF = 3.85), and adult
head (DPF = 5.93) are still used nowadays for quantification of HbO2 and HHb con-
centrations by NIRS.
Since the invention of NIRS, several measurement techniques have been introduced for
the quantification of the concentrations of HbO2 and HHb. These techniques, which
differ in their measurements principles, will be briefly described in the next sections.
5.2 NIRS Measurement Techniques
5.2.1 Time Resolved Spectroscopy
Time Resolved Spectroscopy (TRS), also known as Time domain NIRS, is an NIRS
technique that allows the solution of the modified Beer-Lambert and determination of
absolute concentration values of HbO2 and HHb. The technique determines the optical
properties of the tissue by observing the temporal distribution of light in tissue (time
of flight).
In TRS, a small impulse of coherent light is emitted to the tissue. The impulse lasts
a few tens of picoseconds and is produced by means of lasers [24, 119, 122]. Light
is emitted to and collected from the tissue by optical fibres. The detected light is
collected by a photomultiplier in photon-counting mode, which orders the photons by
their time of arrival [119] . This detected signal is defined as Temporal Point Spread
Function (TPSF) and presents the distinctiveness of being “delayed, broadened, and
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attenuated” with respect to the emitted impulse of light [122]. Figure 5.3 shows an
example of TPSF measured from the brain. The TPSF contains information on the
temporal light propagation into the tissue due to light path length (time delay and
broadening), the attenuation due to absorption and scattering (attenuation, tail’s slope,
and broadening) [122]. Once the TPSF has been obtained, the median intensity (50th
percentile) is extrapolated for the determination of the average arrival time of the
photons [11, 123]. Once this time tm has been determined from the TPSF, the light
path length L can be calculated (knowing the speed of light in vacuum c and the
refractive index of the tissue n).
L = c · tm
n
. (5.9)
Also, the diffusion equation, expressing the light reflectance in function of time and
space, can be used to estimate the absorption and scattering properties of the tissue (µa
and µ′s) [24,122]. Once the time of flight and relative light pathlength have been derived,
the TPSF can be measured at different wavelengths (at least two) [122]. The absorption
and scattering properties of the tissue at several wavelengths can be extrapolated by
fitting the measured TPSF (i.e. temporal and spatial information) and the solution to
the diffusion equation [24, 122]. Once µa and µ′s are obtained, absolute concentrations
of HbO2 and HHb can be calculated from the modified Beer-Lambert law [11,24,122].
5.2.2 Phase Modulated Spectroscopy
Phase Modulated Spectroscopy (PMS) or Intensity Modulated Spectroscopy is an NIRS
measurement technique that exploits the intensity and, more particularly, the phase
shift that light experiences in tissues. When light, modulated in both frequency and
intensity, is emitted into tissues, it undergoes constant attenuation in continuous in-
tensity (DC) and in the alternated component (AC), as well as a phase shift in the AC
component [11, 24]. This is showed in the simulation presented in Figure 5.4, where
a modulated incident light is constantly attenuated in both DC and AC components,
while it undergoes a phase shift as well. The attenuation in DC and AC increases with
increasing scattering µ′s. Therefore, the detected light I can be expressed in the form
of the DC and AC detected signals (respectively IDC and IAC):
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Figure 5.3: Example of Temporal Point Spread Function (TPSF) measured in the brain. The emitted impulse
(dotted line) lasts only a few picoseconds and it is centred at the zero point on the time scale. The detected
photons are detected and ordered on their arrival time, forming the TPSF curve (continuous line). The TPSF
is attenuated in intensity and broadened in time due to absorption and scattering. The time delay t is the
mean time of arrival of the photons, used for estimating the mean light path length by Equation 5.9. Figure
reproduced from [24]
Figure 5.4: Simulation of the light attenuation and phase shift of modulated incident light in Phase Modulated
Spectroscopy for different scattering coefficients. The modulated incident light (dashed line) is attenuated in both
continuous and alternated component (continuous lines). The attenuations increase with increasing scattering
µ′s. Also, the detected light intensities experience a delay (shift) in frequency. Figure reproduced from [24].
I = IDC + IAC · (2pifet+ φ). (5.10)
Where, fe is the modulation frequency of the emitted light, φ is the shift in frequency,
and t is time.
In PMS, a phase and intensity modulated light (usually in the radio frequencies) is
emitted to the tissue and the measured attenuations and frequency shift are used to
estimate the light path length and the absorption and scattering properties of the
tissue [11,24,119]. The light path length L can be estimated from the shift in frequency
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φ, the modulating frequency fe, the refractive index of the tissue n, and the speed of
light in vacuum c [11].
L = φ · c2 · fe · n (5.11)
The absorption and scattering properties of the tissue µa and µ′s are estimated in PMS
by solving a derivation of the diffusion equation [11,24]. With this method, the AC and
DC detected intensities, along with the phase shifts are measured from two detectors
placed close to each other. The measurement of these variables at two locations allows
to fit these in a light diffusion model, in order to extract µa and µ′s [11, 24, 119]. Once
µa and µ′s are derived at least two wavelengths, absolute concentrations of HbO2 and
HHb can be calculated from the modified Beer-Lambert law [11].
5.2.3 Continuous wave NIRS
Continuous wave (CW) NIRS instruments are the earlier versions of the NIRS instru-
ments [119]. As the name suggests, continuous light intensities are emitted in the tissue
by means of laser diodes or light emitting diodes (LED). The backscattered light is then
detected by a photodiode or photomultiplier tube [11,24,119].
CW NIRS instruments ignore the originally emitted intensity, requiring the adoption
of a different approach for the solution of the MBLL in Equation 5.8. The differen-
tial solution of the MBLL is used in CW NIRS, consisting in representing the changes
in attenuation from the baseline (start of the measurement) instead of the absolute
attenuation. These changes in attenuation are then related to relative changes in con-
centrations of HbO2 and HHb. Therefore, the differential version of Equation 5.8, for
HbO2 and HHb becomes:
∆Aλ1 = (εHbO2λ1 ·∆[HbO2] + εHHbλ1 ·∆[HHb]) · d ·DPF + ∆G
∆Aλ2 = (εHbO2λ2 ·∆[HbO2] + εHHbλ2 ·∆[HHb]) · d ·DPF + ∆G.
(5.12)
Where, ∆Aλn is the light attenuation change at wavelength λn, ∆[HbO2] and ∆[HHb]
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are the relative changes from the baseline of HbO2 and HHb, and ∆G are the changes
in scattering. The changes in attenuation ∆Aλn are expressed as ln
(
I(0)
I(t)
)
; with I(0)
being the light intensity at the baseline (or start of the measurement) and I(t) is the
light intensity throughout the measurement. This allows relating the changes in light
attenuation to the changes in concentrations of HbO2 and HHb. The DPF can be
utilised from TRS or PMS measurements previously acquired from different tissues
[120]. If the DPF cannot be derived from the literature, the changes in concentration
∆[HbO2] and ∆[HHb] can be expressed as relative to the path length in mM · cm
(concentration × optical path length).
In order to solve the system of equations in Equation 5.12, few assumptions should be
made. Firstly, it should be assumed that HbO2 and HHb are the only chromophores
changing concentration throughout the short measurement. Secondly, assuming that
the scattering factor G is constant during the measurement allows to rule out the scat-
tering contribution (∆G = 0), and then solving the system for at least two wavelengths.
These assumptions can be valid for the relatively short NIRS measurements, in which
the tissue’s optical properties are assumed constant. Furthermore, the method assumes
that the detected light attenuation is only due to haemoglobin concentrations. Other
absorbers such as myoglobin or lipids could be considered constant for the measurement
duration. However, for prolonged measurements (several hours) or during muscle con-
traction (possible change in myoglobin) the CW NIRS methods may suffer the influence
of other absorbers in tissue.
The CW NIRS measurements are highly sensitive, fast, economical, and the adopted
technology (LEDs/photodiodes) offers a greater level of flexibility, simplicity, and minia-
turisation when compared to TRS or PMS instruments [24].
5.2.4 Spatially Resolved Spectroscopy
Spatially Resolved Spectroscopy (SRS) is an extension of CW NIRS that allows the
estimation of tissue oxygenation (often known as TOI, StO2, or rSO2). In SRS, the
optical properties of the tissue are derived from the spatial distribution of light at-
tenuation with respect to the photodetectors’ distance. When two photodetectors are
placed close to each other, the detected light intensities emitted from a single source
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(i.e. in reflectance configuration) yield information on the optical properties of the tis-
sue measured. By solving the diffusion approximation for a highly scattering medium
(µa  µ′s), the attenuation A, with respect to the photodetectors’ distance ρ, can be
expressed as follows:
∂A
∂ρ
= 1ln 10 ·
(√
3 · µa · µ′s +
2
ρ
)
. (5.13)
Equation 5.13 can be solved by approximating µ′s as constant in the near-infrared region
(µ′s = k). By doing this, the equation can be solved to determine the absorption term
k · µa [124]. However, the scattering coefficient µ′s varies slightly with the wavelength
and a scaling factor h can be introduced to consider the wavelength dependence of µ′s
(i.e. h is the normalised slope of µ′s with respect to λ). Thus, the factor k · µa can be
calculated from Equation 5.13.
k · µa(λ) = 13 · µ′s(λ)
·
(
ln 10 · ∂A
∂ρ
− 2
ρ
)2
; With: µ′s(λ) = k · (1− h · k) (5.14)
By applying light at least two wavelengths, the absorption coefficients k · µa(λ) can be
obtained at different wavelengths. By considering that µa = ε × c, a solvable system
of equation can be created.
k · µa(λ1) = εHbO2λ1 · k · [HbO2] + εHHbλ1 · k · [HHb]
k · µa(λ2) = εHbO2λ2 · k · [HbO2] + εHHbλ2 · k · [HHb]
(5.15)
From the system of equations above, the relative concentrations of oxygenated and
deoxygenated haemoglobin k · [HbO2] and k · [HHb] can be obtained [11,124].
Even though absolute concentrations of HbO2 and HHb cannot be obtained by SRS,
the relative concentrations k · [HbO2] and k · [HHb] can be used to calculate the Tissue
Oxygenation Index (TOI).
TOI = k · [HbO2](k · [HbO2] + k · [HHb]) × 100(%) (5.16)
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Figure 5.5: SRS measurement and schematic of a multi-distance SRS sensor. The emitter shines light into
the tissue and three detectors, placed close to each other, measure the light attenuation A as a function of their
distance ρ from the emitter. Figure reproduced from [124].
The TOI is expressed in percentage and represents the haemoglobin oxygenation sat-
uration of the sampled volume of tissue. Equation 5.16 expresses the tissue oxygen
saturation measured in the SRS case, but the same formula can be applied to TRS or
PMS absolute measurements of HbO2 and HHb. Figure 5.5 shows an example of SRS
measurement and sensor, where three photodetectors are placed close to each other for
the measurement of ∂A∂ρ .
Due to the multi-distance approach and the derivation of the measurement relative to
the two detectors, the SRS is considered less susceptible to the superficial structures
within the light-path. When applied on the forehead for the monitoring of cerebral
oxygenation, SRS-derived TOI demonstrated to be affected by clamping of the internal
carotid artery, while there were no changes and no association with LDF measures
when the external carotid was clamped [125].
Depending on the device manufacturers, TOI is also referred in the literature as StO2
or rSO2, but the acronym TOI will be used throughout this thesis in order to avoid
confusion to the reader.
Figure 5.6 shows a collection of NIRS measurements acquired by CW, PMS and SRS
during vascular occlusions on the forearm. The CW NIRS instrument expressed the
changes in relative units of concentration (µM · cm), the PMS device estimated the
absolute concentrations, and the SRS derived the tissue oxygenation index TOI.
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Figure 5.6: Changes in relative and absolute haemoglobin concentrations and tissue oxygenation measured by
NIRS at the brachioradialis during total occlusion. (A) Changes in relative concentrations of oxygenated (O2Hb),
deoxygenated (HHb), and total haemoglobin (tHb) measured by a continuous wave NIRS instrument. (B)
Changes in absolute concentrations of O2Hb, HHb, and tHb measured by a phase modulated NIRS instrument.
(C) Tissue oxygenation index (TOI) measured by a spatially resolved spectroscopy instrument. All measurements
were acquired from the brachioradialis during vascular occlusion at 250 mmHg, occluding both veins and arteries.
Vertical lines indicate the duration of the occlusion. In (A) and (B), the increases in HHb and tHb indicate the
engorgement of the venous circulation, while the drop in O2Hb is due to the occlusion of the arterial inflow.
Figure reproduced from [13].
After describing the principles of NIRS and the different typology of NIRS measure-
ments, the following sections will provide an overview of the different clinical and re-
search applications of NIRS. However, before introducing the applications of NIRS, it
is necessary to discuss the penetration depth of NIRS measurements and the origin of
the NIRS signals, which still remain among the main topics of debate in NIRS research.
5.3 Penetration depth and origins of NIRS signal
5.3.1 Penetration depth of NIRS signal
NIRS is been known for its great ability to penetrate deep into tissues. The tech-
nique has been initially applied on neonates’ head because the light could be shone
from one side of the head to the other (i.e. transmission mode). The same cannot be
generally applied to adult’s head due to the greater head’s diameter and scalp/skull
thickness. Therefore, the technique is almost always applied in reflectance mode, with
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both emitter and detector on the same side of the tissue. When in reflectance mode,
NIRS light diffuses in tissue in a banana-shaped arc. The penetration depth of this
light beam is dependent on the specific wavelength used (i.e. absorption and scattering
are wavelength-dependent) and the emitter-detector separation distance. For separa-
tion distances greater than 2.5 cm, Van der Zeer et al. found that the DPF measured
by TRS was constant, indicating that this value is the minimum suggested distance to
obtain a penetration depth constantly proportional to the emitter-detector separation
distance [120]. Although increasing the separation distance increases the penetration
depth, it also causes a decrease in the overall signal quality due to high absorption.
Thus, a separation distance greater than 5 cm should be avoided in NIRS measure-
ments [22]. The quality of the signal for larger separation distances can be improved
by increasing the light intensities, but this may cause overheating of the tissue. The
typology of tissue affects the penetration depth due to different scattering and absorp-
tion properties (i.e. absorption is inversely proportional to the DPF, while scattering
is directly proportional) and different fat thickness [120, 121, 126]. For instance, NIRS
seems to penetrate more on the head (DPF = 5.93) than the muscle (DPF = 3.59), due
to higher scattering in cerebral tissue [120]. Overall, the effective penetration depth
of NIRS measurements is difficult to predict, it can only be simulated by Monte Carlo
simulations, and it may vary on the measurement type (TRS, PMS, or other), wave-
lengths, instrumentation, or the complexity of the simulation model [24,119]. For these
reasons, the exact prediction of tissue penetration is still under debate and it cannot be
quantified for each single measurement. However, it is common practice to consider the
penetration depth to be between one-half and one-third of the actual emitter-detector
separation distance [13,22,23,127]. For instance, when an NIRS sensor with an emitter-
detector separation distance of 4 cm is used, the penetration depth of the measurement
can be considered to be roughly between 1.33 and 2 cm.
5.3.2 Origins of the NIRS signal
Due to the deep penetration, NIRS signals are believed to originate from the tis-
sues’ microcirculation. Large vessels such as arteries and veins are considered to affect
NIRS measurements, mainly because light is strongly absorbed by these structures [13].
Therefore, the NIRS signal represents a mixed sample volume composed by arterioles,
capillaries, and venules [12, 13, 22, 128, 129]. The structural composition of tissues un-
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Figure 5.7: Model representing light penetration in NIRS muscle measurements for high and low adipose tissue
content. Light diffuses in tissue in a banana-shape arc and the maximum penetration depth is about half of
the emitter and detector distance (in this figure, the separation distance is 3.5 cm). In the case of high adipose
tissue content, only 49 % of the signal passes through the muscle. In situations of a normal or low adipose tissue
content, most of the light (92 %) passes through the muscle. Figure reproduced from [127].
der normal conditions yields the contribution of arterial-venous blood [22,23,129]. For
instance, cerebral tissue is mostly composed of venous blood (30 % arterial blood and
70 % venous blood) [22]. Generally, the partitioning of the microcirculation is 10 %
arterioles, 20 % capillaries, and 70 % venules [128,129]. Due to the mixed nature of the
NIRS sampled volume, the tissue oxygen saturation measured by NIRS (Equation 5.16)
represents a mixed saturation between arterial and venous blood. This saturation tends
to follow the venous saturation and it has the advantage of indicating a balance be-
tween oxygen supply and oxygen consumption of tissue [13,23,129]. This also explains
why the tissue saturation measured by NIRS is always lower than the arterial oxygen
saturation SpO2 measured by pulse oximetry. NIRS does not discriminate between
arterial blood, capillaries, and venous blood, whereas pulse oximetry assesses only the
arterial blood by filtering the pulsatile component of the signal [12,129].
5.4 Clinical and research applications of NIRS
The previous sections described the principles of NIRS. The technique has found many
clinical and research applications and this section wants to overview some of these.
Although NIRS is relatively new compared to other traditional physiological measure-
ments, the technique has been investigated for a multitude of applications and these
are covered in the extensive literature on the subject. This section offers an overview
of some of the main applications of NIRS.
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5.4.1 Cerebral perfusion, oxygenation and blood flow
NIRS monitoring of changes in cerebral haemoglobin oxygenation saturation (cerebral
oximetry) is considered the primary application of NIRS, with a significantly vast lit-
erature. The reason for the focus of NIRS on cerebral monitoring is the ability of
near-infrared light to penetrate the skull, thus allowing the monitoring of cerebral per-
fusion and oxygenation transcutaneously and noninvasively.
In surgery, cerebral NIRS monitoring (cerebral oximetry) can provide valuable infor-
mation in situations when cerebral perfusion may be compromised. Cerebral oximetry
demonstrated to improve patients’ clinical outcomes when cerebral oxygen saturation
was monitored and restored during coronary artery bypass [22]. Cerebral oximetry was
also found to detect desaturations and changes in perfusion during different scenarios
such as aortic dissection, deep hypothermic circulatory arrest, and carotid endarterec-
tomy [22]. In this context, desaturations greater than 25 % or an absolute saturation
less than 45 % correlated with poor postoperative outcomes [25]. During carotid en-
darterectomy, a sudden drop in TOI greater than 13 % indicated the clamping of the
internal carotid [130].
Decreases in cerebral oxygen saturation were found to be correlated with hypoxic events
in adults and pre-term neonates [131,132], whereas oscillations in the inspired fraction
of oxygen > 3 % reflected variations in the NIRS cerebral oxygen saturation measured
in neonates [133].
By using oxygen as a tracer and the Fick’s principle, cerebral blood flow (CBF) and
volume (CBV) can be derived from NIRS measurements [23, 134]. CBF can be cal-
culated from the increase in HbO2 or HbdD (HbdD = HbO2 - HHb) concentrations
after a sudden increase in inspired fraction of oxygen (FiO2), whereas CBV can be
determined from the change in HbO2 (or HbdD) after a slow change in FiO2 [134]. The
cerebral NIRS signals can also be used to assess vasomotor reactivity during breath
holding in healthy volunteers and to distinguish between healthy, smokers, and stroke
patients [135]. Changes in cerebral NIRS signals can also indicate gravitational changes
caused by head-up or head-down bed tilting [136].
Frequency domain analysis of cerebral NIRS signals can provide important informa-
87
5.4. Clinical and research applications of NIRS
Figure 5.8: Changes in cerebral oxygen saturation (TOI) during clamping in carotid endarterectomy. External
carotid clamping (ECA) causes the forehead laser Doppler signal (LDF) to drop, whereas TOI and transcranial
Doppler flow (FVm) do not vary. Contrary, clamping of the internal carotid artery (ICA) generates a drop in
both TOI and FVm, whereas LDF remains constant. When the carotid shunt is inserted, TOI and FVm return
to values close to the baseline. Arterial blood pressure (ABP), measured via a catheter in the radial artery,
remains mostly stable throughout the procedure. Figure reproduced from [130]
tion related to stimulation, vasomotion, or cerebral autoregulation. Low and very
low-frequency oscillations in NIRS variables demonstrated to be related to functional
visual activation and hypercapnia [137]. Differences in low-frequency oscillations of
HbO2 and TOI were also found during posture changes between supine, standing, and
sitting positions, whereas there were no significant changes in the variables between
the different positions [138]. During haemorrhage, low-frequency oscillations of cere-
bral TOI were correlated with autoregulation indexes from transcranial Doppler, thus
indicating cerebral autoregulation [139].
5.4.2 Muscle perfusion and oxygenation
Monitoring muscle perfusion and oxygenation noninvasively may be challenging due
to the depth at which muscles lay from the surface of the skin. NIRS provides the
means for monitoring perfusion and oxygenation changes in muscle. Hampson and
Piantadosi pioneered the NIRS monitoring of skeletal muscle. In their earlier paper,
Hampson and Piantadosi demonstrated that changes in forearm’s skeletal muscle could
be monitored by NIRS. An NIRS sensor was placed on the skin, above the left forearm
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(a) (b)
Figure 5.9: Changes in oxygenated (tHbO2), deoxygenated (tHb), and total blood volume (tBV) measured by
NIRS during cuff-induced ischaemia (a) and venous occlusion (b). In (a), occlusion of both arterial and venous
vasculatures (ischemia) causes a decrease in tHbO2 and a simultaneous increase of tHb, while the total blood
volume (expressed as the sum of tHbO2 and tHb) does not change. At the release of occlusion, the variables
return to baseline after a hyperaemic shoot. In (b), venous occlusion causes an increase in tHb and total blood
volume tBV, while tHbO2 remains unchanged. The ischemic occlusion lasted for 8 minutes, whereas venous
occlusion was performed for 5 minutes. The concentration of cytochrome oxidase Cyta, a3 is depicted along
with the haemoglobin concentrations. Figure reproduced from [140].
musculature (brachioradialis) and vascular occlusions were produced by inflating a cuff
placed around the left arm. The trends in the changes of HbO2 and HHb indicated that
it was possible to distinguish between forearm ischaemia (i.e. occlusion of both venous
and arterial vasculature) and venous occlusion in the forearm. As showed in Figure 5.9,
ischaemia caused a rapid decrease of HbO2 and an increase in HHb. Contrarily, the
venous occlusion produced an increase in HHb only. The authors also verified that
the changes were mostly originating from the muscle, since the PO2 measured on the
skin and the NIRS signals from the control forearm did not vary [140]. The methods
introduced by Hampson and Piantadosi are still used nowadays to assess muscle activity
and they are often used as a primary in vivo test for NIRS instrumentation [141–143].
The changes in NIRS signals measured from muscle can also be used to assess the
muscle’s oxygen metabolism in vivo, at rest and during exercise. Muscle oxygen con-
sumption (VO2) can be assessed by analysing the rate of changes in NIRS haemoglobin
concentrations during induction of vascular occlusions. The rate at which HbD, defined
as HbD = HbO2 - HHb, or HbO2 only, changes during total occlusion was found to
correlate with muscle’s VO2 and was able to indicate a greater VO2 for muscles during
exercise than at rest [144–147]. Figure 5.10 shows an example of the rate of HbO2
measured by Hamaoka et al. during both rest and exercise. VO2 can also be estimated
from the rate of increase in HHb concentration during venous occlusion [148], but it
may be less reproducible compared to the total occlusion method [147]. Muscle blood
flow may additionally be assessed from NIRS signals by analysing the rate of increase
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Figure 5.10: Decline rate of HbO2 during arterial occlusion at both rest and after exercise (grip). NIRS
measurement was performed from the finger flexor muscles. An arterial occlusion at rest was followed by a grip
exercise and another occlusion quickly after the muscle’s exercise. The oxygen consumption of the muscle was
calculated from the slope of the change during occlusion. The slope was significantly steeper after exercise,
indicating an increased oxygen consumption. Figure reproduced from [146]
of tHb (tHb = HbO2 + HHb) during venous occlusion [148,149].
During muscle exercise, the haemoglobin concentrations measured from muscles vary
consistently with the metabolic demand of the tissue. Muscular workload usually causes
a decrease in HbO2 and a simultaneous increase in HHb, which indicate the elevated
oxygen demand (HbO2) and oxygen consumption (HHb) [141,150–152]. The decrease in
total haemoglobin indicates the blood flow/oxygen supply occlusion due to the increased
intramuscular pressure in contracting muscles [153]. Also, as showed in Figure 5.11,
the tissue oxygen saturation measured at the muscle can indicate deoxygenation due to
muscle exercise [141,152]. The tissue oxygen saturation index, representing the balance
between oxygen supply and oxygen consumption, provides important insights into the
muscle metabolism during exercise. The slope of decline in tissue oxygen saturation
during contraction represents the increased oxygen demand and consumption of the
muscle. The difference between the minimum value during contraction and baseline
values indicates the oxygen demand in relation to the oxygen supply. At the end of
the exercise, the increase of saturation, with respect to the baseline, indicates a greater
oxygen supply than the actual oxygen demand by the tissue [153]. Changes in HbO2
and HHb measured by NIRS during exercise were compared to lactate levels in blood,
observing a good correlation between lactate accumulation in blood and the point of
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Figure 5.11: Changes in haemoglobin concentrations and tissue oxygen saturation during sequential, increasing
muscle’s contractions, and ischaemic occlusion. Measurements were performed by placing the NIRS sensors on
the flexor digitorum superficialis. The workload was increased in 10 %, 30 %, and 50 % of the maximal voluntary
contraction (MVC). Along with changes in haemoglobin concentrations, the changes in tissue oxygen saturation
(TSI) indicates the muscle’s deoxygenations. After few minutes of rest, ischaemia is produced by inflating a cuff
placed on the arm (occlusion pressure of 250 mmHg). Figure reproduced from [141].
inflexion of HbO2 and HHb during exercise [154].
A fascinating advancement in monitoring muscle oxygenation/metabolism by NIRS is
the multichannel approach, also known as NIRS imager. By placing different emit-
ters and detectors over a wide area and analysing the optical attenuation at different
wavelengths, it is possible to reconstruct an image of perfusion/oxygenation in mus-
cles. The created image(s) represents the spatial and temporal changes of haemoglobin
concentrations in the measured area [155]. Figure 5.12 shows an example of NIRS-
muscle-imaging during contractions of the thigh muscles.
5.4.3 NIRS in critical care and perioperative monitoring
NIRS can be adopted to monitor perfusion and oxygenation in critical care and for
perioperative assessment. Monitoring peripheral tissue oxygen saturation (TOI) in
these patients may help clinicians in guiding therapy and detect hypoperfusion events
that may be undetected by conventional macrocirculation parameters (e.g. blood pres-
sure) [25, 129]. The rationale behind this approach is the possibility of monitoring
early compensatory mechanisms that will change peripheral perfusion to protect cen-
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Figure 5.12: Example of NIRS muscle imager. The changes in concentration of oxygenated (DO2Hb), deoxy-
genated (DHHb), and total haemoglobin (DtHb) are represented in time and space. A colour-map is used to
classify the amount of concentration change in the measured area. The image represent sequential contractions
of the thigh muscles. Figure reproduced from [155].
tral organs such as the brain [25]. The TOI values measured at the thenar eminence
demonstrated to discriminate between no-shock and severe shock patients, whereas a
TOI > 75 % can be considered an indicator of survival after trauma [25].
However, the absolute values of TOI can vary between subjects, thus several efforts
have been made to analyse the response of NIRS variables during a vascular occlusion
test (VOT), rather than the absolute values of TOI. Girardis et al. measured the
blood flow and oxygen consumption from the increase rates of total haemoglobin and
deoxygenated haemoglobin respectively during venous occlusion. The NIRS parameters
measured from the brachioradialis of septic patients were significantly different from
the non-septic and control groups, while the absolute values of TOI were similar among
all groups [156]. In a similar approach, Gomez et al. analysed the dynamics of TOI
and total haemoglobin changes during a VOT in an attempt of discriminate between
trauma patients and healthy subjects. Significant differences were observed between
trauma patients and controls in the recovery rate of TOI and total haemoglobin at the
release of an over-systolic occlusion. Again, there was no difference in TOI baseline
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Figure 5.13: Changes in NIRS parameters during venous and arterial thrombosis in flaps postoperative mon-
itoring. Left side plot: venous thrombosis. Right side plot: arterial thrombosis. During venous thrombosis,
deoxygenated (Hb) and total haemoglobin (HbT) increase, while oxygenated haemoglobin (HbO2) drops along
with the tissue oxygen saturation (StO2). During arterial thrombosis, similar trends take place, but with total
haemoglobin dropping and StO2 falling more rapidly than venous occlusion. Figure reproduced from [27].
values between the two groups [157]. In an animal model of induced shock (28 % of
blood loss), Beilman et al. found that changes in TOI measured on the leg, on the
stomach, and on the liver were highly correlated with traditional measures of oxygen
delivery [158].
NIRS can be adopted for the perioperative flap monitoring in plastic surgery. Ear-
lier animal studies demonstrated the ability of the technique to indicate changes in
haemoglobin concentrations due to venous and arterial occlusion [26, 159]. The tech-
nique has been later investigated in human flaps for the identification of postoperative
complications. NIRS was able to indicate all the occurrences of venous and arterial
occlusions, with the ability to differentiate between venous or arterial occlusion (see
Figure 5.13) [27].
5.4.4 Functional Near Infrared Spectroscopy (fNIRS)
The NIRS technique can also be applied for the analysis of haemoglobin concentration
changes as an indication of brain activation. The haemoglobin changes are usually
defined as Blood Oxygenation Level Dependent (BOLD) and the technique is known
as Functional NIRS (fNIRS). In cerebral fNIRS, the changes in haemoglobin concen-
trations yield information on the activation of regions in the brain [160]. In single-
point cerebral fNIRS, the sensors are attached on the forehead and the changes in
haemoglobin concentrations indicate the activation of frontal areas in the brain. In
order to distinguish the responses, a stimulus such as a mental task, problem-solving,
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Figure 5.14: Different types of functional NIRS (fNIRS) measurements and their timeline. The first fNIRS
instruments (left side) were measuring cerebral activation from the haemoglobin changes acquired from single
pairs of light emitters and detectors. The second typology (middle) measured activations at different locations
simultaneously. In these instruments, the changes in haemoglobin concentrations were observed upon application
of a stimulus (grey areas in the plots at the bottom). Nowadays (right side), by using multiple combinations of
different pairs of emitters and detectors, a colour map of the activated areas can be obtained by sophisticated
signal processing techniques. Figure reproduced from [160].
visual/auditory triggers, or others are applied on the investigated subject. Functional
activation is then assessed from the response of HbO2 and HHb following the stim-
uli. The technique was studied to assess the differences in neurological or psychiatric
disorders such as Alzheimer’s disease, schizophrenia, or epileptic patients, and compar-
ison between fMRI and fNIRS showed good correlation in the haemodynamic changes
related to functional activation [160]. Also, if multiple pairs of light emitters and de-
tectors are used, a spatial distribution (i.e. mapping) of the activation areas can be
obtained [160]. In this approach, head-caps with optodes placed in a configuration
similar to EEG are worn by the subject and light attenuations from multiple pairs are
processed to obtain a colour map of the haemodynamic changes. Figure 5.14 depicts a
schematic representation of the different fNIRS modalities.
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5.5 Limitations and open challenges of NIRS
Even though NIRS has found many applications, the technique still suffers from some
limitations. For this, several open challenges still exist and it is hoped that future
developments in technology and computation techniques would contribute overcoming
these drawbacks. Some of the main limitations and open challenges of NIRS are listed
below.
• Relative haemoglobin concentrations. Continuous wave NIRS instruments are able
to provide only relative haemoglobin concentrations from an arbitrary time point,
usually baseline [11,161,162]. These can still be used for intervention studies, but
only Time Resolved and Phase Modulated instruments are capable of determining
absolute haemoglobin concentrations.
• DPF wavelength-dependence. In order to fully quantify the relative changes in
haemoglobin concentrations by CW NIRS, the DPF needs to be used, with the
assumption that scattering is constant during the measurement. Usually, a single
DPF value is used, based on the type of tissue from which the measurements are
acquired (e.g. forearm or head). It is assumed that this value is equal at the
different wavelengths at which the modified Beer-Lambert law is used to infer
haemoglobin concentrations. However, the DPF, being related to scattering, is
wavelength-dependent [119]. This approach used in CW NIRS could introduce
some errors, which could only be eliminated if the DPF at each specific wavelength
used is calculated.
• Other chromophores. NIRS assumes that the only light absorbers (chromophores)
within the light path are oxygenated and deoxygenated haemoglobin. This as-
sumption can hold under certain conditions in which only blood changes are
considered [11, 22, 25]. Cytochrome oxidase can be neglected due to the low
contribution in the overall light absorption, while the effect of other haemoglobin
derivatives such as carboxyhaemoglobin is usually ignored. In muscle NIRS, Myo-
globin cannot be distinguished from haemoglobin due to the overlapping of the
substances’ spectra and the contribution of myoglobin to the signal is still under
debate [13,25,129]. In order to take this into consideration, muscle-NIRS studies
often report their results as mixed haemoglobin-myoglobin changes.
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• Extra cerebral/muscle tissue contributions. The contribution of extracerebral/muscle
tissues such as skin and adipose tissue has been under debate for several years
[13,22,161]. When light is emitted and detected transcutaneously, it crosses sev-
eral layers of tissues before entering the cerebral cortex or muscles. This can cause
NIRS measurements to be affected by skin blood flow or volume changes [162].
A multi-distance approach, in which the signal passing through only superficial
layers is subtracted from the total light beam traversing the entire tissue, could
solve the problem [161]. However, this method is not always used and, single-
distance CW, TRS and PMS instruments collect light that passes through other
layers of tissue. The indexes estimated by Spatially Resolved Spectroscopy seem
to provide isolation from superficial layers of tissues [125].
• Tissues heterogeneities. NIRS assumes that the portion of tissue interrogated by
the light beam is homogeneous [161]. In presence of oedemas or focal changes in
haemoglobin concentrations, this assumption may not hold [22,163].
• Standardization. The continuous development of commercial and research NIRS
instruments in the last decades has created a lack of standardisation in the field.
Currently, available NIRS devices differ in peak emission wavelengths, the num-
ber of wavelengths, the emitter-detector separation distances, the algorithms,
the measured areas, etc. Therefore, the comparison between different studies
or instruments is rather difficult [161, 162]. For instance, in vivo and in vitro
comparison between different NIRS commercial monitors revealed differences in
the absolute values of tissue oxygen saturation between the devices [164, 165].
Also, if the comparison within NIRS instruments is difficult, the NIRS technique
cannot be fully validated in vivo with a gold-standard measure of perfusion or
oxygenation [166]. In this regard, more in vitro studies like Hyttel-Sorensen et
al. and Suzuki et al. are still needed to validate the haemoglobin concentrations
measured by NIRS instruments with gold-standard measures of haemoglobin con-
centrations [124, 166]. Although the lack of standardisation and discrepancies in
absolute values, NIRS devices have demonstrated to be valuable tools for trend
monitoring.
• Absolute values of tissue oxygen saturation. Baseline absolute values of tissue oxy-
gen saturation suffer from inter-subjects variability, due to different tissues’ com-
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position and arterial-venous partitioning between subjects [22, 167, 168]. There-
fore, it has been suggested of using TOI as a trend indicator and cautiously use
its absolute values.
• Movement artefacts. As any other optical technique, NIRS suffers from movement
artefacts [161,162] and subject’s movements should be minimised during the mea-
surements. Although being susceptible to movement artefacts, the technique can
still be used for assessing oxygen metabolism in contracting muscles. By using
the multi-distance approach, movement artefacts could be minimised [161]. NIRS
sensors need a good attachment on the skin, but sensors may detach from the
skin, with possible light interferences and consequent inaccuracies [161,162,167].
• Bulkiness. One of the main strengths of NIRS is the ability to penetrate in deep
tissues such as brain and muscle. This, however, can be only be achieved by a
large separation distance between light emitter and detector. A separation dis-
tance > 2.5 cm is suggested for NIRS measurements [23]. Therefore, NIRS sensors
can have bulky dimensions and usually require an adequately large measurement
area on the skin. While this can be acceptable on large muscles or other tissue
surfaces, some measurement locations such as flaps may not satisfy the spatial
requirements for NIRS sensors.
TRS and PMS devices require large instrumentation for their functioning, making
their transportation and portability rather difficult [161]. For this reason, these
instruments are often used in research rather than at the patient’s bedside. Hope-
fully, the technological developments in the future may allow the miniaturisation
of these instruments, with the possibility of exploiting their potential in clinical
settings [161].
• Costs. Finally, another important limitation of the technique is its elevated costs,
particularly when compared to other technologies such as photoplethysmogra-
phy, pulse oximetry, or laser Doppler flowmetry [25, 36, 44]. The costs of NIRS,
added to the other drawbacks listed above, limits their wide adoption in a clinical
environment.
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5.6 Summary
This chapter presented an overview of Near Infrared Spectroscopy. The principles of
the technique, the different NIRS instruments, and the main applications of NIRS have
been presented. The modified Beer-Lambert law for the determination of haemoglobin
concentration changes in NIRS was introduced and discussed. This will be introduced
again in Chapter 8, where its application to PPG signals will be described. The method
was then investigated in a series of studies described in Chapter 9, Chapter 10, and
Chapter 11, in which photoplethysmographic signals were acquired from different body
locations. The next chapter will describe the design and development of reflectance
photoplethysmographic sensors that were used in the investigations.
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Chapter6
Design and Development of a Reflectance
Photoplethysmography Sensor
This thesis explores the capability of photoplethysmography in providing information
about perfusion and oxygenation other than the conventional PPG signals and the
arterial oxygen saturation (SpO2). In order to investigate this, reflectance PPG signals
were acquired from the forearm, finger, and forehead of healthy volunteers in different
physiological conditions and NIRS principles were applied to the signals. This chapter
describes the design, development, and manufacturing of custom-made reflectance PPG
sensors for the acquisition of PPG signals from those locations. The evaluation of these
sensors is also presented. Later, in Chapter 7, the research PPG processing system
used to drive these sensors will be presented as well.
6.1 Optical components
Optical modalities such as PPG, NIRS or laser Doppler flowmetry use light emitters to
shine light into living tissue and acquire the backscattered light by means of a photode-
tector(s). The quantity, typology, and placement of light emitters and photo-detector
depend on the specific technique, or may vary depending on the anatomical location
where the sensor will be placed on. The PPG sensors that were developed were dual-
wavelength PPG sensors, comprising of red and infrared LEDs for light emission and a
single photodiode to detect the backscattered light. Figure 6.1 shows a simplified block
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PPG Processing 
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Figure 6.1: Diagram showing the PPG sensor and the PPG processing system. The processing system drives
the sensors and processes the signals from the detected. Within the sensors, two red and two infrared (IR) LEDs
emits light, while a photodiode (PD) detects the backscattered light from the tissue.
diagram of the PPG system used in this thesis. The system is composed of reflectance
PPG sensor(s) and a processing system. The PPG processing system drives the LEDs
and acquires the light intensities from the photodiode. The sensor comprises of two
red LEDs, two infrared LEDs, and a single photodiode. In this section, the properties
of the chosen LEDs and photodiode are presented, while the following sections will
describe the electrical and mechanical development of the PPG sensors.
6.1.1 Light Emitting Diodes
The red wavelength light sources selected for the RPS1 PPG sensor were two chip
surface mounting LEDs (KP-2012SRC-PRV, Kingbright, Taiwan). The low-power con-
sumption red LEDs measured 2.0 mm×1.25 mm×1.1 mm (L×W ×H).
The two infrared emitters were two chip surface mounting LEDs as well (KP-2012 SF4C,
Kingbright, Taiwan), with dimensions of 2.0 mm×1.25 mm×1.1 mm (L×W ×H). Fig-
ure 6.2 shows the mechanical drawings of the red and infrared LEDs, while the electrical
and optical characteristics are summarized in Table 6.1 for the red LED and Table 6.2
for the infrared LED.
The selection of the two light sources at different emission wavelengths presents two
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Dimensions in millimeters (inches)
Figure 6.2: Mechanical drawings of the red and infrared LEDs of the RPS1 PPG sensor
Table 6.1: Optical and electrical characteristics of the red wavelength LED (KP-2012SRC-PRV) at 25 ℃
Optical/Electrical characteristics at 25 ℃
Parameter Value
Forward Voltage (IF=20 mA) 1.85 (2.5 max.) V
Reverse current (VR=5 V) 10 µA
Capacitance 45 pF
Peak spectral wavelength (IF=20 mA) 660 nm
Spectral Bandwidth (∆ λ1/2) (IF=20 mA) 20 nm
Power dissipation 75 mW
Peak forward current 155 mA
Reverse voltage (VR) 5 V
Operating temperature -40 to +85 ℃
Table 6.2: Optical and electrical characteristics of the infrared wavelength LED (KP-2012 SF4CV) at 25 ℃
Optical/Electrical characteristics at 25 ℃
Parameter Value
Forward Voltage (IF=20 mA) 1.3 (1.6 max.) V
Reverse current (VR=5 V) 10 µA
Capacitance 90 pF
Peak spectral wavelength (IF=20 mA) 880 nm
Spectral Bandwidth (∆ λ1/2) (IF=20 mA) 50 nm
Power dissipation 80 mW
Peak forward current 1.2 A
Reverse voltage (VR) 5 V
Operating temperature -40 to +85 ℃
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Figure 6.3: Mechanical drawings of the TEMD5010X01 photodiode employed in the PPG sensor RPS1
main advantages. In the first place, these two wavelengths (red and infrared) were
chosen as these are commonly used in pulse oximetry to estimate arterial oxygen sat-
uration (SpO2). Thus, if two photoplethysmography signals at red and infrared are
acquired from a tissue, the SpO2 can be estimated as described in subsection 4.5.1.
Secondly, the acquisition of PPG signals (or more generally, any optical signals) at two
wavelengths permits also the application of the Beer-Lambert law to estimate the con-
centration changes of two light absorbers such as oxygenated and reduced haemoglobin.
As showed previously in Chapter 5, these two chromophores absorb light differently and
measuring absorption at two different light wavelengths permits to calculate their rel-
ative or absolute concentrations.
6.1.2 Photodiode
The photodiode adopted in the PPG sensor RPS1 was a surface mount PIN photo-
diode (TEMD5010X01, Vishay Intertechnology Inc. USA). The TEMD5010X01 is a
high speed and high sensitive photodiode with dimensions of 5 mm × 4.24 mm ×
1.12 mm (L×W ×H). The photodiode can detect visible and near infrared light and
its large active area (i.e. 7.5 mm2) makes it suitable for low-intensity light applica-
tions such as PPG signal detection. Figure 6.3 shows the mechanical drawing of the
TEMD5010X01, whereas Table 6.3 summarizes its optical and electrical characteristics.
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Table 6.3: Optical and electrical characteristics of the photodiode (TEMD5010X01) at 25 ℃
Optical/Electrical characteristics at 25 ℃
Parameter Value
Forward Voltage (IF=50 mA) 1 (1.3 max.) V
Breakdown Voltage (IR=100 µA) 60 V
Reverse Dark Current (VR=10 V) 2 (30 max.) nA
Diode Capacitance (VR=0 V) 70 pF
Reverse light current (VR=5 V, λ=950 nm) 45(55) µA
Angle of half sensitivity ± 65 deg
Range of spectral bandwidth 430-1100 nm
Rise time (VR=10 V, λ=920 nm) 100 ns
Fall time (VR=10 V, λ=920 nm) 100 ns
Operating temperature range -40 to +100 ℃
6.2 Electrical design of the Reflectance PPG probe (RPS1)
Figure 6.1 shows the diagram of the reflectance PPG sensor (RPS1) and its driv-
ing/processing system. The main components of the sensor are the light sources (LEDs)
and photodetector (photodiode), while the processing system is responsible for supply-
ing the driving currents for the LEDs and for processing the signal generated by the
photodiode. The PPG sensors used in this work were designed and manufactured to
conform to the PPG processing system described in Chapter 7. This section describes
the electrical design of the reflectance PPG sensor.
6.2.1 Printed Circuit Board design
In order to provide mechanical support and electrical connections for the LEDs and
photodiode presented in Section 6.1, Printed Circuit Board (PCB) technology was
adopted. PCBs are copper-based sheets on which pads and tracks can be designed in
order to allocate and connect electronic components. In order to use a PCB for the
optical components described in Section 6.1, the PCB was designed in Altium Designer
(Altium Ltd, Australia). Altium Designer is a PCB-design software, which allows the
full customization of PCBs’s tracks and pads.
The PCB had a circular shape, with a diameter d = 20 mm, in order to facilitate contact
with such anatomical regions such as the forearm and forehead. Different shapes (e.g.
rectangular or square) or a larger diameter could have caused a rather difficult attach-
ment to the skin, particularly on curved surfaces. The PCB for the sensor was designed
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in order to allocate the required optical components and connections to the PPG pro-
cessing system. Figure 6.4a shows the PCB footprint for the RPS1 sensor. The pads
were designed for the placement of the LEDs and photodiode presented in Section 6.1,
as suggested by the manufacturers. The PPG signal amplitude in reflectance mode is
a trade-off between separation distance and LEDs driving current. Larger separation
distances allow the acquisition of larger signals with smaller signal variations, but, in
order to maintain a good signal at these separation distances, light intensity must be in-
creased (i.e. large separation distances cause a large decrease in signal amplitudes) [71].
Mendelson and Ochs demonstrated that to maintain a constant reflection during the
increase of the separation distance, LEDs driving currents had to be increased up to
200 mA [71]. These large driving currents are not suggested since they can overheat
the tissue or damage the LEDs. From the study performed by Mendelson and Ochs, a
separation distance comprised between 4-6 mm should guarantee an acceptable signal
quality, without exceeding 50 mA LEDs driving currents [71]. Therefore, the pho-
todiode was positioned at the centre of the PCB, while the LEDs were placed at a
centre-to-centre distance of 5 mm from the photodiode. The electrical connections be-
tween the pads were designed in order to configure the red and infrared LEDs in parallel
with the anode of the red LED connected to the cathode of the infrared LED, as illus-
trated in Figure 6.1. As explained later in Chapter 7, this configuration permits the
intermittent switching of the red/infrared LEDs when connected to the PPG processing
unit. Through-holes pads were also added on the PCB to provide the connection for
wires connecting the sensor and the processing system. Prior manufacturing, a visual
assessment of the PCB and optical components’ 3D model footprint was also performed
in order to test the geometrical positions of the components (Figure 6.4b).
6.2.2 Printed Circuit Board manufacturing
After designing the PCB on the software platform, CAM files were generated in order
to manufacture the PCB by CNC routing technology. CAM files are a set of software-
generated manufacturing instructions, which consent to manufacture an object from
a design file. The PCB was manufactured from a single-layer copper-laminated sheet
by means of an advanced board plotter (Protomat S103, LPKF Laser & Electronics
AG, Germany). The single-layer PCB was deemed sufficient for the manufacturing of
a PPG sensor. Once the tracks, pads and through holes were created by the CNC
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Figure 6.4: Reflectance PPG sensor (RPS1) PCB footprint (a) and PCB’s 3D model (b). In the PCB footprint
in (a), the pads are dedicated to the placement of the optical components, whereas the tracks and the through
holes provide the connection between the components and the processing unit. The 3D model of the PCB in
(b) was used to visually assess the components mounted on the PCB.
machine, the PCB was tin plated in order to protect the copper from oxidation. The
tin plating process was carried out by immersing the manufactured PCBs in a tinning
solution for at least 10 minutes.
The optical components were then soldered on the PCB. Small amounts of solder paste
(SN62RA10BAS86-25G, Multicore, Henkel Techn. USA) were distributed on top of the
pads. The LEDs and photodiode were then placed on top of the pads, taking care of
the correct positioning of anodes/cathodes. Once the optical components were in place
on the PCB, the board was inserted in the re-flow air oven (FT02, C.I.F, France) in
order for the surface mount components to be soldered on the pads.
Once the optical components were soldered on the PCB and all electrical connections
checked, a four-core screened cable was then used to provide connections from the
sensor’s PCB to the PPG processing system. More specifically, the wires provide the
driving currents for the LEDs and transmit the detected signal from the photodiode to
the processing circuit. On one end of the cable, each core was soldered on the PCB,
while on the other end each core was soldered on the corresponding pin of a male D-Sub
9 connector, providing the link with the PPG processing unit (see Section 7.6) .
Once the PCB, the optical components, and the wires were soldered, continuity and
LEDs/photodiode functionality were verified before proceeding to the assembly of the
mechanical structure.
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(a) (b)
Figure 6.5: 3D model views of the RPS1 PPG sensor’s case (a) and cover (b).
6.3 Mechanical structure
The soldering of the optical components on the PCB and provision of connection to
the processing unit is not sufficient for the manufacture of a safe PPG sensor. Since
the sensor needs to be applied on the skin, optical components and PCB required to
be isolated and protected in order to avoid any shunting. In addition, without proper
cover, ambient light may reach the photodiode, with the possibility of generating un-
wanted bias and interference [8]. This section describes the development of the sensor’s
mechanical structure, which was designed in order to cover the optical components,
protect them from ambient light, and facilitate the attachment of the sensor on the
skin.
6.3.1 Mechanical structure design
The mechanical structure of the RPS1 sensor was designed in a 3D CAD design soft-
ware (Solidworks 2013, Dassault Syste´mes SOLIDWORKS Corp., USA). The mechan-
ical structure was composed of a case and a cover. The two parts were ring-shaped and
they were designed separately in order to enclose the PCB. Figure 6.5 shows the views
of the 3D models of the case and the cover of the RPS1 PPG sensor.
Once the case and cover were designed separately, the fit was assessed by generating a
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(b)
Figure 6.6: Exploded views (a) and assembly views (b) of the RPS1 PPG sensor’s 3D model. The exploded
view shows the 3D model composed of the sensor’s case, sensor’s cover, and the PCB with the optical components
and the cable. The assembly view provides a model of the final assembled sensor.
3D model assembly. The model was composed of the sensor’s case, sensor’s cover, and a
3D model of the PCB comprising optical components and cable. The assembly allowed
verifying the dimensions of all components (i.e. case, cover and PCB) by fitting the
3D models in the assembly without the necessity of pre-manufacture the components.
Figure 6.6 shows the views of the 3D model assembly composed by case, cover and
PCB.
As mentioned earlier the mechanical structure of the PPG sensor was designed in two
parts (cover and case) in order to enclose the PCB. Figure 6.7 shows the drawing of
the mechanical structure of the RPS1 PPG sensor. The drawing comprises of PCB,
optical components, case, and cover. The case had an internal diameter of 22 mm in
order to allow the insertion of the PCB (d = 20 mm). The case’s wall had a thickness
of 1 mm, adding to an overall external diameter of 24 mm. At the bottom of the case,
a ring with an external diameter of 28 mm had the function of keeping in place the
PCB by the aid of four hooking plates. In addition, the bottom ring provides a wider
flat surface for the attachment of the sensor on the skin.
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Figure 6.7: Drawing of the mechanical structure of the PPG sensor RPS1. The drawing comprises of case,
cover, PCB and optical components.
6.3.2 Mechanical structure manufacturing
After designing the mechanical structure of the RPS1 sensor comprising case and cover,
these were manufactured by 3D printing technology. 3D printers create objects by Fuse
Filament Fabrication, in which solid filaments are fused and deposited on a heated
surface. The machines deposit material layer-by-layer until the object is completed. In
order to manufacture an object, the printer receives a set of instructions containing the
geometrical information of the model. This method of fabrication has been attracting
interest due to the possibility of in-house manufacturing of customised 3D models and
objects [169]. The technique has also promising applications in bioengineering and
medicine for the manufacture of custom prosthetic devices and, perhaps, even organs
[169]. The 3D models of the sensor’s case and cover previously designed in Solidworks
were converted into a set of instructions (G-Code files) for the 3D printer. The case
and cover were manufactured by a 3D printer (Replicator 2X, Makerbot Industries
LLC, USA) in black Polylactic acid (PLA). While the biodegradability of this material
guarantees a safe application on the skin, the black colour provides cover from ambient
light.
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Figure 6.8: Final manufactured RPS1 PPG sensor.
Once the case and cover were manufactured, the PCB, comprising of previously soldered
optical components and cable, was inserted within the case. When the PCB was in
place, a small amount of glue was applied on the contours of the PCB and the case.
Before the glue was set, the cover was inserted on top as showed in Figure 6.6b. The
application of the glue was performed in order to seal eventual gaps between PCB and
case’s walls and to keep in place the cover on the case.
After the glue was set, the optical components were covered by applying a layer of clear
medical epoxy (Dymax 141-M, Dymax Corp., USA). Prior to application of the epoxy,
the photodiode was shielded by placing a black rubber around its contour. The shield
was placed in order to avoid optical shunting from the LEDs to the photodiode (i.e.
light reaching the photodiode without passing through the tissue) [8].
6.4 Evaluation of the Reflectance PPG sensor
6.4.1 Photoplethysmographic signals
The RPS1 PPG sensor was evaluated post-manufacturing by acquiring PPG signals
from the forehead. The sensor was connected to the PPG processing unit (see Chap-
ter 7) through the D-Sub 9 connector and it was attached on the forehead by means of
a double-sided sided clear medical adhesive tape. The tape was cut in the central part
to not cover the optical components. The sensor was attached on the forehead, above
the eyebrow, as suggested in the literature [110]. The volunteer sat on a chair and
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Figure 6.9: Red and infrared raw PPG traces acquired from the RPS1 sensor. (a) Five minutes measurement
of red and infrared raw PPG (AC + DC). Red trace: red PPG; black trace: infrared PPG. The pulsatile
components are riding on a DC offset (DC PPG). (b) Five-second zoom of the infrared pulsatile component.
(c) Five-second zoom of the red pulsatile component. Signals were low-pass filtered at 7 Hz to remove high-
frequency noise. The PPG traces in (b) and (c) are the raw pulsatile components detected by the photodiode,
without being reversed as usually done in PPG analysis.
the measurements lasted for five minutes at rest and in normal breathing. The signals
were acquired on LabVIEW (National Instruments, USA) at a sampling frequency of
1 kHz and they were later analysed on Matlab2013a (The MathWorks Inc., USA). The
acquired raw PPG signals (AC + DC) were filtered from high-frequency noise by a
low-pass filter with a cut-off frequency fc = 7 Hz.
Figure 6.9 shows PPG signals acquired from the RPS1 sensor. Good quality red and
infrared raw PPG signals (AC+DC) were acquired from the sensor. The DC component
can be noticed from the offsets of the signals. Low-frequency oscillations can also be
observed on the DC component. The time scale zoom reveals a good quality AC PPG
component riding over the DC offset. Thus, the designed and manufactured sensor
successfully demonstrated the capability of measuring satisfactory PPG signals.
6.4.2 Temperature tests
In order to confirm that there will be no thermal injury to the tissue by the sensor when
the LEDs are switched ON, temperature measurements were carried to verify that the
sensor did not reach excessive temperatures.
Two sets of measurements were performed. In the first bench measurement, the tem-
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perature was acquired from the sensor when this was not attached to the skin. In the
second measurement, the temperature of the skin underneath the sensor was measured
while simulating the normal measurement conditions. The purpose of two separate
experiments was to investigate the increase in temperature first and, in second place,
how this could affect the skin temperature.
The temperature was measured by a K-Type thermocouple (SA1-K, Omega Engineer-
ing Inc., USA) connected to a monolithic thermocouple amplifier (AD595AQ, Analog
Devices Inc., USA). The AD595AQ is a thermocouple amplifier with ice point refer-
ence and pre-calibrated amplifier capable of producing a 10 mV/℃ output directly
from a thermocouple. Another amplifier was set-up as suggested by the manufacturer
for the measure of ambient temperature. The two chips measuring the thermocouple’s
temperature (TTH) and ambient temperature (TAMB) were mounted on a breadboard
and the connections were set as suggested by the manufacturer. The power supply of
Vs = 5 V was provided by a bench voltage power supply. The outputs of the thermo-
couple amplifiers were connected to a National Instruments data acquisition in order
to be acquired on LabVIEW.
In the first measurement, the thermocouple was attached to the surface of the RPS1
sensor and covered with insulating tape in order to minimise any influence from fluc-
tuations in room temperature. After five minutes of baseline measurements, the sensor
LEDs were switched ON and they were driven at 60 mA for 30 minutes. Figure 6.10
shows the ambient and the thermocouple temperature traces during the first bench
experiment. During baseline, the mean reference ambient temperature was 24.5 ℃,
while the temperature from the thermocouple attached to the sensor was 24.8 ℃. After
ten minutes with the LEDs ON, the thermocouple-measured temperature reached a
steady state of 30.0 ℃, while the ambient temperature remained constant throughout
the entire measurement.
The second set of temperature measurements aimed at assessing the skin temperature
during the utilisation of the RPS1 sensor on the skin. The RPS1 sensor was attached to
the forehead by double-sided medical adhesive tape. The adhesive was previously cut
in the centre, at the position of the optical components. The thermocouple was placed
on the sensor’s surface and it laid between the skin and the sensor. The thermocouple
was positioned at the centre of the sensor’s footprint. Again, the measurement started
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Figure 6.10: First temperature test on the RPS1 sensor’s surface. The thermocouple was attached on the
sensor’s surface and kept in place by insulating tape. After five minutes of measurement with LEDs OFF, the
light sources were switched ON and they were driven at 60 mA for thirty minutes.
with a five-minute baseline measurement followed by thirty minutes with the LEDs
ON at 60 mA driving current. An independent skin temperature reading (TLDF ) was
provided by a laser Doppler flowmetry device (MoorVMS-LDF2, Moor Instruments,
UK). The laser Doppler sensor was also attached on the forehead by a ring-shaped
double-sided adhesive. Figure 6.11 shows the result of the second measurement. During
baseline, TLDF and TTH were 30.9 ℃ and 32.7 ℃ respectively. When the LEDs were
switched ON, TTH gradually increased to 34.3 ℃ and reached a steady state after
roughly ten minutes. The results from both temperature experiments indicated that
the RPS1 sensor did not produce excessive or dangerous heating. The higher TTH
during baseline is most probably a temperature offset due to the pressure exerted on
the thermocouple between skin and the sensor’s surface. In addition, the LEDs were
driven at the maximum current that the processing system could provide, which is still
far higher the normal usage of 20-30 mA. Therefore, it can be concluded that the sensor
did not pose any thermal risk to the skin.
6.5 RPS1-2 and RPS3 sensors development
The design and manufacturing methods presented in this chapter offer the flexibility
of full customization of PPG sensors. Therefore, other PPG sensors were designed and
manufactured with the same methods used for the RPS1 sensor. The design of an
optical sensor may vary depending on its application, which may require a deeper light
penetration into tissue or the miniaturisation for the attachment to a small measure-
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Figure 6.11: Second temperature test on the RPS1 sensor’s surface. The thermocouple was attached between
the sensor’s surface and the skin. After five minutes of measurement with LEDs OFF, the light sources were
switched ON and they were driven at 60 mA for thirty minutes.
ment area. This section describes the development of two additional sensors, RPS1-2
and RPS3. These sensors differed from the RPS1 in the configuration of their opti-
cal components (for a greater penetration depth) or in the overall dimensions of the
sensors.
6.5.1 Larger emitter-detector separation distance
A second PPG sensor (RPS1-2) with a different separation distance was designed and
manufactured. The RPS1-2 was designed identical to the RPS1 sensor, but with a
different interoptodes distance. While the RPS1 had 5 mm separation distance between
LEDs and photodiode, the RPS1-2 had 7 mm distance between emitters and detector.
The increased interoptodes distance should provide a deeper penetration depth, without
increasing the sensor size. The RPS1-2 sensor’s PCB had the same dimensions of the
RPS1, but the PCB’s footprint was modified in order to allocate LEDs and photodiodes
with 7 mm centre-to-centre separation distance. The PPG sensor comprised of the same
LEDs (KP-2012SRC-PRV and KP-2012 SF4C) and same photodiode (TEMD5010X01)
of the RPS1 sensor. Figure 6.12 shows the final manufactured RPS1-2 sensor.
6.5.2 Further miniaturisation
While NIRS sensors have a limited degree of customisation (due to the obligatory
interoptode distance > 2.5 cm), PPG sensors can be customised to almost any size.
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Figure 6.12: Final RPS1-2 manufactured sensor. The RPS1-2 sensor had the same external dimensions and
optical components of the RPS1 sensor. The LEDs and photodiode were however placed at a centre-to-centre
separation distance of 7 mm.
In this context, the RPS1 sensor may be too bulky for certain applications where the
measuring area is very small. For this reason, the RPS1 sensor was further miniaturised
into a smaller sensor, the RPS3.
Figure 6.13 shows the 3D model of the RPS3 sensor. The sensor comprises of one red
LED, one infrared LED, and one photodiode. The LEDs selected for the RPS3 sensor
were the same as the RPS1 (KP-2012SRC-PRV and KP-2012 SF4C), while the pho-
todiode was changed to a VBPW34S (Vishay Intertechnology Inc. USA), preserving
very similar characteristics to the TEMD5010X01. The PCB and mechanical structure
of the RPS3 sensor were designed and manufactured in the same process used for the
RPS1 sensor. The mechanical structure was again composed of a case and a cover
manufactured in black PLA by 3D printing technology. However, the RPS3 sensor
presented a smaller external diameter (15.5 mm) against the RPS1 (28 mm). In ad-
dition, the RPS3 had a smaller thickness (7 mm) compared to the RPS1 (8.50 mm).
Figure 6.14 shows the picture of the final manufactured RPS1 and RPS3 PPG sensors.
6.6 Finger reflectance PPG sensor
In order to compare photoplethysmographic signals between different locations, a finger
PPG sensor was developed as well.
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Figure 6.13: 3D model views and components of the RPS3 PPG sensor. The sensor comprised of one red LED,
one infrared (IR) LED, and one photodiode soldered on an apposite PCB. A black case provided mechanical
protection and isolation from ambient light interference. The black rubber shield between LEDs and photodiode
avoided optical shunting from LEDs to photodiode.
Figure 6.14: Picture of the final manufactured RPS1 (left) and RPS3 (right) PPG sensors.
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Figure 6.15: Manufactured finger reflectance PPG sensor.
The PCB of the finger PPG sensor was identical to the RPS1 sensor’s PCB. Prior
to the soldering of the optical components, the PCB was cut in a rectangular shape
in order to be fit later into a shell of a pulse oximeter finger clip. The same optical
components as the RPS1 sensor were soldered on the PCB. The PCB comprising of
LEDs and photodiode was soldered to a four-core wire and inserted into the finger clip.
After inserting the PCB and wire, the black rubber, which is used to accommodate the
finger, was re-inserted in its original position. The black rubber was also cut in order
to leave the optical components exposed. After assembling the PCB in the finger clip,
the optical components were covered by a layer of clear medical epoxy (Dymax 141-M)
and the clip’s edges were finally sealed. The other end of the sensor’s wire was soldered
onto a D-Sub 9 connector for connection to the PPG processing system. Figure 6.15
shows the final manufactured finger PPG sensor. Figure 6.16 shows red and infrared
PPG signals acquired from the finger PPG sensor, showing that good quality PPG
signals were measured from the finger sensor.
6.7 Summary
This chapter described the design and development of reflectance PPG sensors. These
were designed to acquire PPG signals from the forearm, forehead, and finger. The
evaluation of the PPG sensors demonstrated that these were capable of acquiring good
quality PPG signals. The temperature tests showed that the operating sensor did not
reach elevated temperatures, thus not presenting any harm for the human skin. Other
prototypes of larger interoptodes distance or smaller dimensions were designed and
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Figure 6.16: Red and infrared PPG signals acquired from the finger reflectance sensor. (a) red PPG. (b) In-
frared PPG. Raw PPG signals were band-pass filtered (pass-band: 0.5-7 Hz) in order to remove high frequency
noise and DC offsets.
manufactured as well. The next chapter will describe the structure, functionalities,
and evaluation of a research PPG processing system that was used to drive the sensor’s
LEDs and process the signal detected by the photodiode.
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Chapter7
Evaluation of a Research
Photoplethysmography Processing
System for the assessment of tissue
perfusion and oxygenation
The reflectance PPG sensors described in the previous chapter require a processing sys-
tem in order to drive the LEDs and to process the currents detected by the photodiode.
This chapter will describe the structure and functionalities a research photoplethysmo-
graphic system that was used for these purposes. The PPG processing system, along
with the sensors, was used for the acquisition of raw PPG signals in the in vivo inves-
tigations that will be presented in the next chapters.
The processing system described in this chapter has been designed by the Research
Group at City University of London. The system, also called ZenPPG, has been created
with the intention of providing a common research tool for photoplethysmographic
signals acquisitions. The system can be considered as an open source project and
provides a common architecture that researchers can tailor for their specific purposes.
As well as the open architecture, some of the main advantages of the processing system
are the possibility of interchanging custom-made sensors and the full control of light
intensities. Although the author of this thesis did not design the system himself, he
carried out a series of tests and evaluations of the technology that led to improvements
to the initial design, particularly on the core board. The main results of these tests
are reported in this chapter and contributed to the acquisition of PPG signals in the
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Figure 7.1: Block diagram of the ZenPPG architecture.
in vivo investigations. Since this PPG processing system played an essential role in
the research objectives of this work, the inclusion of a chapter describing its structure,
functionalities, and evaluation was deemed vital to this thesis.
7.1 Research photoplethysmography system: ZenPPG
ZenPPG is a dual-wavelength, dual-channel research PPG system developed by the
Biomedical Research Group at City University. The main functionalities of ZenPPG
are the acquisition of raw PPG signals (AC + DC), adjustment of light intensities
and the ability of drive custom-made and commercial PPG sensors. The ZenPPG
is composed by independent and interchangeable subsystems, each of them having
different functions. Figure 7.1 shows the architecture of the ZenPPG. The instrument
is composed of five different boards: power board, current source board, core board,
transimpedance amplifier board and bus board.
The current source board supplies the driving currents for the LEDs, while the core
board is responsible for intermittent light switching and separation of the signal in each
respective wavelengths by multiplexer/demultiplexers. The transimpedance amplifier
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Figure 7.2: Generic light switching in pulse oximetry or NIRS. The red (R) and infrared (IR) light sources are
switched sequentially ON/OFF in a 1/3 duty cycle in order to sample each wavelength and the ambient light
separately. Figure reproduced from [105].
board transforms currents from the photodiodes into voltages and the power board is
responsible for supplying power to the entire system. The bus board is responsible for
allowing the connection between these boards and the transmission of the voltages and
signals between boards. The ZenPPG is configured for the acquisition of PPG signals
while the control and monitoring of light intensities are achieved through LabVIEW and
National Instrument Data Acquisition Cards (DAQ). Each component of the ZenPPG
structure illustrated in Figure 7.1 is described in the following sections. The system’s
components will be presented either by presenting each board or by specific functions.
7.2 LEDs currents time multiplexing
7.2.1 LEDs time multiplexing
Optical techniques such as Pulse Oximetry and Near Infrared Spectroscopy employ
light at different wavelengths. In order to use independently these wavelengths, the
light sources (i.e. LEDs) should be sequentially and intermittently switched ON and
OFF. While this process is usually undertaken at high frequencies, the complexity
and timing depend on the number of wavelengths and the specific application of the
system. Figure 7.2 shows the generic dual-wavelength (red and infrared) light switching
employed in pulse oximetry and/or NIRS [105]. The light sources are sequentially
switched ON/OFF in order to sample each wavelength in time.
In ZenPPG, the LEDs switching is achieved by analogue multiplexing technology. Ana-
logue multiplexers are composed of several input lines, a single output line and internal
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(a) (b)
(c)
Figure 7.3: MC14052BD multiplexer connection schematic (a), truth table (b), and outputs vs. logical con-
trols (c).The input voltage references ICPOS and ICNEG are transmitted to the outputs X (or Y) depending
on the state of the logical controls A, B, and INHIBIT. According to the truth table in (b), the multiplexer’s
outputs will follow the signal X in (c), where the inputs X0, X1, and X2 are sequentially transmitted to the
output port.
switches. Logical ports control the state and timing of the switches, transmitting the
input signals to the output port. Multiplexers are commonly used in applications such
as telecommunications where different input signals are passed to a single output line.
The multiplexer (MC14052BD, ON Semiconductor) employed in the ZenPPG is a dual
4-channel multiplexer/demultiplexer and is responsible for sequentially switching of the
LEDs. The system has been designed for the implementation of a 1/3 duty cycle. This
corresponds to a cycle divided into three periods: red wavelength ON and infrared
OFF, red wavelength OFF and infrared ON, and both red and infrared wavelengths
OFF.
The two channels of the multiplexer are used to synchronously drive the LEDs of the
first and second channel of ZenPPG. The inputs of the MC14052BD in the ZenPPG are
constant voltages, which are directly proportional to the driving current of the LEDs
(see Section 7.3). These voltages are set by the system’s user through a graphical user
interface on LabVIEW for the first channel (see Chapter 8), or by trimmers for the
second channel. The outputs of the multiplexer are controlled by the logical ports.
These ports are directly connected to digital clocks driven by a micro-controller (see
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Figure 7.4: ATTiny2313-20SU I/O ports lines in ZenPPG. Ports PD0 and PD1 are used to generate multi-
plexing clocks CMUX0 and CMUX1, while ports PB0-2 are used for demultiplexing clocks MUX0, MUX1, and
SMP INH. Ports PB5-7 and PA2 are adopted for programming the microcontroller.
subsection 7.2.2). Figure 7.3a illustrates the connections in MC14052BD employed in
ZenPPG. The output of the multiplexer depends on the state of the logical ports A,
B, and INHIBIT. The truth table in Figure 7.3b indicates how the switches between
input and outputs in the MC14052BD are driven by the digital logical ports, while
Figure 7.3c illustrates the output X of the multiplexer showed in Figure 7.3a.
7.2.2 Microcontroller
In order to provide the logical controls for multiplexing (and demultiplexing as seen
later) the Atmel ATTiny2313-20SU (Atmel Corporation, CA, USA) microcontroller is
used. The ATTiny2313 is a low-power programmable 8-bit microcontroller with an in-
ternally calibrated oscillator. The microcontroller has 18 programmable I/O lines and
2K Bytes internal programmable memory. The microcontroller is surface mounted on
the ZenPPG’s core board and it can be re-programmed by plugging the AVR STK500
development board (Atmel Corporation, CA, USA) to a 6-PIN connector mounted
on the ZenPPG. This facilitates the customization of the clocks’ sequence for differ-
ent applications. The microcontroller’s I/O lines were programmed through the AVR
STK500 programming kit and Atmel Studio. As shown in Figure 7.4, two bits of PORT
D were used to provide the multiplexing clocks CMUX0 and CMUX1, while three bits
of PORT B were utilised for the demultiplexing clocks MUX0, MUX1, and SMP INH.
Four ports were used to reset and reprogram the microcontroller. Appendix A shows
the code that was implemented and programmed in the microcontroller for the multi-
plexing and demultiplexing sequence in ZenPPG.
122
7.2. LEDs currents time multiplexing
(a) (b)
Figure 7.5: Voltage reference circuit for the first (a) and second (b) channel of ZenPPG.
7.2.3 Voltage Reference Circuits
As mentioned earlier, the inputs ICPOS0, ICNEG0, ICPOS1, and ICNEG1 of the mul-
tiplexer showed in Figure 7.3a are voltages selected directly by the user through trim-
mers or in LabVIEW. These voltages are controlled by the voltage reference circuits.
Figure 7.5a shows the voltage reference circuit, for the first channel of ZenPPG. The
analogue outputs AO0 and AO1 from the DAQ provide voltages ranges of 0/+5V and
0/-5V respectively, and are controlled through a graphical user interface in LabVIEW.
Each of these signals is then connected to a voltage divider and a voltage follower. The
voltage divider is composed by the two resistors at the op-amp input (i.e. R17-R21 and
R18-R22) and it reduces the voltages AO0 and AO1 by a factor Q = 5. This reduction
allows the conversion of 1 V input to a 200 mV output for AO0 and from -1 V input
to a -200 mV for AO1, which are then used to drive the LEDs currents. The outputs
of the voltage followers are then connected to the inputs of the multiplexer as showed
in Figure 7.3a.
Figure 7.5b shows the voltage reference circuit for the second channel of ZenPPG. In
the top circuit of Figure 7.5b, the constant voltage VREF is equal to 1.024 V and is
generated by a low-noise voltage reference (LM4140-1.0, Texas Instruments). VREF is
connected to a voltage divider composed by R19 and R20 and by a voltage follower.
This creates a reduction in the positive voltage ICPOS1 by regulating the variable
resistor R20. The bottom circuit is an inverting amplifier, which reduces VREF by
adjusting the variable resistor R27. The resulting ICPOS1 and ICNEG1 are then used
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as input to the second channel of the multiplexer. Similar to the voltage reference
circuit of the first channel, the ICPOS1 and ICNEG1 can be regulated by trimming
R20 and R27, to provide a voltage directly proportional to the LEDs driving currents.
7.2.4 Evaluation of LEDs time multiplexing and voltage reference
The multiplexing and voltage reference circuits were evaluated by measuring the input
and output voltages of the multiplexer. Figure 7.6 illustrates the voltages at the inputs
and output of the multiplexer. The reference voltages AO0 and AO1 on LabVIEW
were set at 1 V and -1 V, and the output of the voltage reference circuit ICPOS0 and
ICNEG0 were measured on the oscilloscope. The measured voltages were 200 mV and
-200 mV (for AO0 and AO1 at 1 V and -1 V respectively, Figure 7.6a). The voltages
were then increased to 2 V and -2 V, corresponding to 400 mV and -400 mV respectively
(Figure 7.6c). The output of the multiplexer was also measured, along with the logical
controls A and B, at the two different voltage sets (Figure 7.6b and Figure 7.6d).
The measurements were also repeated for the second channel, giving identical outputs
(results not presented).
7.3 Current Source Board
In order for the LEDs to be switched ON, a driving current should be supplied to the
LEDs. For this purpose, ZenPPG adopts a current source circuit for the conversion of
voltages from the multiplexer’s output into driving currents for the LEDs.
Figure 7.7 illustrates the current source in ZenPPG. The central part of the circuit is a
Howland current source, while a non-inverting amplifier and a push-pull circuit (PNP-
NPN pair) have been added in the overall circuit. Since the conventional Howland
current source will transform voltages into currents in a unitary ratio (e.g. 1 V to
1 A), the non-inverting amplifier on the left side of Figure 7.7 has been added to
reduce the input voltages by one-tenth (output of 100 mV with a maximal input of
1 V). The push-pull circuit switches ON either LED1 or LED2 depending whether the
driving voltage is positive or negative and increases the circuit ability to work at high
switching frequencies. The resistors R13 and R14 limit the current flowing through the
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(a) (b)
(c) (d)
Figure 7.6: Reference voltages at 1 V (a) and 2 V (c), multiplexer output and clocks at 1 V (b), and multiplexer
output and clocks at 2 V (d). The yellow traces in (b) and (d) are the multiplexer output, while the purple and
blue are the digital controls
LEDs to 80 mA.
An instrumentation amplifier is employed to measure the voltage across the load resistor
R21. By doing this, the output of the instrumentation amplifier can be used to monitor
the driving currents from a LabVIEW interface. The instrumentation amplifier has a
gain G = 10, in order to amplify even the small voltages before they are acquired by
the DAQ.
Thus, the current source in Figure 7.7 independently switches two different LEDs
(LED1 and LED2). When the output of the multiplexer is connected to the current
source, light switching is achieved, while the sequence and frequency of the switching
between the two LEDs (or wavelengths) are directly controlled by the logic controls A
and B of the multiplexer.
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Figure 7.7: Modified Howland current source in ZenPPG.
7.4 Transimpedance Amplifier Board
Once the light is intermittently switched ON/OFF and emitted into the tissue, the
backscattered light is collected by a photodetector. The ZenPPG is predisposed for
the measurements of light by photodiodes. This section will illustrate how the light
detected by the photodiode is transformed in voltages and amplified in ZenPPG.
Photodiodes are diodes, which are specifically doped to respond to light exposure.
When photons impact on the active area of a photodiode, hole-electron pairs are re-
leased, producing an electric field across the photodiode’s terminals [170]. This electric
field will create a small current, which is directly proportional to the radiant energy
and the characteristics of the semiconductor’s material [170]. Since working with cur-
rents is rather difficult and most circuits measure voltages, the current produced by
photodiodes are usually converted into voltages [170]. The most common circuit used
for the conversion of photodiode currents into voltages is the transimpedance ampli-
fier (TIA) [170]. Figure 7.8 shows the basic circuit of a TIA. A current pump (i.e.
photodiode) is connected to the negative input of an op-amp, while the positive input
is grounded. The negative input of the op-amp is then connected to the op-amp output
through a feedback resistor Rf . When a current start to flow towards the op-amp input,
the negative input is virtually grounded from the positive input of the op-amp. Since
the negative input is virtually grounded and no current flow through the op-amp, the
current flows into Rf only and the output voltage of the circuit is Vo = Rf × i [170].
126
7.4. Transimpedance Amplifier Board
Figure 7.8: Basic transimpedance amplifier circuit. The virtual ground at the negative input creates no current
flowing through the op-amp and the current flows only through the feedback resistor Rf . Thus, the voltage V0
is directly proportional to the current generated by the photodiode PD and Rf .
Figure 7.9: Transimpedance amplifier with compensation feedback capacitor. The capacitor Cf is inserted in
parallel to Rf in order to counteract the unstable output of the circuit in Figure 7.8.
However, this ideal scenario is far from reality. The finite open-loop gain and the
input capacitances of the op-amp can combine with the photodiode’s capacitance and
can result in an unstable circuit. The inductive behaviour of this circuit with the
combination of the op-amp’s noise gain and the open-loop gain create a resonating
circuit [170, 171]. The addition of a capacitor Cf in parallel to Rf counteracts the
inductive nature of the circuit and reduces the gain peaking of the resonating circuit
[170,171].
This compensating capacitor Cf , should be carefully matched with the input capaci-
tances and the gain bandwidth of the op-amp and the photodiode’s capacitance. Equa-
tion 7.1 illustrates the equation for the calculation of the optimal capacitor based on
the above mentioned parameters [170,171].
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Cf =
√
CT
2piRfGBW
Where CT = CPD + Cid + Cicm (7.1)
Where Rf is the feedback resistance, GBW is the gain bandwidth of the op-amp, CPD
is the photodiode’s capacitance, Cid is the differential capacitance of the op-amp, and
Cicm is the common mode input capacitance of the op-amp.
The op-amp used in the ZenPPG for transimpedance amplifier design is an OPA380.
The main characteristics of the OPA380 are high speed, wide bandwidth and low input
bias currents, making it appropriate for the transimpedance amplifier design. The
calculated feedback capacitor of Equation 7.1 for the OPA380, with a feedback resistor
equal to 120 kΩ and the photodiode employed in the sensors presented in Chapter 6,
yields a solution of Cf = 1.04 pF.
Even though Equation 7.1 indicates the optimal value of the capacitor Cf , the dimen-
sioning of this component should match the specific applications of the circuit. This
is due to the fact that the parasitic capacitances of the circuit can still overcome the
selected Cf [170]. Therefore, an additional empirical tuning of the Cf may still be
needed in certain applications. However, an increase of Cf from the calculated value
will further limit the bandwidth of the circuit, but will also increase the stability of the
circuit [170,172].
7.4.1 Evaluation of the Transimpedance Amplifier
Figure 7.10 shows the output of the transimpedance amplifier for the sensor connected
on the forehead and Rf = 120 kΩ and Cf = 15 pF. During this measurement, the LEDs
driving current was maintained at 20 mA. The light switching can be noticed from the
three periods (Red LED ON, IR LED ON, and both LEDs OFF). The highest voltage
can be observed when the IR LED was ON (i.e. lower absorption). This voltage depends
on the light intensity and the feedback resistor Rf and, in order to avoid saturation, it
should not exceed the voltage supply of the op-amp (i.e. 3.3 V). Thus, the value of Rf
should be matched accordingly, depending on the specific location of the sensors (i.e.
more or less light absorption) and the light intensities utilised. One approach can be to
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Figure 7.10: Transimpedance amplifier output in ZenPPG.
initially adopt a low-medium gain (e.g. Rf = 120 kΩ) and increase the light intensities
for each subject, until a satisfactory voltage is achieved.
However, as mentioned above, the value of Cf will also influence the stability of the
circuit. Since the calculated value of Cf from Equation 7.1 was far too small (1.04 pF),
an additional tuning of Cf was required. However, the value of Cf should not be too
high, as this would also affect the transient response at the amplifier’s output. As seen
later, this could have unfavourable consequences on the demultiplexing of the signal
(see Section 7.5 ). Figure 7.11 shows the output of the transimpedance amplifier for
different capacitor values and constant feedback resistor Rf = 120 kΩ. Without capaci-
tor compensation or for low capacitance values such as 2.2 pF, the circuit was unstable,
with ringing over-imposing on the signal. For high capacitance values such as 100 pF
and 680 pF, the transimpedance amplifier’s output started to change shape due to an
increase in the transient response. An optimal value of Cf = 15 pF was empirically
derived based on the stability of the signal at the output of the transimpedance ampli-
fier. This approach overcompensated the circuit, but also increased the stability of the
final transimpedance amplifier’s output.
The selection of the feedback resistor Rf was performed for each measurement location
in the studies presented in this thesis (e.g. forehead, forearm, finger, etc.), in order to
maximise the signal amplification without saturating the op-amp. The capacitor Cf
was also specifically selected depending on each application, sensor (photodiode), or
resistor Rf (i.e. gain).
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(a) (b)
(c) (d)
(e)
Figure 7.11: ZenPPG’s transimpedance amplifier output without feedback capacitor (a), for feedback capacitor
Cf = 2.2 pF (b), Cf = 15 pF (c), Cf = 100 pF (d), and Cf = 680 pF (e). The feedback resistor was kept at
Rf = 120 kΩ
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Figure 7.12: MC14052BD demultiplexer connections schematic in ZenPPG.
7.5 Demultiplexing and Sample & Hold
As mentioned in the previous sections, the signal generated by the photodiode is a
continuous sequence of Red/Infrared light switching. The typical signal at the output of
the transimpedance amplifier can be seen in Figure 7.10, where the switching sequence
can be noticed by three different voltage levels corresponding to the three cycle periods.
Since this signal is mixed, time separation of the signal in the respective wavelengths
is required. In order to achieve this, the ZenPPG employs analogue demultiplexers.
Analogue demultiplexers are devices, which are commonly used in conjunction to mul-
tiplexers. In an opposite fashion compared to multiplexers, demultiplexers receive one
input line and separate it into several output lines. Similar to multiplexers, demul-
tiplexers are composed of internal switches, which are directly controlled by logical
ports.
The ZenPPG employs a separate MC14052BD as demultiplexer. Figure 7.12 shows
the schematics of the demultiplexer’s connections. The outputs of the transimpedance
amplifiers of both channels (MIXED0 and MIXED1) are connected to the inputs of the
demultiplexer. The logical controls MUX0, MUX1 and SMP INH0 are provided by the
microcontroller and control the sequence of the outputs for each channel (RAW0 n and
RAW1 n, for n = 1...3).
The process can be thought as the opposite of time multiplexing showed in Section 7.2,
where the truth table in Figure 7.3b controls the demultiplexer outputs, depending on
the state of the logical controls A, B, and INH. Figure 7.13 graphically illustrates the
process of time demultiplexing achieved for the output of the transimpedance amplifier.
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Figure 7.13: Illustration of the input, outputs, and logical controls of the demultiplexer during two consecutive
cycles. MIXED0 is the output of the transimpedance amplifier and the input of the demultiplexer. A (MUX0),
B (MUX1), and INH (SMP INH) are the logical controls. The input signal MIXED0 is time demultiplexed in
X0, X1, and X2.
In this scenario, when the logical controls close the internal switches of the demulti-
plexer, the input is transmitted to corresponding output of the demultiplexer. If the
logical controls of the multiplexer and demultiplexer are synchronous, the separation
of the three different sequence of light switching is possible (i.e. red wavelength ON,
Infrared wavelength ON and both wavelengths OFF).
However, demultiplexing an entire segment of the transimpedance amplifier’s output
could introduce some inaccuracies. At the margins of each segment, there are big
voltage transitions, which should not be sampled. Moreover, the introduction of the
feedback capacitor Cf in the transimpedance amplifier’s output create a transient re-
sponse during each transition (see Figure 7.11). In order to achieve an adequate quality
in the PPG signal, these features of the intermittent transimpedance amplifier’s output
should be avoided.
The sampling in the entire segment is solved in the ZenPPG by only demultiplexing the
central part of each segment. This is achieved by dividing each segment into four equal
sub-segments (total of twelve sub-segments for each cycle Red ON, IR ON, Dark). The
sampling is only performed in the two central sub-segments, while the other ’peripheral’
sub-segments are avoided. Figure 7.14 shows the output/inputs of the demultiplexer
when only the central part of each period is sampled. While the clocks A and B do not
change compared to the traditional situation in Figure 7.13, the clock INHIBIT changes
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Figure 7.14: Illustration of the input, outputs, and logical controls of the demultiplexer during a single cycle.
MIXED0 is the output of the transimpedance amplifier and the input of the demultiplexer. A (MUX0), B
(MUX1), and INH (SMP INH) are the logical controls. The input signal MIXED0 is time demultiplexed in X0,
X1, and X2 only in the central part of the period (Red ON, IR ON, or Dark), when INH is in a low state (see
truth table in Figure 7.3b).
to a low status (sampling) only in the central part of the period. The implementation
of this division can be seen in the multiplexing/demultiplexing code in Appendix A,
where the programming of the microcontroller was divided in twelve (4 by 3) different
instructions.
The process explained above shows how the mixed raw PPG signal is time-demultiplexed
(or simpler, split) into red and infrared signals. However, the output of the demulti-
plexer illustrated in Figure 7.14 are intermittent voltage pulses produced by the tran-
simpedance amplifier output. Even though these pulses have high frequencies (i.e. in
the order of few hundred Hertz switching frequency), they may not retain the voltage
to the next cycle, with the consequent degradation of the PPG signal. Therefore, a
sample and hold circuit is needed in order to retain the voltage until the next cycle.
The sample and hold circuit is a circuit composed of a switch, a capacitor, and an
operational amplifier. The positive input of the op-amp is connected to the capacitor,
while the negative input is feed-backed to the op-amp’s output. The switch is con-
nected to the capacitor and closes intermittently, passing a certain voltage. When the
switch is closed, voltage is passed to the op-amp input and feed-backed to the op-amp’s
output. During this period, the capacitor charges. When the switch is released, the
capacitor holds the charge and it keeps providing the voltage at the op-amp’s input.
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Figure 7.15: Sample and hold circuit in ZenPPG. The output of the demultiplexer is connected to the input of
the op-amp and a capacitor C1 to hold the voltage. When the switch (i.e. demultiplexer) is closed, the voltage
RAW0 0 is passed to the op-amp output while the capacitor C1 is charged. When the switch is opened the
capacitor C1 continues to discharge to the op-amp input.
This configuration allows a slow discharge of the capacitor due to the low input bias
currents of op-amp and a high output impedance (or low OFF currents) of the switch.
In the ZenPPG, the sample and hold circuit is implemented by a capacitor and an
op-amp connected to the output of the demultiplexer (switch). Figure 7.15 shows the
sample and hold circuit adopted in the ZenPPG. The signal from the demultiplexer
(switch) is connected to the positive input of an op-amp (OP484FSZ) and a capacitor
C1. The negative input of the op-amp is feed-backed to the output. Each output of
the demultiplexer is passed to separate circuits as in Figure 7.15, in order to sample
and hold dual-wavelength PPG.
Once the signal is sampled and hold, the PPG signal needs to be filtered before being
acquired by National Instruments Data Acquisition systems. Thus the output of the
sample and hold circuit is connected to a low-pass RC filter. The filter has a cut-
off frequency of 79.5 Hz in order to remove unwanted high-frequency noise from the
signal and to restrict the signal bandwidth to avoid aliasing in the analogue-to-digital
conversion. Remaining noise is filtered digitally after analogue-to-digital conversion.
The filter is followed by a pre-acquisition voltage buffer. Figure 7.16 shows the sample
and hold circuit, the low-pass filter and the voltage buffer.
7.5.1 Evaluation of time demultiplexing and Sample & Hold
Figure 7.17 shows the output of the transimpedance amplifier output of signal acquired
from the forehead. The voltage reference was set at 1 V, transimpedance amplifier gain
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Figure 7.16: Sample and hold circuit, low-pass anti-aliasing filter and voltage follower (buffer).
Figure 7.17: Transimpedance amplifier output and demultiplexer clocks. From top: transimpedance amplifier
output; INH clock, A and B clocks. The INH clock (sampling) is in a low logical state only in the central part
of each period (Red ON, IR ON, or dark)
Rf = 120 kΩ and Cf = 15 pF. As seen from the second upper trace in Figure 7.17,
the INH clock, which is responsible for sampling the signal, is in a low state only
during the second and third quarter of each period (Red ON, IR ON, or dark). The
sample and hold circuit (comprised of filter and buffer) was evaluated by removing the
transimpedance amplifier board and inputting a ∼100 mVpp sine wave at 1 Hz and
20 Hz. The procedure was later repeated by inputting a simulated ∼60 mVpp PPG
signal at 1 Hz and 20 Hz (Figure 7.18).
7.6 Power board and external connections
The power board in the ZenPPG is responsible for supplying voltages to all working
components in the system. The board provides two positive voltages (+ 5 V, + 3.3 V)
and two negative voltages (- 5 V,-1.3 V), which are used depending on the specific
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(a) (b)
(c) (d)
Figure 7.18: Evaluation of the sample and hold circuit with sine waves and simulated PPG signals. (a) Sine
wave at 1 Hz and 100 mVpp. (b) Sine wave at 20 Hz and 100 mVpp. (c) PPG signal at 1 Hz and 60 mVpp.
(d) PPG signal at 20 Hz and 60 mVpp. The sine wave and simulated PPG signals were connected to one of the
inputs of the demultiplexer. The upper traces (yellow) are the input signals, while the bottom traces (purple)
are the signals measured at the output of the circuit in Figure 7.16.
application. The system can be supplied either by connection through USB (portable
battery packs or PC) or by connection to two 9 V PP3 batteries.
The ZenPPG allowed the connection of custom-made and commercial probes through
two DB-sub 9-pin female connectors placed on the front panel. Two pins of this con-
nector provided the driving currents for the LEDs (pins 2 and 3), two pins received the
currents generated by the photodiode (pins 5 and 9), and one pin was connected to
ground. Figure 7.19 shows the ZenPPG’s front panel and the instrument with two PPG
sensors connected. The research PPG system presented a 64-pin National Instruments
connector for connection to Data Acquisition Card (DAQ). Through this connector, the
PPG signals and functional parameters (e.g. driving currents, batteries status, etc.)
can be digitised, acquired, and controlled through LabVIEW.
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(a) (b)
Figure 7.19: ZenPPG system’s front panel (a) and ZenPPG with two PPG sensors connected (b). D-Sub
9-pin connectors for PPG probes can be noticed on the front panel (a).
7.7 Summary
In this chapter, a research PPG system has been presented. Even though each part of
such complex system cannot be illustrated, the main components and functionalities
for the purposes of this work have been described. The next chapter will describe the
development of a virtual instrument (VI) in LabVIEW that was used for the acquisition
of signals from custom-made (ZenPPG) and commercial devices, for the display of
signals in real time, and for the saving of the acquired signals. Furthermore, the
application of the modified Beer-Lambert law will be proposed and described.
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Chapter 6 and Chapter 7 described the development of reflectance PPG sensors and the
evaluation of a research PPG processing system (ZenPPG). In order to acquire, display
in real time, and save the signals for post-acquisition analysis, the instrumentation was
connected to Data Acquisition devices for analogue-to-digital conversion (ADC) and a
software was developed to acquire the digitised signals on a personal computer. This
chapter briefly describes the connection set-up to dedicated Data Acquisition devices
and the development of a software application designed in LabVIEW and used to
acquire the physiological signals and interface with ZenPPG. For better clarity, only
the configuration for the acquisition of signals from a single ZenPPG and one channel
NIRS will be described in this chapter. However, the software application was adapted
to each of the studies performed in this work, for the acquisition of additional signals.
The modified Beer-Lambert law, used in NIRS to infer haemoglobin concentration
changes, was previously introduced in Chapter 5. This work aims at investigating
the feasibility of applying this NIRS principle to PPG measurements. Therefore, the
application of the modified Beer-Lambert law to PPG signals is proposed and described
in the second part of this chapter.
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8.1 Introduction to LabVIEW
LabVIEW (Laboratory Virtual Instrument Engineering Workbench) is a software tool
by National Instruments used for designing tests, perform measurements and develop
control systems [173]. LabVIEW is a program development application presenting a
different flexibility and an improved productivity compared to other languages such
as C. LabVIEW has been built with a user-friendly graphical interface. It is the first
software application to use the G programming language, adopting graphical scripting
techniques in a Virtual Environment [174].
In LabVIEW, the source code is developed graphically in a Block Diagram and it is ran
in the Front Panel [173]. The Block Diagram contains the graphical code, while the
Front Panel is used to display signals, indicators, and/or controls. These two constitute
the code, also known as Virtual Instrument (VI) [173]. As other programming languages
where the code can be broken into \sub-functions” or \sub-routines”, the code can be
divided in sub-VIs, or more generally called VIs [173]. Each VI usually has input(s) or
output(s). These can be graphically connected to other VIs in order to pass variables
(or to indicators and/or controls for display or automation) [173]. This can help the
user to break complex programs in simpler tasks. Its hierarchical structure permits
easy modification on the code and quicker developmental time [173,174].
The graphical nature of LabVIEW makes it ideal for data acquisition, data analysis,
instrument control, test and measurements, automation, and other tasks [173].
For these reasons, LabVIEW was chosen as the programming language for controlling
ZenPPG light intensities and acquiring signals from ZenPPG and other physiological
monitoring devices used in this work.
8.2 Analogue to Digital conversion set-up
Before being acquired and saved in a text file by a software application, the analogue
signals require being converted in digital form. Data Acquisition Cards (DAQC) are
pieces of equipment dedicated to converting analogue signals into a digital form, before
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being passed to a personal computer [175]. The fundamentals of analogue-to-digital
conversion are not discussed here and they can be found in most signal processing
books such as [175]. This section briefly describes the connection of the physiological
monitoring devices to dedicated data acquisition cards.
As mentioned before, the ZenPPG is equipped with a National Instruments 64-pin
connector. The signals from the ZenPPG were acquired and digitised by connecting
the device to a DAQC (NI-PcIe 6321 DAQ, National Instruments, USA) by a shielded
64-pins cable (SCH68-68-EPM, National Instruments). The NI-PcIe 6321 is a high-
speed data acquisition card with 16-bit resolution and 16 input channels. The following
sections in this chapter describe how the signals were acquired, manipulated, displayed,
and saved in the software application.
The other medical devices such as NIRS or laser Doppler flowmetry, which were used in
this work, were set-up to acquire their analogue outputs voltages. Custom-made cables
were used to connect the analogue output ports of these devices to a shielded screw
terminal block (SCB-68, National Instruments, USA). This block was then connected to
a second NI-PcIe 6321 by another SCH68-68-EPM cable. The subsection 8.3.5 describes
how these analogue voltages were then converted back to their original scale after being
acquired.
8.3 Development of a Virtual Instrument for physiological
signals acquisition and control of light intensities
The first part of the VI described in this chapter was designed by the Research Centre of
Biomedical Engineering at City University of London in conjunction with the ZenPPG.
This section of the software application was designed to acquire signals from the PPG
processing system through the dedicated DAQ connector mounted on the ZenPPG and
to control the light intensities in the first channel of ZenPPG. This already existing
part constituted the starting point from where the rest of the VI was extended further
for the in vivo studies that were carried out in this work. The rest of this LabVIEW
application was specifically developed for this thesis in order to acquire signals from
other instruments such as NIRS or laser Doppler flowmetry, to apply calibration equa-
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Figure 8.1: Block Diagram of the Virtual Instrument (VI) developed for acquisition of PPG and NIRS signals.
The block diagram is split in small tasks/functions (VIs). These are connected between each other for transferring
variables and signals, or they are connected to indicators or charts for display on the front panel.
tions, to display the signal by means of graphs or indicators, and to save the acquired
physiological signals. Therefore, this part of the VI was developed for the acquisition of
a multitude of signals and it was adapted to each single study and for specific settings.
However, in order to avoid confusion to the reader, this chapter will only describe the
acquisition from a single-channel NIRS device, whereas the extension to the acquisition
from other devices will be mentioned but not described in detail. Similarly, the use of
the VI for the acquisition of signals from only a single ZenPPG unit will be described
as well.
Figure 8.1 and Figure 8.2 illustrate respectively the entire block diagram and front panel
of the developed VI. Each part of these will be described in the following sections.
8.3.1 Acquisition of PPG signals from ZenPPG
As shown in Figure 8.1, the entire VI was enclosed in a while loop structure. This
allowed the code to run continuously in time. The code was started by the user through
the user interface and it ran until the STOP button in the front panel is pressed.
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Figure 8.2: Front Panel (or user graphical interface) of the Virtual Instrument (VI) developed for acquisition
of PPG and NIRS signals. The left side of the panel is dedicated to the display of the acquired signals, while
indicators and controls are placed on the right side.
The ADC process was performed by National Instruments DAQC. While the DAQC
transformed the analogue signals to digital, the process of continuously transferring the
created bits to the computer’s buffer is controlled through the VI.
The DAQ Assistant VI allowed reading data from a specific DAQC connected to the
computer. The DAQ Assistant VI was placed in a while loop in order to perform the
reading continuously in time until the user stopped the acquisition. Through the DAQ
Assistant VI , the user could select the DAQC from where to read the signals, select the
input channels, choose the sampling frequency, set the voltage inputs ranges, perform
calibrations, and select other parameters/tasks related to the signal acquisition. The
outputs of the DAQ Assistant VI were the digitized signals acquired by the DAQC.
These output signals were a discrete sequence of numbers (internally represented in
bits) composing the original analogue signals sampled in an equally time interval (i.e.
sampling frequency). In order to separate the acquired voltages into single signals, a
Split Signals function was used at the output of the DAQ Assistant VI. Figure 8.3 illus-
trates the DAQ Assistant VI, the Split Signals function and the acquired measurements
separated into single signals. The first four signals acquired by the DAQ Assistant VI
were the dual-wavelength and dual channel raw PPG signals (i.e. channel 1 Red PPG,
channel 1 IR PPG, channel 2 Red PPG, and channel 2 IR PPG), the fifth and sixth
were the LEDs driving currents, and the last was the voltage level of the battery.
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Figure 8.3: DAQ Assistant VI, split signals function and separated signals in the VI. The signals acquired
by the DAQ Assistant VI are bundled in a single output. The split signals function separate these into single
signals.
Once the signals were acquired together from the DAQC and split into each respective
wavelength or signal, these were then prepared for being displayed on the front panel.
The next section will describe how the signals were processed in order to be displayed
in real time by means of graphical charts or indicators.
8.3.2 Display of acquired signals and indicators
One of the main reasons for adopting LabVIEW for the acquisition of physiological mea-
surements is its graphical user interface and its capabilities of displaying the acquired
signals in real time. The VI developed allowed the display of physiological signals si-
multaneously to their acquisition. Once the raw PPG signals (AC+DC) were acquired
and split into their respective wavelengths and channels, the AC components of the
signals were displayed on the screen in real time. The first four split signals showed
in Figure 8.3 were bundled together by a Merge signals function. This facilitated the
simultaneous and identical processing of the signals. After merging the signals, these
were band-pass filtered by the Filter Express VI (pass-band: 0.5-7 Hz). The Filter
Express VI received an input signal, filtered it and output the filtered signal. The filter
parameters could be easily set through the settings window of the VI. Once the signals
were filtered to obtain the AC PPG component, these were inverted and input into a
graphical chart for display. The chart’s icon was represented on the block diagram,
while the graphical chart displaying the signals was on the front panel (left side of
Figure 8.2). Figure 8.4 shows the connections in the VI for filtering and displaying.
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Figure 8.4: Filter Express VI and signal display chart. The PPG signals are band-pass filtered (pass-band: 0.5-
7 Hz) and displayed on a chart in the VI’s front panel.
8.3.3 Control and monitoring of ZenPPG’s light intensities
As mentioned in Chapter 7, the PPG processing unit ZenPPG allows the control of
the light intensities through voltage reference circuits (subsection 7.2.3) . In addition,
the LEDs driving current can be monitored by measuring, using an instrumentation
amplifier, the voltage drop across a resistor (Section 7.3). This section describes the
digital control of light intensities in the first channel of ZenPPG (the second channel’s
currents are set through trimmers) and the monitoring of the LEDs driving currents.
The voltage reference circuits in subsection 7.2.3 supplied a voltage directly propor-
tional to the LEDs driving currents. In the first channel of ZenPPG, this was performed
by supplying the voltage reference circuit with voltages generated by the analogue out-
puts of the DAQC. The range of the analogue output voltages supplied by the DAQC
was ± 5 V and they can be controlled in LabVIEW by manual controls on the front
panel. Figure 8.5a shows the part of the VI dedicated to supplying a voltage output
through the DAQC. This was achieved by the use of the DAQmx Create Virtual Chan-
nel VI and the DAQmx Write VI. The latter one wrote a specified task (in this case a
voltage, set manually by the user) and wrote it to the task created in the DAQmx Create
Virtual Channel VI (supply voltage to the specified output channel of the DAQ card).
The DAQmx Create Virtual Channel VI used the selected DAQC’s output channel and
the voltage range required to supply an analogue voltage. The DAQmx Create Virtual
Channel VI was placed outside the loop for its independence from the running of the
instrument, while the DAQmx Write VI was inside the while loop, stopping when the
acquisition stopped. When the while loop stopped, the supply of the voltage output
was stopped and the task was cleared by the DAQmx Clear Task VI.
Two instrumentation amplifiers in the ZenPPG’s current source board measured a volt-
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Figure 8.5: LEDs driving current control (a) and monitor (b) in the VI. (a) The LEDs currents are set by
analogue voltages generated through the DAQC by the DAQmx Create Virtual Channel VI and the DAQmx
Write VI. (b) The LEDs currents (red and infrared), in both ZenPPG’s channels, are then monitored by acquiring
the outputs of the ZenPPG instrumentation amplifiers, measuring the minimum and maximum, re-scaling the
values, and displaying these by indicators on the front panel.
age directly proportional to the LEDs driving current. This voltages were measured for
each ZenPPG’s channels and were amplified by a gain G = 10 before being acquired
by the DAQC. These voltages were positive-negative intermittent signals due to the
switching between red and infrared LEDs (see Figure 7.3c). The monitoring of the
LEDs’ driving currents was performed in the VI by acquiring the amplifiers’ outputs
and measuring the minimum and maximum of these oscillating signals by using the
Amplitude and Level Measurements Express VI as illustrated in Figure 8.5b. The min-
imum and maximum of the signals were then reduced by the instrumentation amplifier
gain G = 10 before being displayed by indicators on the front panel.
The DC offset (or DC component) of the acquired PPG signals were also monitored
on the VI. These are important parameters to monitor since they indicate whether the
saturation rail of the transimpedance amplifier has been reached, with the consequent
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corruption of the PPG signal. The DC offsets at both wavelengths were monitored by
low-pass filtering the acquired signals at a cut-off frequency fc = 0.05 Hz and displaying
the filtered signals on the front panel as numerical indicator.
8.3.4 Arterial oxygen saturation estimation from PPG signals
Arterial oxygen saturation (SpO2) was estimated in real time from PPG signals. Fig-
ure 8.6 shows the part of the VI designed to estimate the SpO2. The acquired PPG
signals were low-pass filtered at 7 Hz by a Filter Express VI. The filtered PPG signals
were then input to a Collector Express VI. This function collected a certain amount
of data and output the collected signal only when the target size was reached. The
Collector Express VI was set to collect 3000 points, equivalent to three seconds of data.
This length was deemed sufficient for windowing the signals with at least one cardiac
pulsation, composed by one peak and one valley. The collected signal was then divided
into each corresponding wavelength/channel by the Split Signals. In order for the ratio
of ratios to be calculated from the PPG signals, the DC offsets and the peak-to-peak
amplitude of the pulsatile PPG (AC component) were calculated by the Amplitude
and Level Measurements Express VI. Once the ratio of ratios was calculated from the
DC PPG and the AC PPG peak-to-peak amplitude at each wavelength, the SpO2 was
calculated using the Formula Express VI and Equation 8.1.
SpO2 = 110− 25×R (8.1)
8.3.5 Signal acquisition from commercial devices
The VI was also developed to acquire signals from other devices other than the ZenPPG.
In this section, the part of the VI dedicated to acquiring signals from a commercial NIRS
monitor (NIRO 200NX, Hamamatsu Photonics, Japan) is presented.
The analogue voltages from the device were digitised by a DAQC and acquired on
LabVIEW by a dedicated DAQ Assistant VI. In Figure 8.7a the bundled signals at
the output of the DAQ Assistant VI were separated in the four signals measured per
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Figure 8.6: SpO2 calculation in the VI. The DC PPG and the AC PPG peak-to-peak amplitude were calculated
from dual-wavelength PPG signals by the Amplitude and Level Measurements Express VI. Once the ratio of
ratios was calculated, the SpO2 was calculated by applying Equation 8.1.
channel, TOI, nTHI, HbO2 (O2Hb), and HHb. The analogue voltage outputs from
medical devices are signals representing the measured parameter. However, due to
safety reasons, these voltages are scaled to certain voltage ranges, which usually do
not exceed the ± 5 V. Thus, a re-scaling process is required in order to transform
the analogue voltages acquired back to the scale of the measured parameters (e.g.
percentage for TOI). Therefore, calibration equations were generated as suggested by
the manufacturers. The voltages across the analogue outputs’ pins were measured
by a multimeter. These were measured at two or three voltages in order to generate
calibration lines. Figure 8.7b illustrates the calibration curve created for TOI’s analogue
outputs from the NIRO 200NX. The line and respective equation were obtained by
the regression between two voltage points at 0 V and 1 V. For these two points, the
measured voltages were respectively -0.003 and 0.994. The same process was repeated
for all the parameters that were acquired from other commercial devices.
Once calibration equations were created for each parameter, the acquired analogue
outputs signals were input to a Formula Express VI containing their specific calibration
equation. After being rescaled, the signals were then displayed on the front panel by
means of indicators or charts as showed in Figure 8.7a.
When necessary, the entire process described here (acquisition, rescaling and display)
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Figure 8.7: Acquisition, calibration and display of signals from commercial devices (a) and NIRS TOI analogue
outputs calibration line and equation (b). In (a) the analogue outputs from the device are acquired by the
dedicated DAQ Assistant before being split, re-scaled, and displayed on the front panel by indicators. All the
analogue outputs were re-scaled by using an equation obtained from the calibration line as done in (b) for TOI.
was extended to the other NIRS channels or to other devices such as laser Doppler
flowmetry monitors or pulse oximeters.
8.3.6 Measurements file saving and protocol timers
One of the main function of the developed VI was to save the acquired signals for post-
acquisition analysis. The Write To Measurement File Express VI was used to save the
acquired signals. The signals from all DAQ Assistant VI were first bundled together
and then input to the Write To Measurement File Express VI. This received the signals
as input and save them in a text file in which each column represented a signal. The
saving of the measurements was taking place only when a button on the front panel
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was pressed by the user and a file name was chosen.
In order to measure the experimental protocol times, different timers were developed on
LabVIEW. The first timer, (Timer 1, was dedicated to indicate the overall measurement
time on the front panel. Timer 1 was starting only when the same button dedicated
to initiating the saving of the measurement was pressed on the front panel. This
allowed indicating the time elapsed since the measurement or protocol was started.
The second timer, Timer 2 was started when the same button on the front panel was
pressed. However, Timer 2 was automatically reset when a time target was reached.
This allowed the automatic indication of protocol timing. The final timer, Timer 3, was
restarted manually by the user through a button on the front panel of the VI. Figure 8.8
illustrates the parts of the VI dedicated to saving the measurements (Figure 8.8a) and
timing (Figure 8.8b).
Figure 8.9 shows the front panel of a running VI. The acquired PPG signals are dis-
played on a chart on the left side of the panel. Other physiological parameters such as
SpO2 and TOI are displayed on the panel by means of indicators. The LEDs driving
currents, DC PPG offsets, timers, and battery level are also displayed on the front
panel by numerical or visual indicators.
8.4 Application of the modified Beer-Lambert law to Pho-
toplethysmography
In Chapter 5, the modified Beer-Lambert law in Near Infrared Spectroscopy was intro-
duced. The law associates the light attenuation Aλ at wavelength λ to concentrations
cn of the light absorbers present in a solution.
Aλ = (ε1λ · c1 + ε2λ · c2 + ...εnλ · cn) · d ·DPF +G. (8.2)
The factor G relates to scattering and geometrical properties of the tissue, while the
DPF is known as differential pathlength factor and it relates the increased optical path
length (caused by scattering) to the distance d between light emitter and detector. If
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Figure 8.8: Save measurements and timers in the VI. (a) The acquired signals are bundled together and saved
in a text file by the Write To Measurement File Express VI. (b) The three timers with the start and reset
buttons, and the time indicators for the front panel.
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Figure 8.9: Front panel of the running VI. The PPG signals are displayed on a chart, while NIRS and other
parameter are displayed as numerical or visual indicators.
the light is applied at two wavelengths λ1 and λ2, and assuming that oxygenated HbO2
and deoxygenated haemoglobin HHb are the only absorbers in blood, Equation 8.2 can
be transformed into a solvable system of equations.
Aλ1 = (εHbO2λ1 · [HbO2] + εHHbλ1 · [HHb]) · d ·DPF +G
Aλ2 = (εHbO2λ2 · [HbO2] + εHHbλ2 · [HHb]) · d ·DPF +G.
(8.3)
Photoplethysmography shares several characteristics with NIRS. Both techniques are
optical and NIRS applies light at least two wavelengths for the determination of con-
centrations of HbO2 and HHb. Light switching in photoplethysmography is common
and it is usually performed between two wavelengths for the estimation of SpO2. Thus,
the PPG signals used in pulse oximetry could be potentially adapted to the application
of NIRS processing, obtaining additional information to the conventional SpO2.
For the application to dual-wavelength PPG signals, the wavelengths λ1 and λ2 in
Equation 8.3 can be respectively modified to the common red (R) and infrared (IR)
used in pulse oximetry. The light intensities for the calculation of light attenuations at
these two wavelengths can be expressed from the DC components of the PPG signals,
denoting the overall incident light. However, absolute light attenuations cannot be de-
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termined from DC PPG, but changes in attenuations can be derived from the variations
in DC relative to baseline. Therefore, the relative changes in light attenuations at red
and infrared can be expressed as:
∆AR =
DCR(0)
DCR(t)
(8.4)
∆AIR =
DCIR(0)
DCIR(t)
(8.5)
WhereDCR(0) andDCIR(0) are respectively the red and infrared DC PPGs at the start
of the measurement (baseline), whereas DCR(t) and DCIR(t) are respectively the red
and infrared DC PPG throughout the measurement. With a differential approach to the
modified Beer-Lambert law (see subsection 5.2.3), the relative changes in attenuations
can be related to relative changes in haemoglobin concentrations.
∆AR = (εHbO2R ·∆[HbO2] + εHHbR ·∆[HHb]) · d ·DPF + ∆G
∆AIR = (εHbO2IR ·∆[HbO2] + εHHbIR ·∆[HHb]) · d ·DPF + ∆G.
(8.6)
Assuming constant scattering during the entire measurement, the factor ∆G can be
eliminated (∆G = 0), and solving the system of equations in Equation 8.6 yields the
solution for ∆HbO2 and ∆HHb.
∆[HbO2] =
∆AR · εHHbIR −∆AIR · εHHbR
(εHbO2R · εHHbIR − εHbO2IR · εHHbR) · d ·DPF
(8.7)
∆[HHb] = ∆AIR · εHbO2R −∆AR · εHbO2IR(εHbO2R · εHHbIR − εHbO2IR · εHHbR) · d ·DPF
(8.8)
The actual path length d · DPF cannot be used since DPF values for short interop-
todes distances are not available in the literature [120,121]. Therefore, the haemoglobin
concentration changes should be expressed as relative changes with respect to the op-
tical path length ([concentration × optical pathlength]). Assuming that HbO2 and
HHb are the only haemoglobin species present in blood during the measurement, total
haemoglobin can be calculated as the sum of ∆HbO2 and ∆HHb.
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Table 8.1: Extinction coefficients or millimolar absorptivity, in L · mmol−1 · cm−1, of oxygenated (HbO2) and
deoxygenated haemoglobin (HHb) at 660 nm (red) and 880 nm (infrared). Values obtained from [17].
Extinction coefficient ε (L · mmol−1 · cm−1)
Wavelength λ (nm) HbO2 HHb
660 (R) 0.080 0.814
880 (IR) 0.284 0.200
∆[tHb] = ∆[HbO2] + ∆[HHb] (8.9)
Finally, the extinction coefficients ε for solving Equation 8.7 and Equation 8.8 can be
extracted from standard absorption spectra measurements such as [17]. Table 8.1 shows
the extinction coefficients obtained from Zijlstra et al. for oxygenated and deoxygenated
haemoglobin, at the red and infrared wavelengths employed in the reflectance sensors
described in Chapter 6 (660 nm and 880 nm).
The method described above allows to estimate relative changes in oxygenated, deoxy-
genated, and total haemoglobin from dual-wavelength PPG signals. This method is at
the core of this research work and it has been applied for the determination of perfusion
changes from PPG signals in the in vivo studies described in the next chapters.
8.5 Summary
After presenting the PPG sensors and processing system in Chapter 6 and Chapter 7,
this chapter described the software application used to acquire PPG signals. The ap-
plication was developed in LabVIEW for acquisition, display, and archiving of all the
acquired signals. The application was also extended for the simultaneous acquisition of
signals from other devices such as NIRS. In the second part of the chapter, the applica-
tion of the modified Beer-Lambert law to PPG signals was described and discussed. The
method was investigated in a series of in-vivo studies performed on healthy volunteers.
The next chapters will describe the methods and results of those investigations.
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Chapter9
Investigation of photoplethysmography,
Near Infrared Spectroscopy, laser
Doppler flowmetry and pulse oximetry for
assessing perfusion and oxygenation
changes during vascular occlusions
In the previous chapter, the application of the modified Beer-Lambert law to dual-
wavelength PPG signals has been proposed and the mathematical process to infer
relative changes in haemoglobin concentration has been described. The next chapters
will present a series of in vivo studies that were performed to investigate the feasibility
of using PPG signals to obtain haemoglobin concentration changes as in NIRS. In the
three studies, healthy volunteers underwent vascular occlusions on the arm, head-down
bed tilting, and whole-body cold exposure. Haemoglobin concentrations that were
estimated from PPG signals acquired from the forearm, forehead, finger, and ear canal
were compared with state-of-the-art NIRS measurements.
The principles of different optical techniques such as NIRS, PPG, pulse oximetry, and
laser Doppler flowmetry have been introduced in Chapter 3, Chapter 4, and Chapter 5.
These noninvasive techniques are used daily for the clinical assessment of blood volume,
blood oxygenation, and blood flow. In this chapter, a vascular occlusion study on
healthy volunteers is presented. The PPG signals acquired from a custom-made system
are used to infer haemoglobin concentrations, as done in NIRS. In the first part of this
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chapter, comparative analysis between haemoglobin concentrations estimated by PPG
and NIRS is presented. In the second part of the chapter, the simultaneous responses
of several parameters obtained by different non-invasive optical techniques such as
NIRS, PPG, pulse oximetry, and laser Doppler flowmetry are presented, analysed and
compared.
9.1 Introduction
In Chapter 4, the Photoplethysmography technique was presented. The technique has
found a main application for the non-invasive estimation of arterial oxygen satura-
tion (SpO2) by pulse oximetry [1, 3, 4, 9, 106, 176]. However, the success and potential
of pulse oximetry have almost obscured the potentials of the PPG signal in providing
physiological information other than SpO2 [9]. The pulsatile component of the signal
has also found another fundamental usage by providing the heart rate [1,9,68,177]. In
addition, the visual display of the pulsatile part of the PPG signal has an indisputable
importance in clinical settings such as anaesthesia and emergency and can have huge
impacts in the daily clinical care. In fact, contrary to other haemodynamic signals, the
PPG curve in a standard pulse oximeter can be visualised within just a few seconds,
by applying a single sensor on the fingertip, earlobe, or forehead. In this context, the
steady DC component of the PPG signal is almost neglected. The component is used in
the calculation of the ratio of ratios and it contributes to the calculation of the perfu-
sion index [3,4,80,82,106,178]. In these situations, the DC component is just a factor
in the formula, and it is almost irrelevant compared to the more notorious pulsatile
component. So far, the most important applications of the DC PPG are the estimation
of respiratory rates and the calculation of venous oxygen saturation [1, 115,116].
While the AC PPG mainly contains information on the pulsating arterial blood, the
DC component carries information on different structures within the interrogated tis-
sue [1–3]. The signal is composed of almost-static arterial blood, venous blood, skin,
fat, bones, and all the structure interrogated within the light path [3]. Therefore, the
DC PPG contains plenty of physiological information that has been timidly investigated
in the literature [2,41,79]. The assumption is that the DC PPG component already ac-
quired by PPG systems, and being only used for calculating SpO2 and perfusion index,
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can be used to estimate other important haemodynamic and oxygenation information.
Following the NIRS example, where the pulsatile component is neglected and only the
DC part is used [12], the DC PPG components could be exploited. In particular, if
the DC PPG is measured at two distinct wavelengths (like always done in pulse oxime-
ters), the relative concentrations of oxygenated (HbO2) and deoxygenated (reduced)
haemoglobin (HHb) can be derived, as performed in NIRS.
The first aim of this study was to investigate the feasibility of applying NIRS analy-
sis (modified Beer-Lambert law) to PPG signals in order to infer relative changes in
the concentrations of oxygenated, deoxygenated, and total haemoglobin. These were
compared with standard NIRS-measured parameters simultaneously acquired during
the study.
The second aim of this study is to investigate the simultaneous behaviour of NIRS,
photoplethysmography, pulse oximetry, and laser Doppler flowmetry during proxi-
mal vascular occlusions. These techniques have been investigated singularly, or in
pair, in their ability to indicate haemodynamic changes during vascular occlusions
[38, 41, 118, 157,179–181]. However, the results from these studies are scattered due to
different methods, applications, anatomical areas, or population investigated. To the
author’s knowledge, there has not been an attempt to investigate all these techniques
simultaneously. Therefore, NIRS, laser Doppler flowmetry, PPG, and pulse oximetry
sensors were applied on the forearm and digits of healthy volunteers and two sets of
vascular occlusions were induced by inflating a pressure cuff on the upper arm. The
response of Tissue Oxygenation Index and normalised Tissue Haemoglobin Index from
NIRS, Flux from laser Doppler flowmetry, SpO2 from pulse oximetry, perfusion in-
dex and optical densities from finger PPG were simultaneously recorded, analysed and
compared.
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9.2 Measurements set-up, protocols and data analysis
9.2.1 Measurement system
The research PPG processing unit (ZenPPG) presented in Chapter 7 was used to
acquire raw PPG signals (AC+DC).
A commercial NIRS monitor (NIRO 200NX, Hamamatsu Photonics, Japan) was used
to acquire NIRS signals. The device uses LEDs to shine light at three different wave-
lengths (735, 810 and 850 nm) [182]. The backscattered light is then detected by two
silicon photodiodes placed close to each other. The NIRO 200NX applies the modi-
fied Beer-Lambert law to the light attenuations measured by a single photodiode for
the estimation of relative concentration changes in oxygenated haemoglobin (∆HbO2),
deoxygenated (reduced) haemoglobin (∆HHb), and total haemoglobin (∆tHb) [182].
Furthermore, Spatially Resolved Spectroscopy is adopted for the estimate of the Tissue
Oxygenation Index (TOI), expressed as the ratio of concentrations of HbO2 over tHb
[124, 182]. The monitor measures the Normalised Tissue Haemoglobin Index (nTHI)
as the normalised changes of concentrations of tHb from the start of the measure-
ment. The nTHI has a baseline value of 1 and its changes reflect the variations in
haemoglobin (blood volume) in the measured tissue. Appendix B illustrates the NIRO
200NX’s specifications in details.
A laser Doppler flowmetry device (moorVMS-LDF2, Moor Instruments Ltd, UK) was
used to measure blood flow in the skin. The device employs laser light with peak
emission at 785 nm and fibre optics to transmit the light [183]. The VP1T sensor,
with a fibres separation distance of 0.5 mm, was used to measure the blood flow in this
experiment [183]. The Doppler shift from RBC is measured from the detected light
and the blood flow is expressed as Flux, a unit-less index [183].
A commercial pulse oximeter (Radical 7, Masimo Corp., USA) was adopted as a refer-
ence for arterial oxygen saturation (SpO2) measurements.
Signals were acquired in LabVIEW through two 16-bit NI-PcIe 6321 Data Acquisition
Cards (National Instruments, USA). The VI described in Chapter 8 was adapted for
the additional acquisition of signals from the laser Doppler flowmeter and the pulse
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oximeter. Analogue outputs scaling equations were obtained from all the devices as
described in subsection 8.3.5. All signals were acquired simultaneously at a sampling
frequency of 400 Hz and they were saved in a text file for post-acquisition analysis.
9.2.2 Subjects and investigation set-up
Nineteen (19) healthy subjects with mean age ± SD of 31.05 ± 7.07 (12 males and
7 females) were recruited for the investigation. Ethical approval was granted by the
Senate Research Ethics Committee at City University London and written consent was
sought from the volunteers before commencing of the investigation. Subjects with a
history of cardiovascular disorders were excluded from the study.
The subjects were seated in a comfortable chair in the Biomedical laboratory at City
University London. After measuring the subject’s arterial blood pressure by an auto-
matic blood pressure monitor (HEM-907, Omron Healthcare, USA), the subject’s left
arm was rested on a pillow in order to avoid excessive vascular compression on the
forearm. The room was kept at a constant temperature of 23 (±1) ℃ throughout the
entire measurements.
The NIRS sensor was placed on the left forearm, above the brachioradialis and it
was kept in place by double-sided clear medical adhesive tape. The tape was cut at
the emitter and detectors locations in order to avoid any optical obstruction by the
tape. An emitter-detector distance of 4 cm was used in order to maximise the light
penetration. The LDF VP1T sensor was placed on the forearm’s skin, proximal to the
NIRS sensor. The LDF sensor was kept in place by ring-shaped adhesive pads provided
by the manufacturer. The RPS1 sensor (Chapter 6) was positioned on the volar side
of the same left forearm, distal from the NIRS sensor. The PPG reflectance sensor was
attached to the skin by means of a double-sided clear medical adhesive tape. Again,
the tape was cut in the centre, at the optical components position, in order to avoid
optical obstruction. The sensor was connected to the first channel of the ZenPPG.
PPG signals were also acquired from the fingers. The finger PPG sensor (Section 6.6)
was attached to the second digit of the left hand. In addition, the commercial pulse
oximeter sensor was connected to the third digit of the same hand, in order to measure
arterial oxygen saturation (SpO2).
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Figure 9.1: Measurement system set-up (a) and placement of PPG, NIRS, and LDF sensors on the forearm (b).
A blood pressure cuff was wrapped around the upper left arm. In order to induce vas-
cular occlusions on the forearm, the cuff was connected to a manual sphygmomanome-
ter (Big Ben Round, Riester GmbH, Germany). Figure 9.1a and Figure 9.1b show the
set-up of the investigation in the laboratory and the positioning of PPG, NIRS, and
laser Doppler sensors on the forearm.
9.2.3 Investigation protocols
The investigation consisted of different degrees of vascular occlusions on the forearm.
Two sets of measurement protocols were used:
• Protocol 1: baseline measurements were acquired for five minutes followed by two
minutes of venous occlusion at 60 mmHg. The cuff pressure was then released
for two minutes before being re-inflated for additional two minutes at 20 mmHg
exceeding the volunteer’s systolic pressure. The cuff was finally released until all
the signals returned to their baseline values.
• Protocol 2: five minutes baseline measurements were followed by seven intermit-
tent occlusions at 20 mmHg, 40 mmHg, 60 mmHg, 80 mmHg, 100 mmHg, the
volunteer’s systolic pressure, and total occlusion (20 mmHg over the volunteer’s
systolic pressure). Each occlusion lasted for one minute and it was followed by
one minute of recovery period when the pressure was released. After the last
occlusion (total occlusion), measurements continued until the signals returned to
baseline values.
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The inflations and deflations of the cuff were performed manually by means of a bulb
and a valve connected to the sphygmomanometer. The maximum cuff inflation time
was 5 seconds (for total occlusion), whereas complete deflation time did not exceed
3 seconds. Participants rested for a minimum of 10-15 minutes between the two dif-
ferent protocols in order to allow a full haemodynamic recovery. ECG was monitored
throughout the experimental protocols.
9.2.4 Data analysis & statistics
Post-acquisition analysis was performed in Matlab2013a. Before processing, all the
acquired signals were down-sampled to 100 Hz. TOI, nTHI, haemoglobin concentrations
from NIRS, and Flux signals were cleaned from any high-frequency noise by a zero-
phase low-pass filter (fc = 0.05 Hz). In order to reduce inter-subject variability and
assess only the degree of change, the Flux signals were normalised with respect to 10
seconds baseline reading (nFlux). The finger AC PPG component was obtained from
raw PPG signals by applying a zero-phase band-pass filter (pass-band: 0.5-5 Hz), while
the forearm AC PPG was extracted by another band-pass filter with passband 0.5-4 Hz.
The DC PPGs were obtained by low-pass filtering the signal at fc = 0.1 Hz. SpO2 was
estimated from both the finger and forearm PPG signals by applying Equation 9.1
in a three-seconds rolling window. Perfusion index was calculated from infrared PPG
signals as showed in Equation 9.2, and it was normalised to 10 seconds baseline readings
to compensate for inter-subject variability (nPI).
SpO2 = 110− (25 ·R); Where: R = ACR/DCR
ACIR/DCIR
(9.1)
PI = ACIR
DCIR
× 100 (9.2)
Changes in oxygenated (∆HbO2), reduced (∆HHb) and total haemoglobin (∆tHb) were
estimated by applying the modified Beer-Lambert law to DC PPG signals acquired from
the forearm. From these, the index Hbratio, expressing changes in oxygenations, was
calculated from the ratio Hbratio = ∆HbO2 / ∆tHb. The index indicates the relative
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changes in oxygenation from a starting baseline and it was expressed as percentage
changes.
The dynamic changes of the signals during the occlusions were expressed by the slopes
of the changes. The slopes were computed as the slope of the regression line on the data
during each occlusion, and they were expressed as unit measure/minute, depending on
the variable (e.g. %/min for TOI). In order to test the difference in magnitude of the
measured variables between baseline and occlusions, the signals were averaged over a
period of 30 seconds during baseline and the last 30 seconds of each occlusion.
Trending agreement between techniques or variables was assessed by measuring the
Pearson correlation coefficients r and the 95 % confidence intervals (CI). In addition,
the trending was evaluated by four-quadrant plot analysis [184]. The concordance rate
C was calculated as the ratio of the number of points in the first and third quadrant
and the total number of points in all quadrants. An exclusion zone of 10 % was used
for the calculations [184]. A concordance rate C ≥ 90 % was considered satisfactory
for indicating trending agreement.
Statistically significant changes from baseline were tested by repeated measures using
a Wilcoxon signed-rank test. A p-value less than 0.05 was considered satisfactory for
significance.
9.3 Results
Figure 9.2 illustrates the acquired signals from a volunteer during protocol 1. The
acquired signals indicated changes in perfusion and oxygenation during the vascular
occlusions. These responses are analysed in detail in the next sections. Figure 9.3
shows an example of ten seconds readings of AC PPG signals acquired from the fore-
arm and fingers. Good quality AC PPG signals were acquired from the custom-made
sensors (ZenPPG) and were comparable with the PPG signals acquired from the stan-
dard pulse oximeter.
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Figure 9.2: Example of PPG, NIRS, laser Doppler, and pulse oximetry signals acquired from a volunteer. (a)
Red and infrared raw PPG (AC + DC) acquired from the forearm. (b) Red and infrared raw PPG (AC + DC)
acquired from the finger. (c) TOI from NIRS. (d) nTHI from NIRS. (e) Relative haemoglobin concentrations
from NIRS. Red trace: ∆HbO2; blue trace: ∆HHb; black trace: ∆tHb. (f) normalised Flux from laser Doppler
flowmetry. (g) SpO2 from the commercial pulse oximeter. Vertical lines indicate the duration of the occlusions.
Five minutes of baseline measurements were followed by two minutes of venous occlusion, two minutes of recovery,
two minutes of total occlusion, and final recovery to baseline.
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Figure 9.3: Infrared AC PPG signal acquired from forearm (a), fingers by custom-made PPG (b), and from
commercial pulse oximeter (c).
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Figure 9.4: Example of relative haemoglobin concentrations changes estimated by PPG (a) and NIRS (b).
Vertical lines indicate the duration of the occlusions. Five minutes of baseline measurements were followed
by two minutes of venous occlusion (VO), two minutes of recovery, two minutes of total occlusion (TO), and
final recovery to baseline. HHb: deoxygenated haemoglobin; HbO2: oxygenated haemoglobin; tHb: total
haemoglobin.
9.3.1 Haemoglobin concentration changes from PPG signals
Changes in relative concentrations of oxygenated, reduced, and total haemoglobin were
estimated from DC PPG signals as done in conventional NIRS. Figure 9.4 illustrates an
example of ∆HbO2, ∆HHb, and ∆tHb estimated from PPG, along with the same pa-
rameters estimated by NIRS. As can be seen from Figure 9.4, the relative haemoglobin
concentrations estimated by PPG changed consistently during the occlusions and these
responses are described in detail in this section.
Figure 9.5 shows the mean changes among all subjects of ∆HbO2, ∆HHb, and ∆tHb
estimated from PPG and NIRS during the venous occlusion in the first protocol. The
occlusion at 60 mmHg occluded the veins, with a consequent congestion of venous
blood in the forearm. The accumulation of venous blood can be seen in Figure 9.5 by
the increase of reduced haemoglobin. This increase progressed until the occlusion was
released after two minutes. The occlusion of the venous branch of the circulation in
the forearm also caused an increase in concentration of the oxygenated haemoglobin,
due to the blockage of the arterial-to-venous blood flow. The total haemoglobin tHb,
which is the sum of oxygenated and reduced haemoglobin and represents the total
blood volume, increased as well during venous occlusion. This corresponded to the
incremental venous blood engorgement in the forearm. At the release of the occlusion,
all parameters returned to baseline values.
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Figure 9.5: Mean (±SD) changes in relative haemoglobin concentrations estimated from PPG and NIRS
during venous occlusion in the first protocol. Black traces are the means; grey traces are ± SD. ∆HbO2:
oxygenated haemoglobin; ∆HHb: deoxygenated haemoglobin; ∆tHb: total haemoglobin. Vertical lines represent
the inflation and deflation of the cuff. The occlusion pressure was 60 mmHg and it lasted for two minutes. PPG
and NIRS measurements have been plotted on different y-axis scales to facilitate the visual assessment of the
trends.
Figure 9.6 shows the mean changes among all subjects of ∆HbO2, ∆HHb, and ∆tHb
estimated from PPG and NIRS during the total occlusion in the first protocol. During
total (over-systolic) occlusion, the reduced haemoglobin increased again due to the im-
pediment of venous blood return. The occlusion of the arterial circulation caused a drop
in oxygenated haemoglobin concentration. After slowly increasing at the beginning of
the occlusion, the total haemoglobin ∆tHb reached a steady state. This was due to null
arterial-to-venous flow caused by occlusion of both arterial and venous circulation in
the forearm. The initial increase in ∆tHb at the commencement of the total occlusion
was caused by a residual venous engorgement due to the non-instantaneous (i.e. 3-5
seconds) inflation of the cuff. At the release of the occlusion, the rapid increase of
∆HbO2 and ∆tHb indicated the post-occlusion reactive hyperaemia. After this, the
signals returned to baseline readings.
Table 9.1 summarises the mean values of ∆HbO2, ∆HHb, and ∆tHb estimated by both
PPG and NIRS during the first protocol. The relative haemoglobin concentrations had
significant changes from baseline (p < 0.05) in both venous and total occlusion.
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Figure 9.6: Mean (±SD) changes in relative haemoglobin concentrations estimated from PPG and NIRS dur-
ing total occlusion in the first protocol. Black traces are the means; grey traces are ± SD. ∆HbO2: oxygenated
haemoglobin; ∆HHb: deoxygenated haemoglobin; ∆tHb: total haemoglobin. Vertical lines represent the infla-
tion and deflation of the cuff. The occlusion pressure was 20 mmHg over the subjects’ systolic pressure and it
lasted for two minutes. PPG and NIRS measurements have been plotted on different y-axis scales to facilitate
the visual assessment of the trends.
Table 9.1: [Mean changes (±SD), in mM·cm, of relative haemoglobin concentrations changes estimated by
PPG and NIRS during baseline, venous occlusion, and total occlusion. The values are the average of 30 s
baseline, and the last 30 s of each occlusion.
Baseline Venous Occlusion Total Occlusion
(mM·cm) (mM·cm) (mM·cm)
∆HbO2 (PPG) -0.015 ± 0.022 0.092 ± 0.076∗ -0.048 ± 0.029∗
∆HHb (PPG) 0.010 ± 0.040 0.063 ± 0.040∗ 0.051 ± 0.024∗
∆tHb (PPG) 0.023 ± 0.029 0.153 ± 0.102∗ 0.000 ± 0.034∗
∆HbO2 (NIRS) -0.021 ± 0.047 0.135 ± 0.064∗ -0.050 ± 0.079∗
∆HHb (NIRS) 0.026 ± 0.045 0.227 ± 0.082∗ 0.210 ± 0.076∗
∆tHb (NIRS) 0.063 ± 0.069 0.385 ± 0.132∗ 0.164 ± 0.077∗
∗ Significant change from baseline (p < 0.05)
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Figure 9.7: Mean (±SD) changes in relative haemoglobin concentrations during the second protocol. Black
traces are the means; grey traces are ± SD. ∆HbO2: oxygenated haemoglobin; ∆HHb: deoxygenated
haemoglobin; ∆tHb: total haemoglobin. Grey horizontal bars on top represent the duration of the occlu-
sions. The order of the occlusions was 20 mmHg, 40 mmHg, 60 mmHg, 80 mmHg, 100 mmHg, subject’s systolic
pressure, and over-systolic pressure. Each occlusion lasted for one minute and it was followed by one-minute
recovery.
The second protocol aimed at investigating the responses to different degrees of vascular
occlusions. Figure 9.7 shows the mean changes of ∆HbO2, ∆HHb, and ∆tHb during
the different occlusions of the second protocol. The relative haemoglobin concentrations
estimated from PPG were able to respond to all the different occlusions induced. Even
small venous occlusions of 20 mmHg and 40 mmHg were indicated by the parameters
and the haemoglobin concentrations followed the responses of the same parameters
measured by NIRS. Table 9.2 summarises the mean values of ∆HbO2, ∆HHb, and
∆tHb estimated by the two methods during the steps of the second protocol. The
table also shows the results of the significance tests, showing that there were significant
changes from baseline (p < 0.05) in almost all occlusions.
The haemoglobin concentrations estimated from PPG presented some quantitative dif-
ferences from the haemoglobin concentrations measured by NIRS. This is most probably
due to the different penetration depths and the different wavelengths adopted. To inves-
tigate this, the Bland & Altman plots were used to analyse these differences. However,
since there cannot be limits of agreement set a priori, the ratio of the two measures
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Figure 9.8: Bland & Altman plots and analysis of the haemoglobin concentrations estimated from PPG against
the reference NIRS method during the first protocol. X-axes are the mean between the two methods, while the
y-axes are the ratio of the measures. Blue crosses are the data. Horizontal solid lines are the standard mean
bias and the dashed lines are the standard limits of agreement (mean ± 1.96SD). The black solid line is the
regression line on the data, representing the mean bias. The grey lines are the ± 95 % confidence intervals.
The equation of the fitted regression line is reproduced at the bottom of the graphs. The original signals were
resampled every 5 seconds.
was used instead of the absolute difference [185, 186]. This method still provides com-
parative information on the two measures.
Figure 9.8 shows the Bland & Altman plots of the haemoglobin concentration esti-
mated from PPG against the reference NIRS method during the first protocol. The
dashed lines in the figure show the limits of agreements between the two methods,
calculated with the standard Bland & Altman analysis [185]. The mean bias differ-
ence ± 1.96SD (i.e. 95 % C.I.) for ∆HbO2, ∆HHb, and ∆tHb were 0.9986 ± 0.0031,
0.9987 ± 0.0035, and 0.9973 ± 0.0039 respectively. These represent the mean bias
ratio and suggest an overall underestimation of PPG against NIRS. However, the mean
bias between the two methods varied over the ranges of measurements (average). In
particular, the mean bias ratio between the measures seemed to decrease when the
measurements increased. Thus, a regression line was fitted to the data as suggested by
Bland and Altman [186]. The line and the 95 % C.I. are plotted on the data, along
with the equation line.
The same Bland & Altman analysis was performed on the haemoglobin concentrations
estimated during the second protocol. Figure 9.9 illustrates the Bland & Altman plots
for the second protocol. The standard limits of agreement for ∆HbO2, ∆HHb, and
∆tHb were respectively 0.9985 ± 0.0035, 0.9992 ± 0.0022, and 0.9978 ± 0.0047. These
values were very similar to those calculated for the first protocol. In addition, the
slopes of the fitted regression lines for the second protocol were very similar to the first
protocol. This indicated the presence of a regular bias between the two techniques and
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Figure 9.9: Bland & Altman plots and analysis of the haemoglobin concentrations estimated from PPG against
the reference NIRS method during the second protocol. X-axes are the mean between the two methods, while
the y-axes are the ratio of the measures. Blue crosses are the data. Dashed lines are the standard mean and
limits of agreement (mean ± 1.96SD). The black line is the regression line on the data, representing the mean
bias. The grey lines are the ± 95 % confidence intervals. The equation of the fitted regression line is reproduced
at the bottom of the graphs. The original signals were resampled every 5 seconds.
a good repeatability of the measurements.
9.3.2 Assessment of correlation and trending between PPG and NIRS
Figure 9.5, Figure 9.6, and Figure 9.7 visually showed that the relative haemoglobin
concentrations estimated from PPG followed the trends of the same parameters mea-
sured by the reference NIRS monitor. The correlation between the variables measured
by the two techniques was assessed by the Pearson correlation coefficient r, while the
trending agreement between the measures was assessed by the concordance rate calcu-
lated from the analysis of four-quadrant plots between variables.
In the first protocol, the correlation coefficients calculated between the haemoglobin
concentrations during venous occlusion were 0.74 (95 % CI: 0.46, 0.90), 0.95 (95 % CI: 0.87,
0.98), and 0.96 (95 % CI: 0.89, 0.98) for ∆HbO2, ∆HHb, and ∆tHb respectively. The
same coefficients calculated during total occlusion were 0.84 (95 % CI: 0.62, 0.93),
0.96 (95 % CI: 0.89, 0.98), and 0.80 (95 % CI: 0.54, 0.92) for ∆HbO2, ∆HHb, and
∆tHb respectively. These values indicated high correlation between the haemoglobin
concentrations estimated from PPG and NIRS.
The same correlation coefficients were calculated for ∆HbO2, ∆HHb, and ∆tHb during
the second protocol. Table 9.3 summarises the correlation coefficients calculated during
the occlusions in the second protocol. Again, the haemoglobin concentrations estimated
from PPG showed high correlation with NIRS during all occlusions. However, the
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Table 9.3: Correlation coefficients between PPG and NIRS haemoglobin concentrations during the second
protocol. 95 % confidence intervals are presented within parenthesis.
Correlation coefficient r
Occlusions HbO2 HHb tHb
20 mmHg 0.89 (0.68, 0.94) 0.89 (0.72, 0.95) 0.93 (0.81, 0.97)
40 mmHg 0.92 (0.76, 0.96) 0.94 (0.88, 0.98) 0.97 (0.92, 0.98)
60 mmHg 0.90 (0.78, 0.96) 0.96 (0.89, 0.98) 0.96 (0.91, 0.98)
80 mmHg 0.93 (0.81, 0.97) 0.97 (0.91, 0.98) 0.97 (0.92, 0.98)
100 mmHg 0.85 (0.65, 0.94) 0.97 (0.91, 0.98) 0.96 (0.91, 0.98)
Systolic 0.59 (0.10, 0.79) 0.92 (0.76, 0.96) 0.80 (0.63, 0.93)
Total 0.35 (-0.08, 0.71) 0.93 (0.85, 0.97) 0.88 (0.72, 0.95)
oxygenated haemoglobin ∆HbO2 demonstrated a lower correlation during systolic and
over-systolic occlusions.
The trending agreement between haemoglobin concentrations estimated from PPG and
NIRS was assessed by four-quadrant plots as well. Figure 9.10 shows the four-quadrant
plots for ∆HbO2, ∆HHb, and ∆tHb during venous and total occlusions in the first
protocol. Deoxygenated and total haemoglobin presented high concordance rate C
during both venous and total occlusion. Although the high correlation, oxygenated
haemoglobin did not show high trending agreement during both occlusions.
The four-quadrant analysis was carried on the haemoglobin concentrations during the
second protocol as well. Figure 9.11, Figure 9.12, and Figure 9.13 illustrate the four
quadrant plots of ∆HHb, ∆HbO2, and ∆tHb throughout the occlusions in the sec-
ond protocol. The concordance rates calculated indicated a high trending agreement
of ∆HHb and ∆tHb. Again, the oxygenated haemoglobin showed a poor trending
agreement during systolic and total occlusions.
9.3.3 Slopes from haemoglobin concentration changes
The slopes of the dynamic changes in haemoglobin concentrations from PPG and NIRS
were assessed as well. In particular, the positive slope of ∆HHb during venous occlusion
and the decay of ∆HbDiff (∆HbDiff = ∆HbO2 - ∆HHb) during total (over-systolic)
occlusion were estimated from the signals. These features of ∆HHb and ∆HbDiff
during venous and total occlusion have been previously recognised to provide indication
of the tissue oxygen consumption [147,148,156].
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Figure 9.10: Four quadrant plots between ∆HbO2, ∆HHb, and ∆tHb estimated from PPG and NIRS during
venous and total occlusion in the first protocol. The concordance rate C and correlation coefficients r between
the measures are presented as well. The concordance rate was calculated as the ratio of the number of points
in the first and third quadrant and the total number of points in all quadrants. An exclusion zone of 10 %
was used for the calculation of C. Dashed lines are the line of equality. Grey boxes indicate the 10 % exclusion
zone. (a), (b), and (c) are respectively ∆HHb, ∆HbO2, and ∆tHb during venous occlusion. (d), (e), and (f) are
respectively ∆HHb, ∆HbO2, and ∆tHb during total occlusion. Original signals were resampled every 5 seconds.
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Figure 9.14: Top: example of the slope of the regression lines on ∆HHb and ∆HbDiff during venous and
total occlusions. Grey traces are the signals; black traces are the regression lines on the data. Vertical dashed
lines indicate the duration of the occlusions. Bottom: box and whisker plots of the slopes from ∆HHb and
∆HbDiff , estimated by both PPG and NIRS, during venous and total occlusion.
Figure 9.14 shows the box and whisker plot of the slopes calculated from ∆HHb and
∆HbDiff during venous and total occlusion. During venous occlusion, the slopes cal-
culated from ∆HHb were significantly lower for PPG than NIRS (p<0.01), with mean
values of 0.044 mM·cm/min and 0.131 mM·cm/min for PPG and NIRS respectively.
During total occlusion, the mean slopes for ∆HbDiff were respectively -0.054 mM·cm
and -0.142 mM·cm/min for PPG and NIRS, with an overall significantly lower slope
for NIRS (p<0.01).
Since the PPG signal does not penetrate as deep as the NIRS, the comparison between
slopes could provide an indication of oxygen consumption at different penetrations. In
particular, oxygen consumption of the skin (PPG) and muscle (NIRS) can be compared.
From the results during both venous and total occlusions, the skin had a significantly
lower oxygen consumption than the muscle. This is in concordance with published
oxygen consumption rates of different organs [16].
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Table 9.4: Mean (± SD) changes in ∆HbRatio during the second protocol and correlation coefficients r between
∆HbRatio and TOI during the occlusions of the second protocol. The means were calculated in 30 s baseline
reading and in the last 30 s of each occlusion. The 95 % confidence intervals of r are presented within parenthesis.
Occlusions Mean ± SD (%) r
Baseline 0.19 ± 0.29 -
20 mmHg -0.33 ± 0.44 0.63 (0.29, 0.83)
40 mmHg -1.02 ± 0.56 0.71 (0.42, 0.87)
60 mmHg -0.96 ± 0.56 0.75 (0.49, 0.89)
80 mmHg -1.10 ± 0.48 0.80 (0.58, 0.91)
100 mmHg -0.99 ± 0.53 0.81 (0.59, 0.91)
Systolic -0.73 ± 0.47 0.85 (0.67, 0.93)
Total -0.71 ± 0.46 0.88 (0.77, 0.94)
9.3.4 Haemoglobin oxygenation changes from PPG signals
The relative concentrations of ∆HbO2, ∆HHb, and ∆tHb estimated from PPG were
also used to infer changes in haemoglobin oxygenation during the occlusions in the
first and second protocol. An oxygenation index, ∆HbRatio, was calculated as the ratio
of ∆HbO2 and ∆tHb, similarly to TOI. The changes were then expressed as relative
changes from the baseline, in percentage units.
Figure 9.15 shows the mean changes in ∆HbRatio during the first and second protocol.
During venous occlusion in the first protocol, the ∆HbRatio dropped from a baseline
of 0.39 ± 0.35 % to -2.04 ± 1.18 % (p<0.01), while during total occlusion decreased
to -1.68 ± 0.81 % (p<0.01). In addition, the correlation calculated between ∆HbRatio
and TOI was r = 0.73 (95 % CI: 0.41, 0.87).
In the second protocol, the ∆HbRatio changed consistently during the occlusions. Ta-
ble 9.4 shows the mean values of ∆HbRatio during the second protocol. The drops in
∆HbRatio were statistically significant from baseline in all occlusions (p<0.01). Ta-
ble 9.4 also shows the correlation coefficients r between ∆HbRatio and TOI during the
occlusions of the second protocol.
9.3.5 Estimation of arterial oxygen saturation from PPG signals
Arterial oxygen saturation (SpO2) was estimated from PPG signals acquired from the
custom-made finger sensor and the forearm. The SpO2 was calculated by applying
Equation 9.1 on the acquired red and infrared PPG signals. The response of the
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Figure 9.15: Mean changes in ∆HbRatio during the first protocol (a) and the second protocol (b). Black traces
are means grey traces are the ± SD intervals. Grey horizontal bars indicate the duration of the occlusion.
calculated SpO2 to vascular occlusions will be analysed later in this chapter, along
with other NIRS, laser Doppler, and PPG signals.
The estimated SpO2 were then compared with SpO2 values estimated from the finger
by a state-of-the-art pulse oximeter. Figure 9.16 shows the Bland and Altman plots
between SpO2 values from a standard finger pulse oximeter and from custom-made
finger and forearm PPG sensors.
The custom-made finger slightly under-estimated the SpO2 when compared with the
commercial (standard) pulse oximeter. The limits of agreement between the custom-
made finger SpO2 and the commercial pulse oximeter were -0.34 ± 1.96×1.96. The lim-
its of agreement between custom-made forearm SpO2 and the standard pulse oximeter
were -9.15 ± 1.96×8.58, whereas the limit of agreement between custom-made finger
and forearm SpO2 were -8.81 ± 1.96×9.15. These lower limits of agreement between
the forearm and both fingers SpO2 indicated a consistent underestimation of the SpO2
calculated from the forearm.
9.3.6 Comparison of TOI, Flux, Perfusion Index and SpO2 during
protocol 1
The changes in Tissue Oxygenation Index (TOI), normalised Tissue Haemoglobin In-
dex (nTHI), normalised Flux (nFlux), PPG normalised Perfusion Index (nPI) and
arterial oxygen saturation (SpO2) were compared during the protocols. These indexes
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Figure 9.16: [Bland and Altman comparison plots between the SpO2 estimated from custom-made finger PPG,
custom-made forearm PPG, and standard finger pulse oximeter. (a) Bland and Altman plot between custom
made finger SpO2 and standard finger pulse oximeter. (b) Bland and Altman plot between custom made forearm
SpO2 and standard finger pulse oximeter. (c) Bland and Altman plot between custom made forearm SpO2 and
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lines are the mean bias of the differences. Dotted lines are the limits of agreement, mean bias ± 1.96×SD. The
original signals were resampled every 5 seconds.
are widely used as a measure of perfusion and oxygenation, but they have been rarely
compared in the same settings. Figure 9.17 shows the mean changes in TOI, nTHI,
nPI, SpO2, and nFlux during the first protocol. The nPI, as well as the SpO2, was
derived from both forearm (nPIForearm) and finger (nPIFinger) PPG signals.
During venous occlusion, TOI gradually decreased from 68.10 ± 4.51 % baseline to
63.37 ± 5.33 % (p < 0.001). The blockage of arterial inflow caused a more severe TOI
drop to 56.39 ± 7.52 % (p < 0.001). Venous blood pooling caused an increase in nTHI
from 1.02 ± 0.05 A.U. to 1.22 ± 0.12 A.U. (p < 0.001), while the nTHI slightly increased
to 1.09 ± 0.09 A.U. (p = 0.005) during total occlusion. Theoretically, there should not
be any change in nTHI (i.e. blood volume) during total occlusion since there should
be no net venous-arterial flow. However, this increase is due to the not-instantaneous
inflation of the cuff to over-systolic pressures.
The nPIFinger and nPIForearm respectively dropped to 0.69 ± 0.25 A.U. (p = 0.03)
and 0.43 ± 0.14 A.U. (p < 0.001) during venous occlusion from respective baseline of
0.83 ± 0.21 A.U. and 0.78 ± 0.12 A.U.. During total occlusion, the perfusion indexes
almost reached zero values of 0.06 ± 0.06 A.U. (p < 0.001) and 0.22 ± 0.11 A.U.
(p < 0.001) for finger and forearm respectively.
Baseline SpO2 estimated from the custom-made finger PPG sensor, commercial pulse
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for the signals to return to baseline.
oximeter, and forearm were respectively 98.82± 1.49 %, 98.91± 1.06 %, and 92.0± 3.1 %.
During venous occlusion the commercial SpO2 dropped to 97.85 ± 1.68 % (p < 0.001),
while the SpO2 estimated from the custom-made finger PPG sensor had a non-significant
increase (p = 0.06). The SpO2 on the forearm dropped as well during venous occlusion
(88.9 ± 3.6 %, p = 0.006). The disappearance of arterial pulsations (AC PPG) in total
(over-systolic) occlusion caused the inability to provide reliable SpO2 readings for both
commercial and custom-made devices.
Red blood cells (RBC) flow (Flux) was measured by a laser Doppler device and the
measures were normalised with respect to the baseline. The normalised value, nFlux,
during baseline was 1.00 ± 0.14 A.U. and it significantly reduced during induction
of venous occlusion (0.44 ± 0.27 A.U., p < 0.001). In total occlusion, the nFlux
decreased further to 0.21 ± 0.71 A.U. (p = 0.001). At over-systolic occlusion pressure,
the RBC flow is completely suppressed. However, there is still a residual nFlux signal,
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which is widely defined as biological zero and it is attributed to molecular Brownian
motion [28,187].
9.3.7 Comparison of TOI, Flux, Perfusion Index and SpO2 during
protocol 2
The second protocol aimed at investigating the response of the different techniques to a
sequence of occlusions. These occlusions either induced a degree of venous engorgement
or arterial blockage. Figure 9.18 shows the mean changes during the second protocol,
while Table 9.5 illustrates the numerical results more in details. NIRS TOI and nTHI,
and laser Doppler nFlux demonstrated significant changes (p < 0.05) from baseline in
all the occlusions. The nTHI increased in all occlusions, until reaching maximum values
(i.e. maximum blood volume due to venous pooling) during venous occlusions ranging
from 40 to 100 mmHg occlusion pressures. In this same range of venous occlusions, the
nFlux decreased to half baseline values. The remaining part of the nFlux signal is due
to RBC mobility caused by the unaffected arterial inflow. The normalised Perfusion
Index nPI estimated from finger PPG signals changed significantly from baseline only
for occlusions exceeding 40 mmHg, while the same nPI from forearm PPGs significantly
changed earlier, from 40 mmHg occlusion pressure onwards.
As expected, the SpO2 estimated from the finger by both custom-made and commercial
device significantly changed (p < 0.05) at occlusion pressures exceeding 80-100 mmHg.
At these pressures, the arterial vessels started to occlude, affecting the arterial inflow
in the tissue. However, the SpO2 estimated from the forearm started to decrease
significantly at 60 mmHg occlusion pressure, and showed consistent changes onwards.
At systolic and over-systolic occlusion pressures, due to the absence of arterial blood
pulsations, all the SpO2 from both fingers and forearm failed in providing reliable SpO2
values.
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Figure 9.18: Mean changes in TOI, nTHI, nPI, SpO2, and nFlux during the second protocol. (a) TOI;
(b) nTHI; (c) Finger nPI; (d) Forearm nPI; (e) SpO2 from finger PPG; (f) SpO2 from forearm; (g) nFlux.
Errorbars indicate the ±SD interval. B: baseline; O1: 20 mmHg; O2: 40 mmHg; O3: 60 mmHg; O4: 80 mmHg;
O5: 100 mmHg; O6: systolic pressure; O7: total (over-systolic) pressure.
9.3.8 Changes in finger PPG Optical Densities during vascular occlu-
sion challenges
The optical densities were calculated from finger DC PPG signals in order to investigate
changes in blood volume at the digits. The DC component of the PPG, compared to
the pulsatile component, should be more adequate to detect changes in venous blood
volume due to venous congestion.
The optical densities were calculated from the red DC PPG signals acquired by the
custom-made finger PPG sensor. The rationale behind using the red wavelength
(600 nm) was that reduced haemoglobin (venous blood) has an absorptivity eight to
ten times higher than oxygenated haemoglobin (arterial blood) [17]. Therefore, the DC
PPG at 660 nm should mainly provide changes in venous blood volumes. Figure 9.19
shows the changes in optical densities measured at the finger during the first protocol.
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Figure 9.19: Mean changes (±SD) in optical densities during the first protocol. The optical densities were
calculated from the red DC PPG signal (660 nm) acquired from the finger. Black trace is the mean; grey traces
are the ±SD intervals. Vertical lines indicate the onset and conclusion of the occlusion. VO: venous occlusion;
TO: total (over-systolic) occlusion. Five minutes of baseline measurement were followed by two minutes of
venous occlusion, two minutes of recovery, and two minutes of total occlusion. Signals returned to baseline
before stopping the acquisition.
During the venous occlusion, the optical densities gradually increased, indicating the
accumulation of venous blood (i.e. reduced haemoglobin). The increase in optical den-
sities during venous occlusion was consistent in the population investigated (p = 0.005).
During the total occlusion, the optical densities decreased (p < 0.001).
In the second protocol, the optical densities showed changes in blood volume due to
vascular occlusions. Figure 9.20 illustrates the box and whisker plot of the changes
in optical densities during the second protocol. Significant changes from baseline were
observed only for venous occlusions exceeding 40 mmHg. Maximal changes were at
80 mmHg, when maximal venous occlusion was obtained, resulting in the greatest
accumulation of venous blood. Optical densities dropped in both systolic and over-
systolic pressures.
9.3.9 Dynamic changes in TOI, nTHI and Optical Densities during
vascular occlusions challenges
The dynamic changes of non-stationary signals were analysed. The slopes of the de-
crease/increase of TOI, nTHI and Optical Densities were calculated, as done in sub-
section 9.3.3, in all the occlusions of both the first and second protocol. Figure 9.21
shows the box and whiskers plot of the slopes of TOI, nTHI, and Optical Densities.
In the first protocol, the mean (±SD) TOI desaturations during venous and total oc-
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Figure 9.20: Box and whisker plot of the changes in optical densities during the second protocol. B: baseline;
O1: 20 mmHg; O2: 40 mmHg; O3: 60 mmHg; O4: 80 mmHg; O5: 100 mmHg; O6: systolic pressure; O7: total
(over-systolic) pressure.
clusion were respectively -3.67 ± 1.64 %/min and -6.52 ± 2.51 %/min. The slopes
during venous occlusions were significantly lower than total occlusion (p < 0.001). The
nTHI slope during venous occlusion, which expresses the rate of venous blood pooling,
was 0.10 ± 0.03 A.U./min, while, during total occlusion, it was significantly lower (-
0.02 ± 0.03 A.U./min, p < 0.001). The calculated slopes of the Optical Densities were
significantly higher during venous occlusion than total occlusion (p < 0.001), with
respective mean values of 0.01 ± 0.02 A.U./min and 0.00 ± 0.00 A.U./min.
During the second protocol, TOI’s slopes in the occlusions range 20-80 mmHg (i.e. ve-
nous occlusions) were not different between each other (p < 0.05). Significant changes
in TOI’s slope were only observed between the venous occlusions (20-80 mmHg) and
the occlusions > 100 mmHg (p < 0.003). This suggests that more severe desaturations
were taking place when the arteries began to occlude. Similarly, the nTHI slopes during
40-100 mmHg were very similar between each other (p < 0.05), and a significant vari-
ation of slope in nTHI occurred during systolic and over-systolic occlusion pressures.
The nTHI’s slopes at 20 mmHg were similar to the slopes at 100 mmHg (p < 0.05),
whereas they were different from the slopes at occlusions ranging between 40-80 mmHg
(p < 0.001). The higher nTHI’s slopes during occlusions in the 40-80 mmHg occlu-
sion range indicated the maximal venous blood engorgement in these occlusions. The
marginal slopes during systolic and total occlusions should be attributed to the manual
inflation of the cuff, thus unable to occlude instantaneously both veins and arteries.
Similar to nTHI, the optical densities’ slopes between 60-100 mmHg occlusions were
not different between each other (p > 0.05). In this range, however, only the slopes at
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Figure 9.21: Slope changes for TOI, nTHI and optical densities (OD) during the first and second protocol.
Prot. 1: first protocol. Prot. 2: second protocol. VO: venous occlusion; TO: total (over-systolic) occlusion.
O1: 20 mmHg; O2: 40 mmHg; O3: 60 mmHg; O4: 80 mmHg; O5: 100 mmHg; O6: systolic pressure; O7: total
(over-systolic) pressure.
80 mmHg differed from 40 mmHg, suggesting a maximal venous engorgement during
the occlusion at 80 mmHg. There was no significant difference between the slopes at
20 mmHg, systolic pressure, and over-systolic pressure (p < 0.001).
9.4 Summary
In this chapter, different non-invasive optical techniques have been investigated dur-
ing vascular occlusion challenges. The first aim of the study was to investigate the
feasibility of using photoplethysmography to estimate relative changes in oxygenated
(HbO2), deoxygenated (HHb), and total haemoglobin (tHb), as done in NIRS. The
results obtained from the PPG were then compared with state-of-the-art NIRS mea-
surements. Correlation and trending agreement between PPG and NIRS showed good
correlation and trending agreement. The Bland & Altman agreement analysis revealed
an underestimation of haemoglobin concentration by PPG, with respect to NIRS. In
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addition, the analysis of the slope of HHb and HbDiff by both PPG and NIRS indi-
cated a lower oxygen consumption in the anatomical area measured by the PPG sensor
(skin), compared to NIRS (muscle). Oxygenation changes were also estimated from
haemoglobin concentrations estimated from PPG and they showed good correlation
with oxygenation changes measured by NIRS (TOI).
A comparative analysis between NIRS, laser Doppler, photoplethysmography, and pulse
oximetry during vascular occlusions was also performed, in order to investigate the
simultaneous responses of these optical methods. Changes in TOI (NIRS), Flux (LDF),
PI (PPG), and optical densities (PPG) indicated the onset of occlusions of both venous
and arterial nature, while changes in SpO2 took place mostly during occlusions involving
the arterial vasculature.
This chapter presented the results from a study in which PPG signals were used to
express changes in blood perfusion and oxygenation induced by vascular occlusions
in the forearm. However, in order not to limit the validation to the forearm only, it
was decided to extend the investigation to other measurement locations and to induce
different physiological stimuli. Therefore, the next chapter will present results from
a second in vivo investigation, where PPG and NIRS signals were acquired from the
forehead of healthy volunteers during a head-down bed tilting protocol.
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Chapter10
Photoplethysmography and Near Infrared
Spectroscopy perfusion and oxygenation
changes at the forehead during a bed
tilting protocol
The previous chapter illustrated the results from a vascular occlusion study in which
the haemoglobin concentrations, estimated from PPG signals, showed good levels of
trending agreement and correlation with NIRS measurements. In this chapter, a similar
comparison will be performed during a head-down tilting study. PPG and NIRS sensors
were applied on the forehead of healthy volunteers and the haemodynamic responses
of PPG and NIRS during the orthostatic stress were compared. In the previous study,
measuring PPG from the forearm allowed to investigate the effects of proximal vascular
occlusions. However, the forearm is not a common location for PPG measurements and
this prompted the investigation of a more conventional location such as the forehead.
Since a change in position of the subject (i.e. tilting) should cause a physiological
change, which can be reflected in the PPG acquired at the forehead, a tilting protocol
was performed in order to investigate the ability of the PPG to indicate perfusion and/or
oxygenation changes at the forehead. This new physiological challenge, where changes
are induced by gravitation rather than mechanical restrictions, will offer a unique point
of view in investigating the research hypothesis. Furthermore, the presence of large
veins on the forehead allowed to analyse the effects that such vessels may have on the
haemoglobin concentrations estimated by PPG, as well as on the SpO2.
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10.1 Introduction
The forehead is one of the most common locations for PPG and SpO2 measurements.
The forehead’s region is well perfused by arteries branching from the internal carotid,
thus, providing good quality PPG signals [110, 111, 188]. PPG measurements on the
forehead have been reported to be less affected by vasoconstriction and quicker in
indicating deoxygenations than fingers [109–111,188–190]. In addition, the forehead is
less susceptible to movements and, for intra-operative monitoring, it is a more accessible
location than fingers [188]. However, the PPG signals acquired from the forehead
contain a stronger venous component compared to the fingers [111, 191]. This venous
component can be worsened by the positioning of the patients such as the Trendelenburg
position [111,117,188]. The venous presence in the PPG measured at the forehead could
be identified in the form of cardio-synchronous venous pulsations, which deteriorate the
quality of the signal [111]. In the presence of venous pulsations, pulse oximetry readings
acquired from the forehead could be lower than the digits because of the mixture of
venous and arterial blood in the measurement area [4, 117, 188]. In order to overcome
these limitations, the application of a low pressure on the sensor was suggested for
pushing venous blood from beneath the sensor [111, 117, 188]. This low pressure aims
at removing venous presence (pulsations) from the PPG signals, without affecting the
arterial component of the signal, thus providing more reliable SpO2 readings [111,188] .
Manufacturers usually provide a headband along with their forehead sensors, but these
headbands, however, do not guarantee the full solution to the problem. Since there is
no standard measure of the actual pressure applied, the headband may suppress arterial
pulses (in particular in hypotensive patients) by exerting an excessive pressure and it
can cause skin damages in the measuring site [111]. In addition, the headband can
slip-off from the patient during the measurement and the applied pressure may not be
sufficient to suppress the venous component in the signal [189]. To date, there is no
measure of the presence of venous blood underneath the sensor. Venous pulsations can
only be visually recognised in the PPG signals, or the venous presence can be presumed
from the position of the patient (e.g. Trendelenburg).
Another factor that may influence PPG/SpO2 readings on the forehead is the presence
of large vasculature on the forehead. The forehead is populated with large arteries
and veins, which lay between the skin and scalp. Therefore, the placement of the
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sensor on the forehead plays an important role in performing the correct measurement.
Mannheimer et al. investigated, by tissue optical modelling and in vivo measurements,
the effect of large arteries on the SpO2 measured by three reflectance pulse oximetry
sensors [110]. In their studies, one sensor was placed on the temple (over a large
pulsating artery), another sensor was positioned just above the left eyebrow and one
last sensor was placed just above the right eyebrow. The sensors positioned above
the eyebrows were not laying above a large vessel. The SpO2 readings from the three
sensors were compared in order to determine whether the positioning of the sensors
over large vasculatures affected the SpO2 measurements. The large artery beneath the
sensor (temple) significantly altered the optical path travelled by the light in the tissue,
causing a significant bias with the reference measurements. The authors then suggested
avoiding placing PPG/pulse oximetry sensors on top of large pulsating arteries [110].
The first aim of this study was to investigate whether PPG signals acquired from
the forehead could be used to estimate relative changes in oxygenated, deoxygenated
(reduced), and total haemoglobin as performed in NIRS. The estimated parameters
were then compared with state-of-the-art NIRS measurements as done previously in
Chapter 9. The possibility of estimating haemoglobin concentrations, in particular, de-
oxygenated haemoglobin, from the same PPG/SpO2 sensor could provide an indication
of the increased (or decreased) presence of venous blood underneath the sensor (i.e.
venous blood pooling). In addition, the effect that large vasculature in the forehead
(e.g. a vein) could have on the estimation of haemoglobin concentrations was also in-
vestigated by comparing two identical PPG sensors placed on different locations on the
forehead. In this setting, the bias in SpO2 readings caused by the presence of a large
vein underneath the sensor was also investigated. The experimental methods and the
comparative results of the measurements will be presented in the following sections of
this chapter.
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10.2 Measurements set-up, protocols and data analysis
10.2.1 Measurement system
The research PPG processing unit presented in Chapter 7 was used to acquire raw PPG
signals (AC+DC). Two identical RPS1 sensors were used to acquire PPG signals from
the forehead. As described later, one sensor was positioned on top of a large vessel,
while the other PPG sensor was placed distant from any vessel on the forehead.
A commercial NIRS monitor (NIRO 200NX, Hamamatsu Photonics, Japan) was used to
acquire NIRS signals, whereas a non-invasive blood pressure monitor (CNAP Monitor
500, CNSystems Medizintechnik AG, Austria) was used to monitor non-invasively the
arterial blood pressure (ABP). The device is based on photoplethysmography and it
measures beat-to-beat ABP signal, providing a continuous indication of systolic and
diastolic pressure. The signal is measured at the fingers by a double-fingers sensor,
whereas the blood pressure is calibrated with a pressure cuff placed on the upper arm.
An electric bed was used for head-down tilting the volunteers.
PPG and NIRS signals were acquired on LabVIEW through two 16-bit NI-PcIe 6321
Data Acquisition Cards (National Instruments, USA). The VI described in Chapter 8
was adapted for the acquisition of PPG signals from the ZenPPG and the NIRS monitor.
Analogue outputs scaling equations were applied for the NIRS signals (subsection 8.3.5).
PPG and NIRS signals were acquired simultaneously at a sampling frequency of 1000 Hz
and saved in a text file for post-acquisition analysis. The ABP was acquired separately
through the dedicated signal amplifier (USBamp, g.tec Medical Engineering GmbH,
Austria) at a sampling rate of 600 Hz.
10.2.2 Subjects and investigation set-up
Sixteen (16) healthy subjects with mean age ± SD of 28 ± 6.7 (13 males and 3 females)
were recruited for the investigation. Ethical approval was gained from the Senate
Research Ethics Committee at City University London and written consent was sought
from the volunteers before commencing of the investigation. Subjects with a history of
cardiovascular disorders were excluded from the study.
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Two PPG sensors and one NIRS sensor were applied on the volunteers’ forehead. One
PPG sensor was designated to be placed on top of a large vessel, while the second
PPG sensor and the NIRS sensor were positioned away from large vasculatures on the
forehead. Locating large vessels on the forehead a priori may be challenging. Therefore,
the position of the large vessels was checked and marked before the commencement
of the study. In order to visualise the vein, a head-down tilt was performed before
placing the sensors. The supratrochlear vein, which lays roughly on the centre part of
the forehead, is one of the largest veins present in the forehead and it can be easily
identified by tilting the head. The subjects were secured to the bed by fastening a belt
around their legs, thus avoiding slipping during tilting. After securing the subjects, the
bed was slightly tilted for few seconds in order to facilitate the exposure of vasculatures
on the forehead. The large supratrochlear vein was marked for the positioning of the
first PPG sensor. An area free from large vasculatures, above the eyebrow, was used
for the positioning of the second PPG. The NIRS sensor’s position was on the opposite
eyebrow with respect to the second PPG sensor and slightly superior in order to avoid
midline sinuses. After marking the sensor’s positions, the bed was restored in a supine
position and the subjects were untied. The subjects rested for five minutes before the
placement of the sensors commenced.
The ABP sensor was placed on the digits of the left hand, as suggested by the man-
ufacturer. The ABP monitor also required the placement of a pressure cuff on the
upper left arm for calibration purposes. The two PPG sensors and the NIRS sensor
were placed in the previously marked positions on top of and distant from the large
vessels. Figure 10.1a illustrates the positioning of PPG and NIRS sensors on the fore-
head. The NIRS sensor had an interoptodes separation distance of 4 cm. All sensors
were attached to the forehead’s skin by means of a clear double-sided medical adhesive
tape. The tapes were cut at the optical components positions in order to avoid optical
obstruction.
10.2.3 Investigation protocol
The investigation protocol consisted of three stages: supine, head-down, and supine.
The subjects were lying on the bed in supine position and they were secured to the
bed. The room temperature was kept constant at 23 ± 1 ℃. After all the sensors were
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Figure 10.1: Positioning of the PPG and NIRS sensors on the forehead (a) and investigation set-up (b). The
first PPG sensor (PPG-1) was placed on top of the supratrochlear vein, while the second PPG sensor (PPG-2)
was placed over the eyebrow, distant from any large vasculature. The NIRS sensor was placed lateral and
opposite to the PPG-2 sensor, distant from any large vasculature. The bed was tilted -30 deg as showed in (b)
for five minutes.
positioned as showed in Figure 10.1a and the volunteers were relaxed, the initial cali-
bration of the ABP monitor was initiated. Once this initial calibration was concluded,
the monitor’s auto-calibration was switched OFF and the protocol was started.
Five minutes of baseline were recorded in the supine position. After baseline, the bed
was inclined at -30 deg. The head-down position was maintained for five minutes, at the
end of which the bed was restored in the initial supine position for other five minutes.
Each transition (supine-to-tilt and tilt-to-supine) did not last more than ten seconds.
Figure 10.1b shows the head-down position at which the volunteers were tilted.
192
10.2. Measurements set-up, protocols and data analysis
10.2.4 Data analysis & statistics
Post-acquisition analysis was performed in Matlab2013a. Before processing, all the
acquired signals were down-sampled to 100 Hz. TOI, nTHI and haemoglobin con-
centrations from NIRS were filtered from high-frequency noise and components by a
zero-phase low-pass filter (fc = 0.05 Hz). The finger AC PPG component was obtained
from raw PPG signals by applying a zero-phase band-pass filter (pass-band: 0.5-7 Hz).
The DC PPGs were obtained by low-pass filtering the signal at fc = 0.1 Hz. SpO2
was estimated from PPG signals by applying Equation 10.1 in a three-seconds rolling
window. Similarly, the mean arterial pressure (MAP) was calculated in a three-seconds
rolling window on the acquired ABP signals by computing the diastolic (DP) and sys-
tolic (SP) pressures as in Equation 10.2 [14].
SpO2 = 110− (25 ·R); Where: R = ACR/DCR
ACIR/DCIR
(10.1)
MAP = 23DP +
1
3SP (10.2)
Changes in oxygenated (HbO2), reduced (HHb) and total haemoglobin (tHb) were
estimated by applying the modified Beer-Lambert law to DC PPG signals acquired from
the forehead as described in Section 8.4. From these, the index ∆Hbratio, expressing
changes in oxygenations, was calculated from the ratio ∆Hbratio = ∆HbO2 / ∆tHb.
The index indicates the relative changes in oxygenation from a starting baseline and it
was expressed as percentage changes.
Correlation between techniques or variables was assessed by measuring the Pearson
correlation coefficient r and the 95 % confidence intervals (CI). The trending agree-
ment was evaluated by four-quadrant plot analysis [184]. The concordance rate C was
calculated as the ratio of the number of points in the first and third quadrant and
the total number of points in all quadrants. An exclusion zone of 10 % was used for
the calculations [184]. A concordance rate C ≥ 90 % was considered satisfactory for
indicating trending agreement.
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Figure 10.2: Example of PPG, arterial blood pressure and NIRS signals acquired from one volunteer. (a)
Red and infrared raw PPG signals (AC+DC) acquired from the first PPG sensor (on top of the vein). (b) Red
and infrared raw PPG signals (AC+DC) acquired from the second PPG sensor (distant from large vessels). (c)
Arterial blood pressure (ABP). (d) Relative haemoglobin concentrations from NIRS. Red trace: ∆HbO2; blue
trace: ∆HHb; black trace: ∆tHb. (e) TOI from NIRS. (f) nTHI from NIRS. The tilting was performed in the
central part of the protocol, after five minutes of baseline readings. The head-down tilting was followed by five
minutes of recovery in the supine position.
The changes during each stage of the protocol (i.e. baseline, tilting, and recovery) were
averaged over the central three minutes of each step. Statistically significant changes
from baseline were tested by repeated measures Wilcoxon signed-rank tests. A p-value
less than 0.05 was considered satisfactory for significance.
10.3 Results
Figure 10.2 illustrates the acquired signals from a volunteer during the investigation
protocol. The acquired signals indicated the haemodynamic changes due to head-down
tilting. These responses of each signal are analysed in detail in the next sections.
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Figure 10.3: Mean changes (±SD) in mean arterial pressure (MAP) across all subjects investigated during the
tilting protocol. Black trace is the mean, while the grey traces are the ±SD intervals.
10.3.1 Haemoglobin concentration changes estimated from PPG
The all-body head-down tilting created a quick shift of blood to the upper part of the
body, causing temporary hypovolaemia in the lower body. This caused a consequent
drop in the systemic arterial blood pressure measured at the digits. The mean arterial
pressure (MAP) dropped during tilting and it recovered when the volunteers returned
to supine position. Figure 10.3 depicts the mean changes in MAP caused by the head-
down tilting. The mean drop during tilting was -16.24 ± 5.90 mmHg and it was
statistically significant in the population investigated (p < 0.01). In addition, there
was no difference between baseline and post-tilting recovery MAP readings (p > 0.05),
indicating a full recovery of the blood pressure when the supine position was restored.
Relative concentration changes in oxygenated, reduced, and total haemoglobin were es-
timated from PPG signals by applying the modified Beer-Lambert to DC PPG signals.
Figure 10.4 shows the mean changes (±SD) of ∆HbO2, ∆HHb, and ∆tHb estimated
from the PPG2 sensor and NIRS on the forehead during bed tilting. The changes
in haemoglobin concentration indicated the haemodynamic changes occurred due to
bed tilting. The -30deg head-down tilt produced a simultaneous impediment of the
venous return from the upper part of the body (head) and an increase in arterial in-
flow due to the hydrostatic position. This gravitational change was reflected in an
increase in the concentration of oxygenated haemoglobin (∆HbO2). The venous blood
pooling on the upper part of the body (head) produced an increase in the concen-
tration of reduced haemoglobin (∆HHb). Both increases in oxygenated and reduced
haemoglobin contributed to the rise of total haemoglobin ∆tHb measured at the fore-
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Figure 10.4: Mean changes (±SD) in ∆HbO2, ∆HHb, and ∆tHb from the forehead estimated by PPG and
NIRS during bed tilting. The haemoglobin concentrations were estimated from the PPG sensor positioned
distant from large vasculature on the forehead (PPG-2). The tilting was performed in the central part of the
protocol, after five minutes of baseline readings. The head-down tilting was followed by five minutes of recovery
in the supine position. Black traces are the means, while grey traces represent the ±SD intervals. PPG and
NIRS measurements have been plotted on different y-axis scales in order to facilitate the visual assessment of
the trends.
head (i.e. ∆tHb = ∆HbO2 + ∆HHb ). Therefore, the increase in ∆tHb could be
attributed to both an increase of arterial inflow and to a reduced return of venous
blood.
Table 10.1 presents the mean changes (±SD) in ∆HbO2, ∆HHb, and ∆tHb, estimated
by both PPG and NIRS, during baseline, tilting, and recovery. Tilting caused significant
changes from baseline (p < 0.05) in all parameters estimated by both PPG and NIRS.
As can be noticed from the y-axis scale of Figure 10.4 and Table 10.1, there was a
quantitative difference between the haemoglobin concentrations estimated from PPG
and NIRS. Therefore, the bias between the two technique was assessed by the same
Bland & Altman analysis performed in Chapter 9. The analysis involved the calculation
of limits of agreements with respect to the ratio between the two techniques, instead
of the traditional difference [185, 186]. Figure 10.5 illustrates the Bland & Altman
plots of the ∆HbO2, ∆HHb, and ∆tHb estimated by PPG and NIRS during the bed
tilting protocol. The standard limits of agreement for ∆HbO2, ∆HHb, and ∆tHb were
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Table 10.1: Mean changes (±SD), in mM·cm, of relative haemoglobin concentrations changes estimated by
PPG and NIRS during baseline, tilting, and recovery. The PPG-derived haemoglobin concentrations refer to
the second PPG sensor, which was placed distant from the large vasculature. The values are averaged over the
central three minutes of baseline, tilting, and recovery.
Baseline Tilting Recovery
(mM·cm) (mM·cm) (mM·cm)
∆HbO2 (PPG) -0.104 ± 0.056 0.202 ± 0.109∗ -0.110 ± 0.069
∆HHb (PPG) 0.033 ± 0.143 0.068 ± 0.031∗ -0.039 ± 0.019
∆tHb (PPG) 0.130 ± 0.057 0.262 ± 0.115∗ -0.150 ± 0.065
∆HbO2 (NIRS) -0.001 ± 0.006 0.032 ± 0.028∗ 0.001 ± 0.017
∆HHb (NIRS) 0.000 ± 0.002 0.018 ± 0.014∗ 0.004 ± 0.005∗
∆tHb (NIRS) -0.001 ± 0.005 0.050 ± 0.041∗ 0.004 ± 0.018
∗ Significant change from baseline (p < 0.05)
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Figure 10.5: Bland & Altman plots and analysis of the haemoglobin concentrations estimated from the second
PPG sensor (PPG-2) against the reference NIRS method during the bed tilting protocol. X-axes are the mean
between the two methods, while the y-axes are the ratio of the measures. Blue crosses are the data. Horizontal
solid lines are the standard mean bias and the dashed lines are the limits of agreement (mean ± 1.96SD). The
second solid line in black is the regression line on the data, representing the mean bias. The grey lines are the
± 95 % confidence intervals. The equation of the fitted regression line is reproduced at the top of the graphs.
respectively 0.999 ± 1.96×0.0032, 0.999 ± 1.96×(9.45·10−4), and 0.999 ± 1.96×0.0039.
These represent the consistent mean bias ratio between the measures and it indicated
a small underestimation of PPG compared to NIRS. However, the Bland & Altman
analysis revealed a non-constant linear relationship between the average (x-axis) and the
ratio (y-axis) of the measures. Regression analysis shows that the mean bias between
the measures increased when the magnitude (average) of the measurements increases,
with an overestimation of PPG compared to NIRS. The best-fit regression lines on the
data, representing the mean bias, are showed in Figure 10.5, along with the ± 95 % CI
and the regression line’s equation.
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Figure 10.6: Four quadrant plots between ∆HbO2, ∆HHb, and ∆tHb estimated from the second PPG sensor
(PPG-2) and NIRS during the bed tilting protocol. The concordance rate C and correlation coefficients r
between the measures are presented as well. The concordance rate was calculated as the ratio of the number of
points in the first and third quadrant and the total number of points in all four quadrants. An exclusion zone
of 10 % was used for the calculation of C. Dashed lines are the lines of equality. Grey boxes indicate the 10 %
exclusion zone. (a) changes in ∆HbO2. (b) Changes in ∆HHb. (c) Changes in ∆tHb.
10.3.2 Assessment of correlation and trending between PPG and NIRS
As shown in Figure 10.4, the haemoglobin concentrations estimated from PPG followed
the trends of the same NIRS-derived parameters. The correlation between PPG and
NIRS parameters was assessed by calculating the Pearson correlation coefficient r. The
two techniques had good correlation, with coefficients of r = 0.91 (95 % CI: 0.83, 0.97),
r = 0.88 (95 % CI: 0.72, 0.96), and r = 0.97 (95 % CI: 0.92, 0.99) for ∆HbO2, ∆HHb,
and ∆tHb respectively.
Trending agreement was evaluated by four-quadrant plots analysis between ∆HbO2,
∆HHb, and ∆tHb measured by PPG and NIRS. Figure 10.6 depicts the four-quadrant
plots of ∆HbO2, ∆HHb, and ∆tHb estimated from PPG and NIRS during the bed
tilting protocol. The haemoglobin concentrations from PPG presented a satisfactory
trending agreement with NIRS measurements. The concordance rates were 89.86 %,
97.45 %, and 97.13 % respectively for ∆HbO2, ∆HHb, and ∆tHb.
10.3.3 Haemoglobin oxygenation from PPG signals
The haemoglobin concentrations changes ∆HbO2, ∆HHb, and ∆tHb indicated changes
in perfusion in the measurement area. The parameters were also used to estimate
changes in haemoglobin oxygenation. The index ∆HbRatio was calculated from the
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Figure 10.7: Mean changes (±SD) of ∆HbRatio during the bed tilting protocol. Black trace is the mean, grey
traces are the ±SD intervals.
ratio of ∆HbO2 over ∆tHb and it was expressed as percentage change from the baseline.
Figure 10.7 shows the mean changes in ∆HbRatio from the PPG sensor placed distant
from the large vasculature. Significant changes from baseline were observed in ∆HbRatio
during tilting (p < 0.01) and recovery (p < 0.01).
Differently from subsection 9.3.4, the changes in ∆HbRatio were not correlated with
the TOI changes. ∆HbRatio and TOI had a mean correlation coefficient r = -0.33
(95 % CI: -0.70, 0.17), showing a poor and negative correlation. The TOI, differently
from HbRatio, did not exhibit any significant change from baseline (p > 0.05). This
different behaviour is most probably originating from the different penetration depths
of TOI (NIRS) and ∆HbRatio (PPG). In this specific case, TOI is believed to reflect
the oxygenation of the cerebral cortex, while PPG interrogates the forehead’s skin
only. The different responses of TOI and ∆HbRatio may suggest that tilting triggered
an auto-regulatory mechanism in the brain, which was absent in the forehead’s skin.
Contrarily to TOI, the nTHI exhibited significant increases (p < 0.01) during tilting.
Provided that TOI is the ratio between HbO2 and tHb (i.e. tHb = HbO2+HHb) and
that nTHI and TOI originate from the interrogation of the same tissue volume, the
increase in nTHI (blood volume, tHb) and the stationary TOI, suggest that the brain
auto-regulated its consumption (HHb) after an abrupt increase in HbO2. Figure 10.8
illustrates the changes in ∆HbRatio, TOI and nTHI in all the subjects investigated,
while Table 10.2 summarises the mean changes in HbRatio, TOI, and nTHI.
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Figure 10.8: Changes in ∆HbRatio, TOI, and nTHI in all volunteers during the bed tilting protocol. (a)
Changes in ∆HbRatio. (b) Changes in TOI. (c) Changes in nTHI. The signals were averaged over the central
three minutes of each stage (baseline, tilting, and recovery). The consistent drops in ∆HbRatio and stationary
TOI may suggest that the brain, differently from the skin, responded to tilting with some degree of auto-
regulation. The increases in nTHI, which represent total blood volume changes (∆tHb), indicate that the brain
may regulate the HHb concentrations. B: baseline. T: tilting. R: recovery.
Table 10.2: Mean changes (±SD), of ∆HbRatio, TOI and nTHI during the bed tilting protocol. The signals
were averaged over the central three minutes of each stage (baseline, tilting, and recovery).
Baseline Tilting Recovery
∆HbRatio (%) 1.14 ± 0.56 -1.94 ± 0.99∗ 1.33 ± 0.70∗
TOI (%) 74.16 ± 10.53 73.94 ± 8.82 73.75 ± 10.20
nTHI (A. U.) 1.00 ± 0.03 1.12 ± 0.16∗ 1.01 ± 0.07
∗ Significant change from baseline (p < 0.05)
10.3.4 Influence of large vasculature on haemoglobin concentrations
estimation by PPG
In the previous sections, the comparison between changes in haemoglobin concentra-
tions measured by PPG and NIRS during bed tilting was presented. The PPG demon-
strated to indicate the same haemodynamic changes measured by NIRS when a -30deg
bed tilting procedure was performed. However, quantitative differences between the
two techniques were present. Bland & Altman analysis indicated an overestimation of
relative haemoglobin concentrations estimated by PPG when compared to NIRS. Cor-
relation and trending analysis showed a high correlation and a good level of trending
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concordance between the techniques.
This section will focus on analysing the effect of the large vasculature in the estimation
of haemoglobin concentrations. It is expected that large vasculature will affect the
estimation of haemoglobin concentrations. This is due to the greater light absorption
of large vasculatures. In particular, the PPG should be more affected by the superficial
large vasculatures present on the forehead due to its shallower penetration. In addi-
tion, the venous nature of the investigated vasculature is expected to affect mainly the
estimation of deoxygenated haemoglobin.
Figure 10.9 shows the mean changes (±SD) of ∆HbO2, ∆HHb, and ∆tHb estimated
from both PPG sensors. The PPG sensor placed on top of the large vein (PPG-
1) indicated the same changes in the parameters as the PPG sensor positioned dis-
tant from large vasculatures (PPG-2). The sensor on the large vessel followed the
same trends as the other PPG sensor. There was a good correlation between the two
PPG measures, with Pearson correlation coefficients r = 0.98 (95 % CI: 0.94, 0.99),
r = 0.96 (95 % CI: 0.89, 0.98), and r = 0.98 (95 % CI: 0.96, 0.99), for ∆HbO2, ∆HHb
and ∆tHb respectively.
Differences between the two PPG measures were assessed by testing for statistical sig-
nificance between the means averaged over the central three minutes of each stage (i.e.
baseline, tilting, and recovery). Figure 10.10 shows the box and whiskers plots of the
means of haemoglobin concentrations calculated from both PPG sensors. When com-
pared to the sensor placed distant from large vessels, the deoxygenated haemoglobin
HHb estimated from the PPG sensor on the large vein demonstrated a significant
difference during baseline (p = 0.03), tilting (p = 0.03), and recovery (p = 0.01). Oxy-
genated haemoglobin (HbO2) and total haemoglobin (tHb) did not show any significant
difference (p > 0.05).
Bland & Altman analysis was also performed on the deoxygenated haemoglobin con-
centration changes (∆HHb) estimated by both PPG sensors. Figure 10.11 depicts the
Bland & Altman plots between the ∆HHb estimated by both PPG sensors during
the three stages of the bed tilting protocol (i.e. baseline, tilting, and recovery). The
limits of agreement were 1.0002 ± 1.96×(4.21·10−1), 0.9995 ± 1.96×(8.20·10−1), and
1.0003 ± 1.96×(4.63·10−1). These limits of agreement indicated that the PPG sensor
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Figure 10.9: Mean changes (±SD) in HbO2, HHb, and tHb from the forehead estimated by the two PPG
sensors. The haemoglobin concentrations were estimated from the PPG sensor positioned on the large vessel
(PPG-1) and from the PPG sensor placed distant from large vasculature on the forehead (PPG-2). The tilting
was performed in the central part of the protocol, after five minutes of baseline readings. The head-down tilting
was followed by five minutes of recovery in the supine position. Black traces are the means, while grey traces
represent the ±SD intervals.
on top of the large vein slightly overestimated ∆HHb during baseline and recovery,
while in tilting the presence of the vein underneath the sensor causes an underestima-
tion of ∆HHb. In addition, the positioning of the sensor on top of the vein caused an
increase of the limits of agreements between the two PPG sensors during tilting.
Mean absolute errors (MAE) were calculated between the haemoglobin concentrations
estimated from the two PPG sensors. The MAE values were calculated in the three
minutes central section of each stage (i.e. baseline, tilting, and recovery) and are
summarised in Table 10.3. MAE analysis revealed a greater error during tilting than
baseline or recovery and a larger error in deoxygenated haemoglobin compared to oxy-
genated and total haemoglobin. The MAE values indicated that the sensor positioned
on the large vein overestimated the deoxygenated haemoglobin during baseline and re-
covery, while it underestimated the parameter during tilting. Even though the error for
HHb during tilting may seem very small, it may signify an underestimation of roughly
25 % of the full range measured in this study by the PPG sensor placed in the correct
position (i.e. away from large vasculature).
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Figure 10.10: Box and whiskers plots of the mean changes in HbO2, HHb, and tHb estimated from both PPG
sensors during baseline, tilting, and recovery. Black boxes on the left side of each sub-plot are the changes from
the PPG sensor positioned on top of the large vessel (PPG-1). Blue boxes on the right side of each sub-plot
are the changes from the PPG sensor placed distant from large vasculatures (PPG-2). B: baseline. T: tilting.
R: recovery. The values were averaged over the central three-minute section of each stage (baseline, tilting, and
recovery).
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Figure 10.11: Bland & Altman plots of the deoxygenated haemoglobin (∆HHb) estimated from the PPG
sensor on the large vein (PPG-1) and the PPG sensor distant from large vasculatures on the forehead (PPG-2)
during the three stages of the bed tilting protocol. (a) Baseline. (b) tilting. (c) Recovery. X-axes are the mean
between the two measures, while the y-axes are the differences between the measures. Blue crosses are the
data. Horizontal solid lines are the standard mean bias ratios and the dashed lines are the limits of agreement
(mean ± 1.96SD).
Table 10.3: Mean absolute errors (MAE) between haemoglobin concentrations estimated from the two PPG
sensors during the bed tilting protocol. The MAE values were calculated over three-minutes long section at each
stage of the protocol (baseline, tilting, and recovery).
Baseline Tilting Recovery
(mM·cm) (mM·cm) (mM·cm)
∆HbO2 -0.007 0.014 -0.011
∆HHb 0.013 -0.026 0.013
∆tHb 0.005 -0.011 0.002
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Figure 10.12: Box and whiskers plots of the mean changes in ∆HbRatio estimated from the PPG sensor on
the large vein and the PPG sensor distant from large vasculatures on the forehead during the three stages of
the bed tilting protocol. PPG-1: sensor placed on top of the large vein. PPG-2: sensor positioned distant from
large vasculatures on the forehead.
10.3.5 Influence of large vasculature on haemoglobin oxygenation es-
timation by PPG
The ∆HbRatio was also estimated from the PPG sensor placed on top of the large
vein. Figure 10.12 illustrates the box and whiskers plot of the mean values of ∆HbRatio
estimated from both PPG sensors. The changes measured by the sensor positioned
over the vein correlated well (r = 0.96, 95 % CI: 0.88, 0.98) with the measurements
from the sensor placed just above the eyebrow. However, there was a statistically
significant difference between the two ∆HbRatio during tilting (p = 0.04) and recovery
(p = 0.02), while there was no difference during baseline (p > 0.05). The mean absolute
errors MAEs between HbRatio measured by the two sensors during baseline, tilting and
recovery were respectively -0.406 %, 0.746 %, and -0.432 %.
Bland & Altman analysis between ∆HbRatio estimated from the two PPG sensors re-
vealed mean bias ratios of 0.992± 1.96×0.014, 1.015± 1.96×0.026, and 0.991± 1.96×0.015
respectively for baseline, tilting, and recovery. The Bland & Altman plots for the dif-
ferent stages of the protocol are presented in Figure 10.13. The limits of agreement,
along with the MAE values, indicated that the presence of the large vein beneath the
PPG sensor caused a consistent overestimation of ∆HbRatio during tilting, whereas in
recovery and baseline ∆HbRatio was underestimated.
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Figure 10.13: Bland & Altman plots of ∆HbRatio estimated from the PPG sensor on the large vein (PPG-1)
and the PPG sensor distant from large vasculatures on the forehead (PPG-2) during the three stages of the bed
tilting protocol. (a) Baseline. (b) Tilting. (c) Recovery. X-axes are the mean between the two measures, while
the y-axes are the ratio of the measures. Blue crosses are the data. Horizontal solid lines are the standard mean
bias ratios and the dashed lines are the limits of agreement (mean ± 1.96SD).
10.3.6 Influence of large vein on SpO2 estimation by PPG
Arterial oxygen saturation (SpO2) was estimated from PPG signals acquired by both
PPG sensors, either placed on top of or distant from the large vein. When the two
sensors were compared, there was no statistical difference (p > 0.05) in the mean
SpO2 values throughout baseline. However, Bland & Altman analysis (Figure 10.14)
revealed a mean bias of 0.96 % between the two SpO2 and limits of agreement of
0.96 ± 1.96×4.17 %. Although the mean bias is not excessive, the limits of agreement
are wide. This may indicate that the SpO2 measured on top of the vein has a sub-
stantial variability compared to an identical sensor placed distant from vasculatures.
In addition, when the root mean square error (RMSE) between the SpO2 at the two
locations was calculated like Mannheimer et al. did in [110], it revealed a greater error,
with RMSE = 4.38 %.
Figure 10.15 shows the mean changes of the estimated SpO2 from both sensors through-
out the entire protocol. During baseline, both SpO2 dropped significantly from base-
line (p < 0.01). This drop was mainly due to two factors. Firstly, during tilting, the AC
PPG signal deteriorated due to venous engorgement. Figure 10.16 shows an example
of AC PPG traces acquired at baseline, tilting and recovery. The negative tilting, and
consequent venous engorgement, caused a significant deterioration of the signal due to
the appearance of venous pulsations in the PPG signals [111]. Secondly, the shifting of
venous blood underneath the sensor caused the mixture of venous and arterial blood,
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Figure 10.14: Bland & Altman plots of SpO2 estimated from the PPG sensor on the large vein (PPG-1)
and the PPG sensor distant from large vasculatures on the forehead (PPG-2) during baseline. X-axes are the
means between the two measures, while the y-axes are the differences between the measures. Blue crosses are
the data. The horizontal solid line is the mean bias ratio and the dashed lines are the limits of agreement
(mean ± 1.96SD). Limits of agreement were 0.96 ± 1.96×4.17 (%). The original signals were resampled every
5 seconds.
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Figure 10.15: Mean changes (±SD) in SpO2 estimated from the PPG sensor placed on top of the large vein
PPG-1 (a) and the PPG sensor positioned distant from large vasculatures PPG-2 (b) during the bed tilting
protocol. Black traces are the means, while grey traces represent the ±SD intervals.
with a consequent overestimation of the ratio of ratios and SpO2. The drop in SpO2
during the protocol should not be interpreted as a decrease in the oxygen content of ar-
terial blood, but instead be related to a limitation of the technique in providing reliable
SpO2 readings in the presence of venous blood and/or venous pulsations.
10.4 Summary
After investigating in Chapter 9 the response of haemoglobin concentrations estimated
by PPG during vascular occlusions on the forearm, this chapter aimed at analysing
the haemoglobin concentrations from PPG signals acquired from the forehead. PPG
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Figure 10.16: Five second traces of infrared AC PPG signals acquired from the PPG sensor on top of the large
vein (PPG-1) and distant from large vasculature (PPG-2) during the three stages of the bed tilting protocol
(i.e. baseline, tilting, and recovery). During tilting the shape of the PPG signal changes due to the presence of
venous pulsations.
and NIRS sensors were applied on the forehead and a negative bed tilting protocol was
performed in order to induce a haemodynamic change. One PPG sensor was placed on
top of a large vein, whereas another identical PPG sensor and one NIRS sensor were
positioned distant from any large vasculature.
Relative changes in oxygenated, deoxygenated, and total haemoglobin estimated from
the PPG sensor distant from large vasculature were compared with the same parameters
measured by NIRS. Haemoglobin concentration changes correlated well with NIRS mea-
surements. In addition, four-quadrant plots analysis revealed good trending agreement
between haemoglobin concentrations estimated by PPG and NIRS. However, there were
quantitative differences between the measures most probably due to the different pen-
etration depth. Bland & Altman analysis revealed a bias between the measures, which
was dependent on the magnitude of the change. Changes in haemoglobin oxygenation
(∆HbRatio) were also calculated from the haemoglobin concentrations. The ∆HbRatio
significantly changed during bed tilting. However, the measure of HbRatio did not cor-
relate with the oxygenation changes estimated from NIRS (TOI). The absence of any
significant change in TOI, concomitant to the increase in nTHI, was probably due to
an autoregulatory response of the brain to tilting.
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The effect of the placement of the PPG sensor on top of a large vein was investigated.
The changes in haemoglobin concentrations, haemoglobin oxygenation, and SpO2 esti-
mated from the two PPG sensors were compared during the three stages of the protocol
(i.e. baseline, tilting, and recovery). There was a good correlation between the changes
measured by both PPG sensors. Amongst the haemoglobin concentration changes
measured at the two locations, only deoxygenated haemoglobin (∆HHb) showed a sig-
nificant difference in all stages of the protocol. In particular, the ∆HHb measured on
top of the vein seemed to be underestimated when compared to the location free from
the large vasculature. The haemoglobin oxygenation changes (∆HbRatio) measured at
the two locations also showed a bias during tilting.
The analysis of differences in SpO2, when this was measured on top of a large vein,
revealed a large mean error with the SpO2 measured distant from any vein. Bland
& Altman plots also showed wide limits of agreement between the SpO2 measured
at the two locations, indicating a large variability caused by the presence of the vein
underneath the sensor.
After investigating the response of PPG at the forearm during vascular occlusions and
at the forehead during tilting, a new physiological challenge and other measurement
locations were also explored. The next chapter will present results from an investi-
gation in which PPG signals measured at the finger and ear canal were used to infer
relative haemoglobin concentration changes during a whole-body exposure to a cold
temperature.
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Chapter11
Investigation of Photoplethysmography
and Near Infrared Spectroscopy during
an induced thermal stress
The studies presented in the previous chapters showed the response of PPG signals ac-
quired from two different anatomical locations (forearm and forehead) and during two
different physiological challenges (vascular occlusions and tilting). In those investiga-
tions, the PPG signals acquired from a single sensor were analysed (Chapter 9) or two
identical sensors placed close to each other were compared (Chapter 10). The study
presented in this chapter differs from the previous studies in both the physiological
challenge induced and in the measurement locations from which the PPG signals were
acquired. After mechanically occluding the vasculature (occlusions) or causing blood
pooling by changing the subject’s position (tilting), the study in this chapter aims at
causing a vasoconstrictive response by exposing the subjects to a cold temperature.
This can be considered a more natural stimulus, to which most people are exposed in
winter. This study also aims to compare the perfusion at two different locations by
analysing the haemoglobin concentration changes estimated from the PPGs acquired
from the finger and the ear canal.
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11.1 Introduction
In Chapter 9 and Chapter 10, the feasibility of estimating relative concentration changes
of oxygenated (∆HbO2), deoxygenated (∆HHb), and total haemoglobin (∆tHb) from
PPG signals was investigated. In Chapter 9, the changes in ∆HbO2, ∆HHb, and
∆tHb estimated from PPG indicated the changes in perfusion when venous outflow or
arterial inflow were blocked by different levels of vascular occlusions on the arm. In
Chapter 10, the changes in haemoglobin concentrations revealed an increased presence
of venous blood in the forehead when the subjects were tilted head-down. In both
studies, ∆HbO2, ∆HHb, and ∆tHb estimated from PPG signals were well correlated
and showed good trending agreement with state-of-the-art NIRS measurements.
The changes in perfusion performed in Chapter 9 and Chapter 10 (i.e. vascular occlu-
sions and bed tilting) were achieved by directly occluding vasculature or forcing venous
engorgement on the head by gravitation. This chapter investigates the response of rel-
ative haemoglobin concentrations estimated from PPG during a more natural change
in perfusion such as an exposure to a cold temperature. Healthy subjects were placed
in a room kept at 10 ℃ and the haemodynamic responses were recorded.
In the previous studies, the haemoglobin concentrations were estimated from reflectance
PPG signals acquired from the forearm or the forehead. In this study, other measure-
ment locations such as the finger and the ear canal were also investigated. In addition,
the haemoglobin concentrations from the two locations were compared in order to
reveal any differences in perfusion between the two locations. The ear canal, being
supplied by branches of the carotid artery, should be more resilient to vasoconstriction
when compared to the fingers. This property of the ear canal was previously described
by Budidha and Kyriacou, who reported more stable SpO2 measurements and higher
signal amplitude in the ear canal compared to the fingers in the presence of vasocon-
striction [93,94].
In the study presented in this chapter, haemoglobin concentrations were acquired by
a state-of-the-art NIRS sensors applied on the forearm and forehead and they were
used as a reference for the PPG measurements. The Tissue Oxygenation Index (TOI)
and normalised Tissue Haemoglobin Index (nTHI) were also acquired by NIRS. TOI
and nTHI, measured by spatially resolved spectroscopy, reflect changes in oxygenation
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and blood volume in deep tissues. TOI and nTHI were also analysed and compared in
order to reveal any variation in oxygenation or blood volume in the brain and muscle
during exposure to cold temperatures. The following sections in this chapter describe
the study’s methods and results.
11.2 Measurements set-up, protocols and data analysis
11.2.1 Measurement system
The research PPG processing unit presented in Chapter 7 was used to acquire raw PPG
signals (AC+DC). As described later, one finger PPG sensor was used to acquire PPG
signals from the finger, whereas a second sensor was used to measure PPG signals from
a more central location such as the ear canal.
A commercial NIRS monitor (NIRO 200NX, Hamamatsu Photonics, Japan) was used
to acquire NIRS signals, whereas a laser Doppler flowmetry device (moorVMS-LDF2,
Moor Instruments Ltd, UK) was used to measure blood flow in the skin.
PPG and NIRS signals were acquired on LabVIEW through two 16-bit NI-PcIe 6321
Data Acquisition Cards (National Instruments, USA). The VI described in Chapter 8
was adapted for the acquisition of PPG signals from the ZenPPG, the NIRS monitor
and the laser Doppler monitor. Analogue outputs scaling equations were applied for the
NIRS, Flux, and temperature signals (subsection 8.3.5). All the signals were acquired
simultaneously at a sampling frequency of 1000 Hz and saved in a text file for post-
acquisition analysis.
11.2.2 Subjects and investigation set-up
Thirteen (13) healthy subjects with mean age (± SD) of 28 ± 3.6 (6 males and 7
females) were recruited for the investigation. Ethical approval was gained from the
Senate Research Ethics Committee at City University London and written consent was
sought from the volunteers before commencing of the investigation. Subjects with a
history of cardiovascular disorders were excluded from the study.
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(a) (b)
Figure 11.1: Figures showing the placement of PPG, NIRS, and LDF sensors on the forearm (a) and the PPG
ear canal sensor (b).
Subjects were asked to sit in a comfortable chair, with their arms placed on the armrests.
Finger PPG signals were acquired from the second digit of the left hand by a reflectance
PPG sensor. A reflectance ear canal PPG sensor was used to acquire PPG signals
from the subjects’ left ear canal [93, 94, 192]. The sensor comprised the same optical
components (LEDs and photodiode) as the PPG finger sensor applied on the left hand.
The ear canal and finger PPG sensors were developed by Budidha as part of another
research project [93,94,192] and they were conjointly used for this investigation.
The Laser Doppler flowmetry (LDF) VP1T sensor was positioned on the dorsal side
of the left hand. The LDF sensor was kept in place by ring-shaped adhesive pads
provided by the manufacturer. In addition to measuring skin blood flow (Flux), the
sensor measured continuously the subject’s skin temperature.
An NIRS sensor with a separation distance of 4 cm was placed on the left forearm,
above the brachioradialis. A second NIRS sensor, with a separation distance of 4 cm,
was placed on the subject’s forehead in order to measure cerebral NIRS signals. The
sensor was positioned high above the left eyebrow and external in order to avoid midline
sinuses. The sensors were attached to the skin by means of clear double-sided medical
adhesive tapes. The tapes were previously cut at the emitter and detector positions
in order to avoid any optical obstruction. All the instrumentation comprising of the
PPG system, NIRS monitor, LDF monitor, and personal computer were positioned on
a wheelbase trolley.
Figure 11.1 shows the placement of the sensors on the left forearm and hand, and the
position of the ear canal sensor.
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11.2.3 Investigation protocol
Throughout the study, the subjects were exposed to different ambient temperatures.
The investigation protocol consisted of three stages: baseline, cold exposure, and re-
covery. In the baseline, the volunteers sat for two minutes on the chair, in a room at a
constant ambient temperature of 23 ± 1 ℃. After these two minutes baseline readings,
the subjects were moved into a second temperature controlled room, at a temperature
of 10 ± 1 ℃. The subjects were exposed at this temperature for ten minutes, before
being moved back to the initial room at 23 ℃ (recovery stage). The subjects were left
to recover at 23 ℃ for an additional ten minutes.
The volunteers were moved between each room by carefully pushing the trolley contain-
ing the instrumentation and the wheelchair on which they were sitting on. In order to
avoid recording any movement artefacts caused by the transfer, the measurements were
paused during the transfer. In addition, the NIRS measurements (haemoglobin con-
centrations and nTHI) were zero-set at the end of each transfer to obtain only relative
changes in each stage (i.e. baseline, cold, recovery).
The volunteers were wearing only light clothes such as t-shirts or shirts and they were
asked to remove their shoes. Prior to commencing the investigation, the volunteers
were left for at least 15 minutes to acclimatise at 23 ℃.
11.2.4 Data analysis & statistics
Post-acquisition analysis was performed in Matlab2013a. Before processing, all the
acquired signals were down-sampled to 100 Hz. TOI, nTHI and haemoglobin con-
centrations from NIRS were filtered from high-frequency noise and components by a
zero-phase low-pass filter (fc = 0.05 Hz). The finger AC PPG component was obtained
from raw PPG signals by applying a zero-phase band-pass filter (pass-band: 0.5-7 Hz).
The DC PPGs were obtained by low-pass filtering the signal at fc = 0.1 Hz.
The perfusion index (PI) was calculated in a three seconds rolling window from infrared
PPG signals by computing the AC PPG amplitude and normalise it to the DC value
(see Equation 9.2). The PI and the laser Doppler Flux were normalised to ten seconds
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baseline readings in order to compensate for inter-subject variability.
Changes in oxygenated (∆HbO2), reduced (∆HHb) and total haemoglobin (∆tHb) were
estimated by applying the modified Beer-Lambert law to DC PPG signals acquired from
the finger and ear canal, as showed in Section 8.4.
Correlation between techniques or variables was assessed by measuring the Pearson
correlation coefficient r with the 95 % confidence intervals (CI). The trending agree-
ment was evaluated by four-quadrant plot analysis [184]. The concordance rate C was
calculated as the ratio of the number of points in the first and third quadrant and
the total number of points in all quadrants. An exclusion zone of 10 % was used for
the calculations [184]. A concordance rate C ≥ 90 % was considered satisfactory for
indicating trending agreement.
The changes during each stage of the protocol (i.e. baseline, cold, and recovery) were
averaged over the central minute of baseline, the last minute of cold exposure, and the
last minute of recovery. Statistically significant changes from baseline were tested by
repeated measures Wilcoxon signed-rank tests. A p-value less than 0.05 was considered
satisfactory for significance.
11.3 Results
Figure 11.2 shows all the acquired signals from one of the subjects investigated. During
the protocol, all the signals indicate the haemodynamic changes caused by the exposure
to cold. The following sections will analyse these changes in more detail.
11.3.1 Haemoglobin concentration changes estimated from PPG
Haemoglobin concentrations were estimated from dual-wavelength finger PPG sig-
nals by applying the modified Beer-Lambert law to DC PPG signals. Figure 11.3
shows examples of changes in oxygenated (∆HbO2), deoxygenated (∆HHb), and total
haemoglobin (∆tHb) estimated from the finger throughout the protocol. The cold ex-
posure caused an almost immediate vasoconstriction of the microcirculation. This was
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Figure 11.2: Example of PPG, NIRS, laser Doppler flowmetry and skin temperature signals acquired from
one subject during the investigation protocol. (a) Raw PPG signals (AC+DC) acquired from the finger. (b)
Raw PPG signals acquired from the ear canal. (c) NIRS relative haemoglobin concentrations measured at the
forearm. (d) NIRS relative haemoglobin concentrations measured at the forehead. (e) NIRS TOI measured at
the forearm. (f) NIRS TOI measured at the forehead. (g) NIRS nTHI measured at the forearm. (h) NIRS nTHI
measured at the forehead. (i) Laser Doppler Flux. (l) Skin temperature. Vertical lines indicate the duration of
the exposure to cold.
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Figure 11.3: Example of ∆HbO2, ∆HHb, and ∆tHb estimated from finger (PPG) and forearm (NIRS) of
four subjects during cold exposure. Each column represent one volunteer. Top row: skin temperatures. Middle
row: haemoglobin concentrations estimated from the PPG measured at the fingers. Bottom row: haemoglobin
concentrations estimated by NIRS at the forearm. Red traces: ∆HbO2. Blue traces: ∆HHb. Black trace:
∆tHb. Vertical lines represent the duration of the cold exposure.
represented by the drop in ∆HbO2 as soon as the volunteers were introduced in the cold
room. Contrarily to ∆HbO2, the ∆HHb, representing venous blood, did not appear to
change significantly during exposure to cold. The ∆tHb, being the sum of ∆HbO2 and
∆HHb, followed the drop in HbO2. The ∆HbO2, ∆HHb, and ∆tHb estimated from
the PPG signals acquired from the finger followed the changes of the same parameters
estimated from the forearm by NIRS.
Figure 11.4 shows the box and whiskers plots of the means of the haemoglobin con-
centration changes estimated from the finger PPG in the three different stages of the
protocol (i.e. baseline, cold, and recovery) for all volunteers. Exposure to cold caused
a statistically significant drop of ∆HbO2 from baseline (p < 0.01), whereas ∆HHb did
not change from baseline (p > 0.05). Similar to ∆HbO2, a significant change in ∆tHb
occurred during exposure to cold temperature (p < 0.01).
Figure 11.5 illustrates the box and whisker plots of ∆HbO2, ∆HHb, and ∆tHb measured
at the forearm by NIRS. Again, ∆HbO2 and ∆tHb significantly decreased during cold
(p < 0.01), while ∆HHb increased. However, the increase in ∆HHb was not statistically
significant (p = 0.06). While the decrease in ∆HbO2 and ∆tHb could be attributed to
vasoconstriction, the increase in ∆HHb, although not significant, was most probably
caused by an increase in muscle oxygen consumption due to shivering in some subjects.
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Figure 11.4: Box and whiskers plot of the means of ∆HbO2, ∆HHb, and ∆tHb measured at the finger by PPG
during cold exposure. (a) ∆HbO2. (b) ∆HHb. (c) ∆tHb. B: baseline; C: cold exposure; R: recovery. Values
were averaged in the central one minute of baseline, last one minute of cold, and last one minute of recovery.
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Figure 11.5: Box and whiskers plot of the means of ∆HbO2, ∆HHb, and ∆tHb measured from the forearm
by NIRS during cold exposure. (a) ∆HbO2. (b) ∆HHb. (c) ∆tHb. B: baseline; C: cold exposure; R: recovery.
Values were averaged in the central one minute of baseline, last one minute of cold, and last one minute of
recovery.
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Figure 11.6: Box and whiskers plot of the means of normalised Flux and skin temperature during cold exposure.
(a) Flux. (b) Skin temperature (c). B: baseline; C: cold exposure; R: recovery. Values were averaged in the
central one minute of baseline, last one minute of cold, and last one minute of recovery. Flux was normalised
with respect to ten seconds of baseline readings.
The decreases in ∆HbO2 and ∆tHb could be attributed to skin vasoconstriction, which
was taking place as soon as the subjects were introduced in the cold room. The severe
vasoconstriction was confirmed by laser Doppler flowmetry and skin temperature read-
ings. Figure 11.6 shows the box and whiskers of the mean changes in Flux and skin
temperature throughout the protocol. During the cold exposure, the Flux significantly
dropped from 1.12 ± 0.18 A.U. in baseline to 0.44 ± 0.22 A.U. (p < 0.01). Similarly,
the skin temperature decreased to 18.62 ± 1.40 ℃ from a baseline of 29.40 ± 1.94 ℃.
11.3.2 Assessment of correlation and trending between PPG and NIRS
As can be seen from Figure 11.3, the haemoglobin concentrations estimated from
the finger by PPG and from the forearm by NIRS indicated similar haemodynamic
variations caused by exposure to cold. The variables of interests followed the same
trends except for deoxygenated haemoglobin (HHb). Correlation analysis between PPG
and NIRS showed a correlation between ∆HbO2 during cold exposure (r = 0.75, 95
% CI: 0.35, 0.92) and recovery (r = 0.68, 95 % CI: 0.19, 0.89). ∆HHb had revealed
a poor correlation between PPG and NIRS during both cold exposure (r = -0.14, 95
% CI: -0.64, 0.44) and recovery (r = -0.08, 95 % CI: -0.66, 0.41). Changes in total
haemoglobin ∆tHb had correlation coefficients of r = 0.61 (95 % CI: 0.12, 0.87) and
r = 0.66 (95 % CI: 0.17, 0.88) respectively for cold exposure and recovery.
Analysis of trending agreement was also performed by four-quadrant plots analysis.
218
11.3. Results
−0.2 0 0.2
−0.2
−0.1
0
0.1
0.2
∆HHb PPG (mM ⋅ cm)
∆H
H
b 
N
IR
S 
(m
M 
⋅
 
cm
)
(b)
−0.5 0 0.5
−0.5
0
0.5
∆HbO2 PPG (mM ⋅ cm)
∆H
bO
2 
N
IR
S 
(m
M 
⋅
 
cm
)
(a)
−0.5 0 0.5
−0.5
0
0.5
∆tHb PPG (mM ⋅ cm)
∆t
H
b 
N
IR
S 
(m
M 
⋅
 
cm
)
(c)
−0.5 0 0.5
−0.5
0
0.5
∆HHb PPG (mM ⋅ cm)
∆H
H
b 
N
IR
S 
(m
M 
⋅
 
cm
)
(e)
−0.5 0 0.5
−0.5
0
0.5
∆HbO2 PPG (mM ⋅ cm)
∆H
bO
2 
N
IR
S 
(m
M 
⋅
 
cm
)
(d)
−1 0 1
−1
−0.5
0
0.5
1
∆tHb PPG (mM ⋅ cm)
∆t
H
b 
N
IR
S 
(m
M 
⋅
 
cm
)
(f)
C = 96.84 % 
r = 0.74
C = 98.65 % 
r = 0.61
C = 29.56 %
r = 0.15
C = 94.32 % 
r = 0.62
C = 43.82 %
r = −0.02
C = 92.16 % 
r = 0.62
Figure 11.7: Four-quadrant plots between ∆HbO2, ∆HHb, and ∆tHb estimated from PPG (finger) and NIRS
(forearm) during cold exposure and recovery. The concordance rate C and correlation coefficients r between the
measures are presented as well. The concordance rate was calculated as the ratio of the number of points in the
first and third quadrant and the total number of points in all quadrants. An exclusion zone of 10 % was used
for the calculation of C. Dashed lines are the line of equality. Grey boxes indicate the 10 % exclusion zone. (a),
(b), and (c) are respectively the four-quadrant plots of ∆HHb, ∆HbO2, and ∆tHb during cold exposure. (d),
(e), and (f) are respectively the four-quadrant plots of ∆HHb, ∆HbO2, and ∆tHb during recovery. Original
signals were resampled every 5 seconds.
Figure 11.7 illustrates the four quadrant plots between ∆HbO2, ∆HHb, and ∆tHb
estimated from PPG and NIRS during cold exposure and recovery. ∆HbO2 and ∆tHb
exhibited good trending concordance during both cold exposure and recovery. However,
∆HHb showed a poor agreement during both stages of the protocol.
11.3.3 Comparison between haemoglobin concentrations from finger
and ear canal
As mentioned earlier, PPG signals were also acquired from a more central location like
the ear canal. The ear canal, being supplied by branches of the carotid artery, is less
affected by vasoconstriction when compared to a peripheral location such as the fingers,
and it has been proved to provide more resilient SpO2 readings than the fingers [93].
The relative haemoglobin concentrations estimated from PPG signals, acquired from
two different locations, should provide a comparative measure of the differences in per-
fusion during exposure to cold temperatures. Therefore, the haemoglobin concentra-
tions estimated from the finger and ear canal were compared in order to test whether
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Figure 11.8: Example of ∆HbO2, ∆HHb, and ∆tHb estimated from ear canal (PPG) and forehead (NIRS) of
four subjects during cold exposure. Each column represent one volunteer. Top row: haemoglobin concentrations
estimated from the PPG measured at the ear canal. Bottom row: haemoglobin concentrations estimated by
NIRS at the forehead. Red traces: ∆HbO2. Blue traces: ∆HHb. Black trace: ∆tHb. Vertical lines represent
the duration of the cold exposure.
the ear canal’s perfusion is less influenced than the fingers during exposure to cold
temperatures. The ear canal PPG sensor comprised of identical optical components
as the finger sensor, therefore facilitating the comparison between the two locations.
The perfusion index (PI) was used to confirm any difference in perfusion at the two
locations.
Figure 11.8 illustrates examples of haemoglobin concentrations estimated from ear canal
PPG signals and simultaneous NIRS measurements from the forehead from four vol-
unteers. ∆HbO2, ∆HHb, and ∆tHb estimated from the ear canal indicated the same
haemodynamic responses measured by NIRS. During exposure to cold, oxygenated
haemoglobin ∆HbO2 and total haemoglobin ∆tHb decreased indicating the onset of
vasoconstriction. Deoxygenated haemoglobin ∆HHb increased in a lower magnitude or
it did not change during the cold exposure.
Figure 11.9, Figure 11.10, Figure 11.11 show the comparative box and whiskers plots of
the mean changes in ∆HbO2, ∆HHb, and ∆tHb from both finger and ear canal. The
∆HbO2 estimated from the finger dropped to -0.103 ± 0.105 mM·cm from baseline,
while the drop in the ear canal was significantly lower (-0.060± 0.030 mM·cm, p = 0.02).
There was no statistical difference (p> 0.05) between changes in deoxygenated haemoglobin
∆HHb from finger and ear canal (-0.004 ± 0.030 mM·cm and 0.007 ± 0.012 mM·cm
respectively) during exposure to cold.
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Figure 11.9: Box and whisker plot of the changes in oxygenated haemoglobin (∆HbO2) estimated from finger
and ear canal during exposure to cold. F: finger; E: ear canal. Values were averaged over the central minute of
baseline, last one minute of cold, and last one minute of recovery.
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Figure 11.10: Box and whisker plot of the changes in deoxygenated haemoglobin (∆HHb) estimated from
finger and ear canal during exposure to cold. F: finger; E: ear canal. Values were averaged over the central
minute of baseline, last one minute of cold, and last one minute of recovery.
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Figure 11.11: Box and whisker plot of the changes in total haemoglobin (∆tHb) estimated from finger and ear
canal during exposure to cold. F: finger; E: ear canal. Values were averaged over the central minute of baseline,
last one minute of cold, and last one minute of recovery.
Similar to ∆HbO2, the changes in total haemoglobin ∆tHb from the finger and ear
canal were different (p < 0.01), with mean drops of -0.120 ± 0.087 mM·cm and -
0.049 ± 0.039 mM·cm for finger and ear canal respectively.
The differences in perfusion (∆HbO2 and ∆tHb) between the two locations were also
verified by measuring the perfusion index. The normalised PI measured at the finger
dropped from 1.00 ± 0.28 A.U. in baseline to 0.34 ± 0.22 A.U. (p < 0.01) during cold
exposure. The PI at the ear canal dropped from 1.04 ± 0.14 A.U. baseline readings
to 0.65 ± 0.28 A.U (p < 0.01) during cold exposure. During exposure to cold, the
perfusion index measured at the finger was lower (p < 0.01) than the perfusion index
measured at the ear canal, suggesting that the perfusion at the ear canal was less
compromised during exposure to cold. Figure 11.12 illustrates the comparative box
and whiskers plot of the mean changes in PI at both locations.
11.3.4 Comparison of muscle and brain TOI and nTHI during expo-
sure to cold
The haemoglobin concentrations estimated from NIRS indicated the changes in perfu-
sion due to exposure to cold. However, these were composed by the mixed contribution
of superficial (skin) and deep structures (muscle/brain). When the light is emitted to
the tissue, the light is detected by a single photodiode for inferring the haemoglobin
concentrations, thus making difficult to distinguish the origins of the signal.
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Figure 11.12: Box and whisker plot of the changes in perfusion index estimated from finger and ear canal
during exposure to cold. F: finger; E: ear canal. Values were averaged over the central minute of baseline, last
one minute of cold, and last one minute of recovery. The perfusion index was normalised with respect to ten
seconds of baseline readings.
Table 11.1: Mean changes (±SD), of TOI, measured at the forehead and forearm, during the cold exposure
protocol. The signals were averaged over the central minute of baseline, last minute of exposure to cold and the
last minute of recovery.
Baseline Cold Recovery
TOIHead (%) 70.31 ± 5.80 68.10 ± 7.17 69.59 ± 5.93
TOIForearm (%) 72.76 ± 5.39 71.04 ± 3.23 72.59 ± 3.26
When the subject was exposed to cold for a relatively short period (i.e. 10 min), the
haemoglobin concentrations underwent significant changes from baseline (Figure 11.3).
Since these changes represent a mixed contribution of different tissue’s structures, anal-
ysis of nTHI and TOI signals would give an insight on the origin of the changes. Dif-
ferently from the haemoglobin concentrations, nTHI and TOI are computed by using
the Spatially Resolved Spectroscopy, providing an assessment of oxygenation and blood
volume of only deep structures, with little contribution of shallower regions such as the
skin [125]. Therefore, the analysis of nTHI and TOI measured at the forehead (brain)
and forearm (brachioradialis) would reveal if exposure to cold caused any significant
change in oxygenation or blood volume in these organs.
Figure 11.13 shows the mean changes in TOI measured at the forehead and forearm
during the protocol. The mean TOI across the subjects had a drop in both brain
and muscle when the volunteers were exposed to a cold temperature. However, these
deoxygenations did not result statistically significant at both locations in the population
investigated (p > 0.05). Table 11.1 summarises the means (±SD) of TOI during all
stages of the protocol (i.e. baseline, cold, recovery).
The nTHI expresses the normalised changes in total haemoglobin, which reflects changes
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Figure 11.13: Mean changes in TOI in all volunteers during the protocol. Values were averaged over the
central minute of baseline, last one minute of cold, and last one minute of recovery. B: baseline; C: cold; R:
recovery.
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Figure 11.14: Mean changes in nTHI in all volunteers during the protocol. Values were averaged over the
central minute of baseline, last one minute of cold, and last one minute of recovery. B: baseline; C: cold; R:
recovery.
in the overall blood volume in the measured area (i.e. brain or muscle). The exposure
to cold caused no significant decrease in nTHI measured at the forearm (p > 0.05). On
the contrary, nTHI originating from the brain had a significant increase from baseline
(p = 0.04). This increase in nTHI may suggest the shifting of blood from vasocon-
stricting peripheries (finger) to a central organ such as the brain. Even though the
decrease in nTHI at the forearm was not statistically significant, the blood volume
increased during recovery (p = 0.01), suggesting a hyperaemic response when normal
room temperature (23 ℃) was restored. Figure 11.14 illustrates the response of nTHI
measured at both locations, while Table 11.2 summarises the mean (±SD) values of
nTHI during the different stages of the protocol.
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Table 11.2: Mean changes (±SD), of nTHI measured at the forehead and forearm during the cold exposure
protocol. The signals were averaged over the central minute of baseline, last minute of exposure to cold and the
last minute of recovery.
Baseline Cold Recovery
nTHIHead (A.U.) 0.99 ± 0.02 1.03 ± 0.07∗ 0.95 ± 0.07
nTHIForearm (A.U.) 1.00 ± 0.02 0.96 ± 0.07 1.05 ± 0.08∗
∗ Significant change from baseline (p < 0.05)
11.4 Summary
This chapter investigated the feasibility of measuring haemoglobin concentrations from
PPG signals during a whole-body cold exposure protocol. PPG sensors were applied
on the finger and ear canal, whereas NIRS sensors were positioned on the forearm and
forehead. The volunteers were moved from a room which was set at a temperature of
23 ℃ to a second room where the temperature was set at 10 ℃.
The haemoglobin concentrations estimated from finger PPGs indicated haemodynamic
changes related to the exposure to a cold temperature. Oxygenated (∆HbO2) and total
haemoglobin (∆tHb) decreased, indicating vasoconstriction, while the deoxygenated
haemoglobin (∆HHb) did not change. ∆HbO2 and ∆tHb estimated from PPG signals
acquired from the finger were in good correlation and trending agreement with the NIRS
measurements from the forearm. However, ∆HHb was not correlated. This difference
between finger PPG and forearm NIRS should be attributed to the shivering occurring
in the muscle during exposure to cold, causing an increase in ∆HHb measured by NIRS.
Haemoglobin concentrations were also estimated from PPG signals measured at the
ear canal and they were compared with finger PPG measurements. The two locations
were compared in order to determine whether the haemoglobin concentration changes
revealed a more reliable perfusion at the ear canal compared to the fingers. There was
a significant difference between ∆HbO2 measured at the two locations. A difference
was also found between ∆tHb. These differences in perfusion indicated by ∆HbO2
and ∆tHb were in agreement with the PPG perfusion index measured from the two
locations.
The response of TOI and nTHI measured by NIRS were also analysed in order to
investigate whether the exposure to cold caused any substantial change in oxygenation
or blood volume in muscle and brain. Although there was a mean decrease in TOI
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11.4. Summary
measured at both muscle and brain, the deoxygenations were not statistically significant
in the population investigated. Cold exposure caused a significant increase in blood
volume (nTHI) in the brain, but it did not cause any significant change in the muscle.
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Chapter12
Discussion
This thesis proposes the utilisation of Photoplethysmography as an alternative nonin-
vasive and continuous technique in monitoring tissue perfusion, by estimating relative
haemoglobin concentrations changes, as currently done in Near Infrared Spectroscopy
(NIRS). The hypothesis is that the continuous DC component of the PPG signal at
two different wavelengths could be employed to extract information on the changes in
haemoglobin content in blood. In order to investigate this, in vivo studies on healthy
volunteers were carried out, in which PPG signals were acquired from various locations
at different haemodynamic interventions.
In order to acquire PPG signals from the forearm and forehead, a reflectance PPG
sensor was designed and developed. The optical components were two red (660 nm)
and two infrared (880 nm) light emitting diodes and a single photodiode. The sensor
comprised a PCB on which the optical components were soldered, and a mechanical
structure that was designed to cover from ambient light and facilitate the attachment
on the skin. In addition, a similar finger PPG sensor, with the same optical compo-
nents, was developed for the simultaneous acquisition of PPG signals from the finger.
Additional sensors, with larger interoptodes distances (i.e. the distance between LEDs
and photodiode) or smaller dimensions, were developed with similar design and manu-
facturing procedures. A research photoplethysmography processing system (ZenPPG)
was employed to drive the sensors and to acquire the currents produced from the pho-
todiode. The ZenPPG was able to drive dual-wavelength PPG sensors and to process
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the PPG signal before the acquisition. The system allowed the acquisition of raw
(AC + DC) PPG signals, the flexibility of sensors customization, and the possibility
to control light intensities. The evaluation of the PPG sensors and processing system
demonstrated that satisfactory raw PPG signals could be acquired. Furthermore, tem-
perature tests showed that the sensor did not produce any harmful overheating when
applied on the skin under maximal working conditions. A software application, devel-
oped in LabVIEW, was used to acquire the signals from the ZenPPG and provided the
interface for controlling LEDs’ light intensities and archive of all acquired physiological
data. The second part of the software application was developed specifically for the ac-
quisition of signals from state of the art devices such as NIRS, laser Doppler flowmetry,
and pulse oximetry. These were used, along with the PPG system, for the measurement
of haemodynamic parameters during the in vivo studies performed in this thesis.
The first investigation on healthy volunteers presented in Chapter 9 described vascular
occlusions on the forearm. The custom-made reflectance PPG sensor and a commercial
NIRS sensor were attached to the left forearm and the responses of PPG and NIRS
were simultaneously acquired. The protocols consisted of different levels of intermittent
vascular occlusions induced by inflation of a cuff pressure positioned around the upper
left arm. This approach was used since it allowed a simple method to induce blood per-
fusion changes in the forearm. Furthermore, this method is commonly used as a first in
vivo evaluation of NIRS instruments, and the changes in haemoglobin concentrations
induced by this procedure are covered in the literature [13, 140, 141, 143, 155]. Rela-
tive concentrations changes in oxygenated (∆HbO2), deoxygenated (∆HHb), and total
haemoglobin (∆tHb) were estimated for the first time from PPG signals by applying the
modified Beer-Lambert law (MBLL) to PPG signals (see Chapter 8). ∆HbO2, ∆HHb,
and ∆tHb estimated from PPG changed accordingly during the different venous or total
occlusions (i.e. combined venous and arterial occlusions). In particular, venous occlu-
sions caused the increase of all the three parameters, while additional occlusions of the
arterial vasculature caused the simultaneous drop of ∆HbO2, increase in ∆HHb, and a
minor increase in ∆tHb. Therefore, the relative haemoglobin concentrations estimated
from PPG showed the ability to differentiate between venous or arterial occlusions.
Furthermore, ∆HbO2, ∆HHb, and ∆tHb from PPG were responsive enough to in-
dicate partial occlusions of the venous circulation induced by low-pressure occlusions
(e.g. 20-40 mmHg). As explained above, the pattern of the changes in haemoglobin
concentrations indicates the typology of haemodynamic change that is occurring (e.g.
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venous or total occlusion). For this reason, correlation analysis was performed between
the changes in ∆HbO2, ∆HHb, and ∆tHb estimated from PPG and the reference NIRS
monitor. There was a high correlation between the haemoglobin concentrations esti-
mated by both techniques during almost all different occlusions. The lower correlation
for ∆HbO2 during the systolic and total occlusions in the second protocol could be
associated with a short recovery time between occlusions. This is also supported by
the good correlation during the total occlusion in the first protocol, in which a longer
recovery between occlusions was allowed. The four-quadrant plot analysis is usually
used to assess the agreement in the direction of change between different measure-
ments of cardiac output [184]. The technique does not consider the magnitude of the
change but it only assesses the agreement in the direction of change by calculating
the concordance index expressed in percentage [184]. Therefore, the four-quadrant
plot analysis provided an additional tool to assess the direction of change, or trend-
ing, of the haemoglobin concentrations from PPG against NIRS measures. There was
good concordance between the two techniques, indicating the trending capabilities of
the haemoglobin concentrations estimated from PPG. Although ∆HbO2, ∆HHb, and
∆tHb from PPG showed comparable trending against NIRS, there were quantitative
differences between the techniques. During both occlusion protocols, there was a con-
sistent underestimation of PPG over NIRS assessed by Bland & Altman plots analysis.
This was probably expected and possible reasons are discussed later in this chapter.
The relative haemoglobin concentrations estimated from PPG were also used to express
oxygenation changes by calculating the ratio of ∆HbO2 over the total haemoglobin
content as expressed by TOI in NIRS. Correlation analysis against TOI showed that
∆HbRatio was able to indicate the oxygenation changes due to blood flow occlusions in
the forearm.
The addition of a laser Doppler flowmetry (LDF) sensor on the forearm, and custom-
made and commercial PPG/pulse oximetry finger sensors, offered for the first time the
possibility of investigating the simultaneous responses of NIRS, LDF, photoplethysmog-
raphy, and pulse oximetry during vascular occlusions. Several studies in the literature
have investigated these modalities, either alone or in pair, for detecting changes in
perfusion and/or oxygenation, or for differentiating between healthy and diseased sub-
jects [35, 38, 39, 41, 75–77, 79, 118, 141, 143, 157, 165, 179–181]. However, to the author’s
knowledge, NIRS, LDF, photoplethysmography, and pulse oximetry have never been
investigated altogether during vascular occlusions, thus providing with this study a
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unique setting for investigating all these techniques simultaneously. Different indexes
were obtained from the different modalities and their changes were simultaneously
recorded and analysed. NIRS (TOI and nTHI) and LDF (Flux) demonstrated to be
able to indicate changes in perfusion and oxygenation during all different occlusions.
However, differentiation between venous or arterial occlusions by LDF may be chal-
lenging since the Flux decreased similarly during both types of occlusions, with values
close to the biological zero of LDF measurements. A very analogous behaviour was
previously observed and reported by Galla et al. [41]. In the literature, it has also
been reported that the decay time of Flux during arterial occlusion is significantly
shorter than venous occlusion, with an abrupt fall subsequent to arterial occlusion and
a gradual decrease during venous occlusion [41, 179]. However, such difference was
not observed in the signals acquired in this thesis. Also, LDF measurements have a
wide inter- and intra-subject variability, thus normalising the Flux with respect to the
baseline, as done in this work, seems to provide an indication of the actual change in
perfusion, with a decrease to half baseline readings being associated with full venous
or total occlusion. The TOI from NIRS significantly decreased in all the occlusions,
whereas the nTHI, expressing blood volume changes, increased in all the venous occlu-
sions, or increased to a lower degree during systolic and total occlusions. Observing
the trends in both TOI and nTHI could provide information for the differentiation of
venous or arterial/total occlusions. The perfusion index (PI) was calculated from in-
frared PPG signals acquired from both forearm and finger. Although there have been
some previous efforts to determine a threshold in PI for indicating the adequacy of
perfusion [80, 83], any inter-subject variability in the measurements was avoided by
normalising the PI to baseline. The PI changed during all occlusions and it reached
almost nil values during arterial/total occlusions. However, there were not significant
changes for partial venous occlusions, thus doubting the sensitivity of the PI on detect-
ing this kind of occlusions. It should also be noted that the PI is strictly dependent
on the amplitude of the pulsatile component. This component of the PPG can change
during gradual occlusions [77], but variations in this component may also depend on
different factors other than vascular occlusions [1, 9]. The arterial oxygen saturation
SpO2 was estimated from forearm and finger PPG signals, as well as acquired from
a reference pulse oximeter attached to another finger. Significant changes in SpO2s
were only noticed at occlusion pressures exceeding 60 mmHg. Similar results have been
observed in previous studies in which these changes in SpO2 were still in the normoxic
230
range of pulse oximetry [77, 118], making difficult to assess venous occlusions by pulse
oximetry. Only the SpO2 estimated from the forearm had major changes during venous
occlusions. This was most probably due to the origin of the PPG signal acquired from
the forearm. The signal was likely to originate from the skin capillaries, where the
arterial blood and venous blood are mixed. This was also confirmed by lower baseline
SpO2s at the forearm compared to fingers. As expected, all the SpO2s failed when the
arterial flow began to be compromised by occlusions close to the volunteers’ systolic
pressure. The response of the light attenuations or optical densities (OD) obtained from
finger DC PPGs may provide an additional indication of venous occlusion when the PI
and SpO2 may not be sufficient. In particular, using the red wavelength PPG (660 nm)
increases the sensitivity to light attenuations due to increases in venous blood volumes
(i.e. venous engorgement). Obtaining direct indication of venous engorgement from the
DC PPG was also observed in previous studies that reported changes in the DC PPG
during venous occlusions [78,79]. The OD estimated from the DC PPG changed during
venous occlusions, and the additional analysis of the slopes of changes demonstrated
that the magnitude of change in OD was directly proportional to the degree of venous
engorgement, with a maximal engorgement in the range 60-100 mmHg.
Overall, correlation and trending analysis between PPG and NIRS showed that PPG
had comparable trending capabilities to NIRS for indicating changes in blood perfusion
and oxygenation during vascular occlusions. These promising results could offer the use
of relative haemoglobin concentrations estimated from PPG for detecting and differen-
tiating vascular perturbations. For instance, in some clinical applications such as the
monitoring of flaps in plastic surgery, the early detection of vascular complications is
essential and could have a significant impact on the patient’s clinical outcomes [27,44].
The comparison between NIRS, LDF, PPG, and pulse oximetry suggests that NIRS and
LDF, differently from conventional PPG and pulse oximetry analysis, may be the most
appropriate measures to indicate changes in blood perfusion and oxygenation during
vascular occlusions. In this context, estimating ∆HbO2, ∆HHb, and ∆tHb from PPG
signals could provide complementary indicators of the changes in perfusion that would
probably be undetected by PI or SpO2 alone.
The bed tilting study allowed the investigation of ∆HbO2, ∆HHb, and ∆tHb from fore-
head PPG measurements. Differently from the mechanical occlusions performed in the
previous study, tilting the bed caused the movement or congestion of blood by gravity.
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Previous studies such as Kurihara et al. have shown how haemoglobin concentrations
and TOI measured by NIRS can reveal changes induced by variations in posture or,
more generally, by gravity [136, 138]. Therefore, the current study wanted to evaluate
if these gravity-induced changes could also be detected by the haemoglobin concen-
trations estimated from PPG signals measured at the forehead. The ∆HbO2, ∆HHb,
and ∆tHb estimated from PPG changed accordingly to the haemodynamic changes
caused by bed tilting. ∆HbO2 increased due to the gravitational difference between
supine and negative tilting. ∆HHb increased as well for the induction of venous blood
engorgement on the upper part of the body, while ∆tHb increased proportionally to
the sum of ∆HbO2 and ∆HHb. The parameters were again compared with reference
NIRS measurements at the forehead. PPG and NIRS correlated highly during the pro-
tocol, whereas trending analysis by four quadrant plots also indicated good agreement
in the direction of change between the parameters estimated from the two techniques.
Again, there were quantitative differences in the magnitude of changes between PPG
and NIRS as assessed by Bland & Altman analysis. Oxygenation changes were assessed
from PPG by estimating ∆HbRatio and comparing it with TOI. The poor correlation
between these two measures suggested a possible autoregulation of the brain in the
presence of tilting. TOI and nTHI are believed to represent respectively deep tissue
oxygenation and blood volumes, with little contribution of extra-cerebral tissues such
as skin. Interestingly, nTHI increased, indicating an increase in blood volume during
tilting. This may suggest that the brain autoregulates its oxygenation (TOI) despite
the blood volume change, but more work is still needed to elucidate this further.
The anatomy of the forehead offered the possibility to investigate the effect of large
vessels on the PPG measurements. An identical reflectance PPG sensor was placed on
top of a large vein on the forehead and ∆HbO2, ∆HHb, and ∆tHb were estimated from
the PPG signals. The responses recorded from the two PPG sensors were compared
in order to assess any difference caused by the presence of a large vein beneath the
sensor. There were no differences in the direction of change between the two locations,
thus apparently not affecting the trending in the presence of a large vessel. However,
there was a significant quantitative difference in ∆HHb between the two locations,
while there was no significant difference for ∆HbO2 and ∆tHb. As expected, this
affected the ∆HbRatio as well, with a significant difference between the two sensors.
It appeared that the vein, containing a larger concentration of deoxygenated blood,
influenced the estimation of ∆HHb. Furthermore, optical modalities such as NIRS
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and PPG suffer from heterogeneity within the sample volume, and large vessels tend
to absorb light abnormally compared to their surroundings [13], and a large vessel
underneath the sensor could affect the optical path [110]. However, it is difficult to
conclude which of these possible effects (i.e. an elevated presence of HHb underneath
the sensor or the optical heterogeneity) contributed most on the measurements in this
work. The influence of the large vein on the SpO2 estimation was also assessed, as
similarly performed by Mannheimer et al. for pulsating arteries underneath the sensor
[110]. As expected, the presence of a large vein beneath the sensor caused a significant
overestimation and a greater variability in the population investigated. During tilting,
the SpO2 measured by both sensors dropped below the baseline. It is believed that this
drop in SpO2 is due to the degradation of the PPG signal with the appearance of cardio-
synchronous venous pulsations (i.e. arterial and venous blood pulsate synchronously,
making impossible to separate them) [111,188,189]. Also, the shifting of venous blood
underneath the sensor (venous engorgement), causes the mixture of arterial and venous
blood, with a consequent drop in SpO2 [188].
Forehead PPG measurements are known for the influence of the venous circulation on
the forehead. While in normal conditions this does not cause any issue, the situation
can be worsened by the position of the patient (e.g. Trendelenburg position) [188,189].
Although elastic headbands have been introduced to overcome this problem, there
have been limited attempts to assess the pressure exerted [188], whereas there are no
measures of the venous presence underneath the sensor. Furthermore, these bands
may not fully solve the problem or may slip of the patient [189]. Monitoring the
relative haemoglobin concentrations from PPG may provide a tool to assess the presence
of venous blood in the volume sampled by the sensor. The main advantage of this
method is that dual-wavelength PPG signals are already measured by the sensor for
the determination of SpO2, thus not requiring any additional sensor or instrumentation.
In the cold study, blood perfusion changes due to cold exposure were investigated. In
addition, the study allowed to explore the changes in ∆HbO2, ∆HHb, and ∆tHb from
other PPG measurements locations such as the finger and the ear canal. The exposure
to a cold temperature environment caused the instantaneous change in blood perfusion
and the onset of vasoconstriction was observed by the quick drop in ∆HbO2 and ∆tHb.
The vasoconstriction of blood supply to the peripheries was reflected by the simultane-
ous drop in the skin temperature and blood flow measured by laser Doppler flowmetry.
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Since changes in ∆HHb mostly correspond to changes in venous blood perfusion, there
were no significant changes in ∆HHb. Comparison with forearm NIRS measurements
revealed a correlation for ∆HbO2 and ∆tHb from finger PPG and NIRS measurements.
Analysis of trending by four-quadrant plots showed a concordant direction of change
between ∆HbO2 and ∆tHb measured by the two techniques. However, ∆HHb from
the fingers had a poor correlation and trending with forearm NIRS. This difference
could be attributed to the different measurement location (finger vs. forearm) and the
penetration depth of NIRS. At the forearm, the NIRS light pathway transverse skin,
adipose tissues, and muscle. While the drops in ∆HbO2 and ∆tHb originate from the
vasoconstriction of the skin, the increase in ∆HHb in NIRS measurements could be as-
sociated with shivering. It is common that during hypothermia, skeletal muscles start
to contract in order to increase the metabolic rate. This increase in metabolic rate
also coincides with the increase in oxygen consumption as depicted by the increase in
∆HHb measured by NIRS. The relative haemoglobin concentrations from PPG were
also used to assess blood perfusion differences between a peripheral (finger) and a more
central location (ear canal). The finger and the ear canal PPG sensors had identical
optical components, thus differences between the two locations could be hypothetically
assessed. Raw PPG signals acquired from the ear were used to infer ∆HbO2, ∆HHb,
and ∆tHb. The ear canal demonstrated to be more resilient to vasoconstriction com-
pared to the finger. The results were also confirmed by comparison of the perfusion
index measured at the two locations and showed that the relative haemoglobin con-
centrations from PPG might be used to compare perfusion measurements between two
locations, similarly to the perfusion index.
The cold study also allowed to assess differences in oxygenation and blood volumes at
the muscle and brain measured by NIRS. Comparison of TOI and nTHI, representing
deep tissue oxygenation and blood volumes, revealed that oxygenation in deep muscle
and brain did not change during exposure to cold temperatures. However, nTHI at the
brain showed a significant increase during cold, which may represent blood volumes
shifts from peripheries to a central organ like the brain. Although these results may
be promising for the assessment of blood flow regulations in the human body by NIRS,
more rigorous studies are still required to investigate this further.
Photoplethysmography and Near Infrared Spectroscopy have very different penetration
depths. Light penetrates in tissue in a banana-shaped trajectory and the depth of the
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path is directly dependent on the wavelength (i.e. scattering is wavelength-dependent)
and the interoptodes distance [24]. The interoptodes distance in PPG usually does not
exceed 7 mm, whereas in NIRS a minimum separation of 2.5 cm is required [23]. There-
fore, the techniques have significantly different penetration depths, with an assumed
penetration of only a few millimetres for PPG, while NIRS has been reported to pene-
trate up to two centimetres into tissue [13,23]. This different penetration depth can be
considered the primary cause of quantitative differences between ∆HbO2, ∆HHb, and
∆tHb estimated by PPG and NIRS. The comparison of the slopes of change in ∆HHb
during venous occlusion and ∆HbDiff during total occlusion, from both PPG and
NIRS, also supported the hypothesis that the techniques interrogate different depths.
In the occlusion and bed tilting studies, the different penetration depth did not cause
any effect on the correlation or trending agreement between parameters, since the per-
turbations induced similar changes as measured by both PPG and NIRS. However, in
the cold study, this difference became more evident and, as explained beforehand, had
primary effects on the changes in ∆HHb. Additional reasons for the quantitative dif-
ferences could also be the different wavelengths adopted in the two techniques and the
different algorithms. It should also be emphasised that PPG cannot be used to replace
NIRS for the assessment of perfusion and oxygenation in deep tissues such as muscle
and brain. If applied transcutaneously, PPG can only measure blood perfusion and
oxygenation in the skin, whereas NIRS would be able to reach deep tissues. However,
monitoring the skin has still several advantages, since global disturbances in the blood
circulation are first seen in the skin while central organs such as brain or kidneys tend
to maintain an adequate blood perfusion and oxygenation [34, 193]. In addition, mon-
itoring skin blood perfusion and oxygenation changes by PPG can be used in certain
clinical applications such as flap monitoring, where the small measurement areas of
these tissues may not provide an adequately large surface for NIRS sensors. Finally, if
deep tissue perfusion and oxygenation is not required, PPG has the main advantage of
being relatively inexpensive, compared to NIRS devices.
So far, the application of the modified Beer-Lambert law to PPG allowed the measure-
ment of relative changes in haemoglobin concentrations from a stable baseline. From
these, only relative changes in oxygenation (∆HbRatio) can be estimated. This novel
work was a pilot investigation of the feasibility of applying NIRS processing to PPG,
therefore the MBLL was used as a first approach. Absolute haemoglobin concentrations
can only be determined by other methods such as Time Resolved Spectroscopy (TRS)
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or Phase Modulated Spectroscopy (PMS), which cannot be applied to conventional
PPG/pulse oximetry measurements due to specific requirements in the instrumentation
adopted in TRS and PMS (e.g. laser light, streak camera, high frequency light modula-
tion, etc.) [11,24,119]. However, by using two photodiodes, the application of Spatially
Resolved Spectroscopy may be investigated in the future as well. Furthermore, NIRS
algorithms assume that oxygenated and deoxygenated haemoglobin are the only light
absorbers present in blood, excluding any contribution of other haemoglobin deriva-
tives. This assumption holds in the great majority of cases, but other haemoglobin
derivatives may be present in critical patients (e.g. subjects who were exposed to and
inhaled high concentrations of carbon monoxide). This, however, can be excluded in
the healthy volunteers that were investigated in this thesis. Since the DPF for the
specific separation distance employed in the PPG sensors employed, the changes in
haemoglobin concentrations have been expressed throughout the thesis as relative to
the light path length (mM × cm). If future studies would determine the DPF values for
short distances, the changes in haemoglobin concentrations could be expressed directly
in concentration units (mM).
Although the studies that were carried out allowed to investigate the proposed aims
of this research, some limitations existed and should be acknowledged. The vascu-
lar occlusions performed were not instantaneous since they were induced by manual
inflation of the cuff. This had an effect in the total occlusions, in which a residual
increase in blood volume was observed at the onset of the occlusion. Unfortunately, it
is not possible to occlude only the arterial vasculature and this could only be achieved
by occluding the venous circulation as well. The occlusion of the arterial vasculature
required occluding the venous circulation first during the occlusion, causing an initial
venous blood engorgement. In the second protocol, the recovery period between inter-
mittent occlusions was probably short. Although the recovery period was identical to
the occlusion time, the short recovery had an impact on the total occlusions, where
the arterial vasculature needed more time to recover fully from the previous occlusion.
However, extending the occlusion and recovery time would have prolonged excessively
the duration of the protocol. In the same study, the finger clip on the custom-made
sensor was exerting a significant pressure on the finger vascular bed. This pressure
did not cause any shortcoming during venous occlusion, but it caused an abnormal
response in the optical densities calculated from finger PPGs during total occlusions.
The absence of arterial inflow in the total occlusions caused the clip to press the blood
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from beneath the measurement area. As a result, the optical densities decreased in-
stead of increasing as expected. The use of a pressure-free clip could have solved the
problem and should be used in future similar studies. In the bed tilting study, it would
have been interesting to investigate the effect of a forehead headband. However, due
to the numerous presence of sensors on the forehead in the current settings, the use of
a headband was rather difficult. Following this preliminary investigation, a forehead
headband could be used to investigate the presence of venous blood during tilting.
Nevertheless, monitoring the applied pressure would be the ideal approach and more
work is still required to develop an instrument capable of doing so.
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Chapter13
Conclusion
This chapter concludes this thesis by summarising the main results and linking these
to the initial aims and objective. Whereas some suggestions for the improvement of
the methodologies used have been given in the previous chapter, final suggestions on
the direction of future work are also given at the end of this chapter.
This thesis aimed to investigate the feasibility of using the DC component of the PPG
signal to infer relative changes in oxygenated (∆HbO2), deoxygenated (∆HHb), and
total haemoglobin (∆tHb), and use these parameters to assess changes in blood per-
fusion. In order to do so, reflectance PPG sensors were designed and manufactured
for the acquisition of PPG signals from different locations and in vivo investigations
in healthy volunteers were carried out. The developed reflectance PPG sensors were
successfully coupled to a PPG processing system and they demonstrated to be able to
acquire dual-wavelength PPG signals. By inducing different changes in perfusion and
by acquiring signals from different measurement locations, the in vivo studies in the
healthy volunteers allowed to investigate the aim in different settings. The limitations
of the single studies have been previously acknowledged in the Discussion chapter, and
it is suggested to consider these for any future similar study.
The modified Beer-Lambert was successfully applied to PPG signals. As mentioned pre-
viously, the absolute haemoglobin concentrations could not be extracted at this point
with the conventional PPG/pulse oximetry instrumentation and the current method
allowed to provide an indication of the changes in perfusion. Similarly to NIRS, the
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trends in the haemoglobin concentrations are most important, since any variation in the
signals could reveal a change in perfusion. Also, it is hoped that future studies would
contribute in determining the DPF for short separation distances of PPG measure-
ments, whereas the application of more sophisticated algorithms may be investigated
as well.
The comparison between the haemoglobin concentration changes estimated by PPG
and NIRS revealed very promising results. During different types of changes in per-
fusion and in different measurement locations, ∆HbO2, ∆HHb, and ∆tHb from PPG
demonstrated to be able to indicate the changes in perfusion similarly as NIRS. As
well as revealing strong similarities between the PPG and NIRS, the comparison also
showed some differences between the techniques. These dissimilarities appeared more
evident during the cold study, where the different volumes of tissues sampled by the
two techniques played a major role in the physiological responses recorded. Similar
investigations in the future may help in further exploring these differences.
The in vivo studies that were carried out in this thesis also allowed the investigation
of some secondary aims. One of these secondary aims was the comparison of some
optical techniques during different levels of vascular occlusions. By comparing NIRS,
LDF, PPG, and pulse oximetry, an insight into the simultaneous responses of the
techniques during vascular occlusion was provided. From the comparison, it appeared
that NIRS and LDF were the most responsive to the full range of vascular occlusions
induced. Future similar comparisons may focus on the diagnostic usefulness of all these
techniques in differentiating between healthy and diseased subjects. Another research
aim that this thesis wanted to address was the investigation on the influence that
large vasculature on the forehead may have on PPG measurements. More specifically,
the influence that a large vein on the forehead may have on PPG measurements was
analysed. The results revealed that a large vein underneath the sensor can cause
a significant difference in the deoxygenated haemoglobin concentration and a large
variability in the measured SpO2. The haemoglobin concentration changes estimated
from PPG also showed to be useful in assessing any difference in perfusion between two
measurement locations, such as finger and ear canal, during exposure to cold. These
results open to new possible applications, in particular, the haemoglobin concentrations
from PPG could be used, similarly to the perfusion index, to reveal any difference in
perfusion between two body locations.
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Future work could focus on the developments of new sensors and improvement of the
current algorithms. The addition of a third wavelength at the isobestic point (either in
the green or near-infrared region) would provide a direct measure of total haemoglobin
concentrations (blood volume), independently from the oxygenation status. Different
wavelength pairing could be investigated as well. As mentioned earlier, the addition
of multiple photodiodes could provide the ability to apply Spatially Resolved Spec-
troscopy. This approach could also lead to the development of multi-distance sensors
incorporating PPG and NIRS measurements into one sensor, with proximal photodi-
odes acquiring PPG signals and distal photodiodes for the assessment of blood perfusion
and oxygenation in deep tissue. Subtraction algorithms could then be applied to iso-
late the contribution from shallower regions. Extensive in vivo or in vitro studies could
focus on the validation of the method against a gold standard measure of haemoglobin
concentrations such as co-oximetry. However, the in vivo evaluation will require the
withdrawal of blood samples, which could only be performed in clinical settings.
Concluding, the novel results presented in this thesis demonstrate that the full capa-
bilities of the PPG signal are still not fully exploited and the range of applications of
this technique may be successfully extended beyond its current limits.
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AppendixA
Multiplexing/demultiplexing code
implementation
The following illustrates the code used to program the microcontroller’s clocks. The
code programs the timing sequence of the multiplexing/demultiplexing cycle by assign-
ing logical states to the microcontroller ports. These, in turn, transmit the sequence to
the control inputs of the multiplexer/demultiplexer. This cycle was divided into three
periods: first wavelength ON, second wavelength ON and dark period (both LEDs
OFF). These periods were then divided into four segments in which the demultiplexing
(sampling) occurred in the two central segments.
/*
* ZENPPG_CLOCKS.c
* Author: Tomas Ysehak Abay
*/
// The code multiplexes the driving currents for the LEDs in ZenPPG.
// The Demultiplex part samples the middle part of the multiplex period.
// The three periods of the cycle (RED ON, IR ON and DARK) are each divided
in four parts
// --> Total of 12 segments.
#include <avr/io.h>
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# define F_CPU 1000000
#include <util/delay.h>
int main(void)
{
DDRD = _BV(DDD1) | _BV(DDD0); // Ports (register D) as outputs
DDRB = _BV(DDB2) | _BV(DDB1) | _BV(DDB0); // Ports (register B) as outputs
// or this version is also possible:
// DDRD = 0x03; // Assign ports (register D) as outputs
// DDRB = 0x07; // Assign ports (register B) as outputs
while(1)
{
int dt1;
dt1 = 104; // Duration of the period. dt1=(1/fs)/12, where fs= 800 Hz.
// First Period (first Wavelength ON)
// 1st segment
PORTD = 0b00000000; // X0(Y0) [ICPOS0 or ICPOS1]
PORTB = 0b00000100;
_delay_us(dt1);
// 2nd segment
PORTD = 0b00000000; // X0(Y0) [ICPOS0 or ICPOS1]
PORTB = 0b00000000; // Demultiplexer: Sampling X0
_delay_us(dt1);
// 3rd segment
PORTD = 0b00000000; // X0(Y0) [ICPOS0 or ICPOS1]
PORTB = 0b00000000; // Demultiplexer: Sampling X0
_delay_us(dt1);
// 4th segment
PORTD = 0b00000000; // X0(Y0) [ICPOS0 or ICPOS1]
PORTB = 0b00000100;
_delay_us(dt1);
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// Second Period (second Wavelength ON)
// 5th segment
PORTD = 0b00000001; // X1(Y1) [ICNEG0 or ICNEG1]
PORTB = 0b00000101;
_delay_us(dt1);
// 6th segment
PORTD = 0b00000001; // X1(Y1) [ICNEG0 or ICNEG1]
PORTB = 0b00000001; // Demultiplexer: Sampling X1
_delay_us(dt1);
// 7th segment
PORTD = 0b00000001; // X1(Y1) [ICNEG0 or ICNEG1]
PORTB = 0b00000001; // Demultiplexer: Sampling X1
_delay_us(dt1);
// 8th segment
PORTD = 0b00000001; // X1(Y1) [ICNEG0 or ICNEG1]
PORTB = 0b00000101;
_delay_us(dt1);
// Third Period (Dark)
// 9th segment
PORTD = 0b00000010; // X2(Y2) [AGROUND]
PORTB = 0b00000110;
_delay_us(dt1);
// 10th segment
PORTD = 0b00000010; // X2(Y2) [AGROUND]
PORTB = 0b00000010; // Demultiplexer: Sampling X2
_delay_us(dt1);
// 11th segment
PORTD = 0b00000010; // X2(Y2) [AGROUND]
PORTB = 0b00000010; // Demultiplexer: Sampling X2
_delay_us(dt1);
// 12th segment
PORTD = 0b00000010; // X2(Y2) [AGROUND]
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PORTB = 0b00000110;
_delay_us(dt1);
}
}
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AppendixB
NIRO 200NX Specifications
Measured Data Oxygenated haemoglobin changes (∆HbO2)
Deoxygenated haemoglobin changes (∆HHb)
Total haemoglobin changes (∆tHb)
Tissue Oxygenation Index (TOI)
Normalised Tissue Haemoglobin Index (nTHI)
Signal Processing Modified Beer-Lambert law (∆HbO2, ∆HHb, and ∆tHb)
Spatially Resolved Spectroscopy (TOI, nTHI)
Light source Light Emitting Diodes
Wavelengths: 735, 810, and 850 nm
Output power: less than 2 mW
Pulse frequency: 1.7 kHz
Spectrum width: < 60 nm
Detection PIN - Si (Silicon) photodiodes
Probe separation distance 3 or 4 cm centre-to-centre distance
Analogue outputs Connector: D-Sub-9-pin (female)
TOI: 0 V to 1 V (corresponding to 0 % and 100 %)
nTHI: 0 V to 5 V (corresponding to 0 and 5 A.U.)
∆HbO2 and ∆HHb: -5 V to +5 V
(corresponding to -1000 µM · cm and +1000 µM · cm)
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